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Summary 
22q11.2 deletion syndrome (22q11.2DS) is a copy number variant syndrome 
affecting approximately 1 in 4000 live births. It has a variable phenotype in terms 
of its physical, cognitive and psychiatric manifestations. People with 22q11.2DS 
have a range of cognitive difficulties. They also have extremely high rates of 
psychopathology, particularly attention deficit hyperactivity disorder, autism 
spectrum disorder, anxiety disorders and psychotic disorders. The mechanisms 
underlying the risks of cognitive impairment and psychopathology are not well-
understood. The balance between excitation and inhibition in the brain may be 
affected in 22q11.2DS and could underlie its cognitive and psychiatric features.  
In this thesis markers of excitatory-inhibitory (E-I) balance were investigated in 
children with 22q11.2DS (probands) and typically developing children (controls). 
It was hypothesised that probands would have alterations in E-I balance and that 
the severity of these alterations would be associated with cognitive and 
psychiatric features. The phenotypes of children taking part in the brain imaging 
study was first compared to those of children who did not participate in brain 
imaging to assess the representativeness of the imaging sample. Resting-state 
brain networks and visually-induced gamma oscillations were then investigated 
using magnetoencephalography (MEG) and gamma-amino-butyric acid (GABA) 
concentrations were investigated using magnetic resonance spectroscopy (MRS). 
Between-group comparisons were performed and the relationships between 
markers of E-I balance, psychopathology and cognitive impairment were explored 
using linear regression.  
The phenotypes of children with 22q11.2DS who participated in brain imaging 
were broadly similar to those who did not participate, suggesting that the imaging 
sample does not represent a highly-functioning subsample. Compared with 
controls, probands had alterations in resting-state networks in the delta, alpha 
and beta bands which were associated with anxiety, social communication 
problems and cognitive deficits. In the gamma band, there were reductions in the 
total induced gamma power in probands, which was similarly associated with 
social communication and cognitive difficulties. There were no alterations in 
GABA concentrations in 22q11.2DS, suggesting that further work is needed to 
better understand the mechanisms underlying excitatory-inhibitory imbalance in 
22q11.2DS. 
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1 Introduction 
1.1 Copy number variants 
1.1.1 What are copy number variants? 
Copy number variants (CNVs) are submicroscopic deletions or duplications of 
segments of chromosomes, which constitute a major source of variation between 
individuals. A high proportion of the genome is subject to copy number variation 
and this can arise both meiotically (in gametes) or mitotically (in somatic cells). 
Each CNV may range in size from 1 kilobase (Kb) to several megabases (Mb). 
Recurrent CNVs occur most often due to non-allelic homologous recombination 
events in which unmatched regions of chromosomes are mistakenly recombined 
during meiosis. These events often occur at regions of low-copy repeats (LCRs). 
LCRs are segmental duplications that occur at several points in the genome and 
are therefore particularly susceptible to genomic rearrangement.  
 
CNVs can be inherited, or may occur de novo. They can be detected using a range 
of different techniques such as fluorescent in-situ hybridization (FISH), array 
comparative genomic hybridization (aCGH), virtual karyotyping with single-
nucleotide polymorphism (SNP) arrays and more recently with next-generation 
sequencing (NGS). 
 
CNVs can result in chromosomes having too many or too few dosage-sensitive 
genes. This may be advantageous, indeed CNVs are thought to be important in 
human evolution, however, they may also have a negative impact on human 
development and disease. Of particular interest for the purpose of this thesis is 
the association between CNVs, neurodevelopmental and psychiatric disorders.  
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Figure 1-1 Copy number variant formation 
The cartoon shows a segmental deletion and duplication, whereby the pair of 
chromosomes in the centre have two copies of genes A-D, the pair on the left have only 
one copy of gene C and the pair of chromosomes on the right have three copies of gene 
C. 
 
1.1.2 What are the associations between copy number variants, 
psychopathology and cognitive impairment? 
It has been shown that the overall burden, size and location of CNVs are 
associated with a broad spectrum of neurodevelopmental and psychiatric 
phenotypes including schizophrenia (International Schizophrenia Consortium, 
2008; Walsh et al., 2008; Kirov et al., 2009), autism spectrum disorder (ASD, (Pinto 
et al., 2010; Griswold et al., 2012; Sanders et al., 2015)), attention deficit 
hyperactivity disorder (ADHD , (Williams et al., 2010; Lionel et al., 2011; Jarick et 
al., 2014)), cognitive impairment (Stefansson et al., 2014; Kendall et al., 2017), 
and developmental delay (Cooper et al., 2011). People with neurodevelopmental 
and psychiatric disorders have a higher burden of CNVs than healthy controls 
(International Schizophrenia Consortium, 2008; Kirov et al., 2009; Pinto et al., 
2010; Williams et al., 2010; Griswold et al., 2012).  In particular, they have higher 
rates of large de novo CNVs (Sebat et al., 2007; Xu et al., 2008; Rees et al., 2011; 
Kirov et al., 2012). Interestingly the presence of CNVs at particular loci is 
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associated with very high rates of neurodevelopmental and psychiatric 
phenotypes. For example, CNVs at eleven distinct loci have been robustly 
associated with schizophrenia risk (Rees et al. 2014a), with a further locus at 
16p12.1 being recently identified (Rees et al., 2016). Table 1-1 shows the 
replicated loci associated with schizophrenia with their reported penetrance 
scores and associated phenotypes (Doherty and Owen 2014). 
 
Table 1-1 Replicated CNV loci associated with schizophrenia  
 
Abbreviations: ID, intellectual disability; ASD, autism spectrum disorder; ADHD, attention 
deficit hyperactivity disorder; OCD, obsessive compulsive disorder. Adapted from Doherty 
and Owen 2014. 
 
As can be seen in table 1-1, individual CNVs do not map onto single disorders on 
a 1:1 basis, rather they seem to confer risk across a spectrum of 
neurodevelopmental and psychiatric disorders as well as intellectual disability. It 
is also interesting to note that the penetrance of individual CNVs is extremely 
Locus Copy number  
change 
Penetrance for  
schizophrenia 
Associations 
 
1q21.1 Deletion/ 
duplication 
5.2/2.9 ID, ASD, ADHD  
2p16.3  Deletion 
 
6.4 ID, ASD 
3q29 Deletion 
 
18.0 ID, ASD 
7q11.2 Duplication 
 
6.0 ID, ASD, ADHD, anxiety  
disorders 
15q11.2 Deletion 
 
2.0 ID, ASD, ADHD, OCD 
15q11-13 Duplication 
 
4.2 ID, ASD 
15q13.3 Deletion 
 
4.7 ID, ASD, ADHD 
16p11.2 Deletion/ 
duplication 
2.6/8.0 ID, ASD, ADHD, mood  
disorders, anxiety disorders 
16p13.11 Duplication 
 
2.2 ID, ASD, ADHD 
17q12 Deletion 
 
4.0 ID, ASD 
22q11.2 Deletion 12 ID, ASD, ADHD, mood disorders,  
anxiety disorders  
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variable, with some CNV carriers exhibiting few or no symptoms, while others are 
severely impaired.  
 
The causes of this phenotypic variability are not well understood but are crucial 
to our understanding of neurodevelopmental and psychiatric risk in specific CNV 
carrying populations and may also give us broader insights into the biological 
mechanisms underlying risk in the general population. One could hypothesise that 
genetic factors (such as the nature, quantity, size and location of deleterious 
genetic variants) and environmental factors (e.g. prematurity, birth trauma, 
substance use and psychosocial stressors) could act together to alter 
neurodevelopmental trajectories, with the timing, severity and anatomical 
location(s) determining the ultimate clinical phenotype. Further investigation 
integrating genetic findings with cellular, animal, clinical and neuroimaging 
research will shed further light on whether such a model is plausible. 
 
 
Figure 1-2 Hypothesised relationship between mutational load, cognitive ability and 
psychopathology 
Abbreviations: ID, intellectual disability; ASD, autism spectrum disorder; SZ, 
schizophrenia; BD/MDD, bipolar disorder/major depressive disorder. Adapted from 
Doherty and Owen 2014. 
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1.2 22q11.2 deletion syndrome 
1.2.1 What is 22q11.2 deletion syndrome? 
22q11.2 deletion syndrome (22q11.2DS), also commonly known as 
velocardiofacial syndrome and Di George syndrome, is one of the most common 
copy number deletion syndromes, affecting at least 1 in 4000 live births (Botto et 
al., 2003; Oskarsdottir, 2004; Maisenbacher et al., 2017). It results from a 1.5-3Mb 
deletion at region q11.2 on chromosome 22. The 22q11.2 region is spanned by 
four low copy repeats (LCR22 A, B, C and D), making it particularly susceptible to 
meiotic error during non-allelic homologous recombination (Morrow et al., 2018). 
The majority of patients diagnosed with 22q11.2DS (90-95%) have de novo 
mutations (McDonald-McGinn et al., 2015), with the remainder inheriting the 
deletion from a parent.  
 
The typical 3Mb A-D deletion is present in ~ 85% of patients (Edelmann, Pandita 
and Morrow, 1999; Shaikh et al., 2000) and affects about 45 known protein coding 
genes, seven miRNA and 10 non-coding genes (Morrow et al., 2018). Nested 
proximal A-B and A-C deletions are less common but are associated with the 
major phenotypic features of the A-D deletion. Distal deletions (B-D or C-D) have 
lower penetrance than the proximal deletions and are more likely to be inherited, 
presumably due to higher reproductive fitness in distal deletion carriers 
(McDonald-McGinn et al., 2015). 
 
As with many CNV syndromes, the 22q11.2DS phenotype is extremely variable, 
involving multiple organ systems. Some of the most common physical 
manifestations include: structural brain abnormalities, seizures, facial 
dysmorphology, velopharyngeal insufficiency, parathyroid dysfunction, immune 
deficiencies, conotruncal cardiac defects, renal and gastrointestinal abnormalities 
(McDonald-McGinn et al., 2015). The mechanisms underlying the variability in the 
physical features of 22q11.2DS are, as yet, not well understood. 
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1.2.2 What is the relationship between 22q11.2 deletion syndrome, 
psychopathology and cognitive impairment?  
As with the physical manifestations, psychiatric, neurodevelopmental and 
cognitive outcomes are extremely variable in 22q11.2DS. Data from increasingly 
large samples of children and adults with 22q11.2DS (including data pooled as 
part of the 22q11.2DS International Brain and Behaviour Consortium (IBBC)) has 
revealed that schizophrenia (and related psychotic disorders), attention deficit 
hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety disorders 
and cognitive impairment are highly prevalent in 22q11.2DS (Swillen et al., 1997; 
Vorstman et al., 2006; De Smedt et al., 2007, 2009; Antshel et al., 2007a; Antshel 
et al., 2007b; Niarchou et al., 2014; Schneider et al., 2014). 
 
Schizophrenia 
Schizophrenia is a severe and enduring mental illness characterized by ‘positive’ 
symptoms (such as hallucinations and delusions), ‘negative’ symptoms (such as 
flattened affect and avolition) and cognitive impairment. In the 1990s, it was 
observed that a very high proportion of adults with 22q11.2DS had schizophrenia, 
and this finding has been consistently replicated (Murphy, Jones and Owen, 1999; 
Monks et al., 2014; Schneider et al., 2014). The clinical features of schizophrenia 
in 22q11.2DS do not differ from those seen in the non-deleted population (Bassett 
et al., 2003; Monks et al., 2014). The current estimate for lifetime prevalence of 
schizophrenia is approximately 25% in 22q11.2DS compared to about 1% in the 
general population (Schneider et al., 2014). Furthermore, Rees et al. (2014a) 
found the prevalence of the 22q11.2 deletion to be 10-20 times higher in patients 
with schizophrenia than the general population. 22q11.2DS is therefore one of 
the strongest known risk factors for schizophrenia. Interestingly, Rees and 
colleagues found that the reciprocal duplication of chromosome 22 was less 
common in patients with schizophrenia than controls, suggesting that it is 
associated with a lower risk of schizophrenia (Rees et al., 2014b). This further 
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highlights the importance of studying this genetic locus to better understand 
resilience as well as risk, and to identify potential novel therapeutic targets. 
 
Since carriers of the deletion are often identified as young children, there has 
been much interest in 22q11.2DS as a high-risk population in which the clinical, 
cognitive and neurobiological antecedents of schizophrenia can be studied. 
Studies of children with 22q11.2DS have found elevated rates of psychotic 
symptoms even in the absence of a schizophrenia diagnosis (Green et al., 2009; 
Baker and Skuse 2005; Gothelf et al., 2007a; Lewandowski et al., 2007; Schneider 
et al., 2014; Chawner et al., 2019). Identification of additional risk factors for 
psychosis in 22q11.2DS would have clear implications for both research and 
clinical practice. 
 
Attention deficit hyperactivity disorder (ADHD) 
ADHD is a childhood-onset neurodevelopmental disorder in which clinically 
significant levels of inattention, hyperactivity and/or impulsivity are present 
across more than one setting to a degree that causes significant impairment. It 
can be divided into three subtypes: inattentive, hyperactive-impulsive or 
combined according to the symptom dimensions that are present. The 
background prevalence of ADHD in the general population is 3.4% (Polanczyk et 
al., 2015). The ADHD rate in 22q11.2DS is considerably higher than that of the 
general population, indeed ADHD is one of the most common childhood mental 
disorders in 22q11.2DS, affecting 37% of children in the IBBC sample. The 
symptoms persist over time with 24% of adolescents and 16% of adults with 
22q11.2DS also meeting diagnostic thresholds for ADHD (Schneider et al., 2014). 
 
Unlike schizophrenia, the clinical presentation of ADHD in 22q11.2DS does seem 
to differ from that of clinically ascertained and population samples (Antshel et al., 
2007b; Niarchou et al., 2015). Children with 22q11.2DS have higher rates of the 
inattentive subtype, higher rates of comorbid anxiety disorders and lower rates 
of oppositional defiant and conduct disorder symptoms than either clinically 
ascertained or population samples (Niarchou et al., 2015). These differences are 
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not accounted for by differences in levels of intellectual disability. Recently an 
association has been found between ADHD and the development of psychotic 
symptoms in 22q11.2DS (Niarchou et al., 2018). This finding merits replication 
but, if confirmed, has important clinical and research implications.   
 
Autism spectrum disorder 
Autism spectrum disorder is a pervasive neurodevelopmental disorder in which 
there are deficits in social interaction and communication as well as patterns of 
restricted and repetitive behaviours. Reported rates of ASD in 22q11.2DS vary 
greatly between studies from 15-50% (Fine et al., 2005; Vorstman et al., 2006; 
Antshel et al., 2007a; Ousley et al., 2017) compared with a population prevalence 
of approximately 1% (Baxter et al., 2015).  
 
Although the high rates of social communication problems are well documented 
in 22q11.2DS, there has been much debate in the literature as to whether these 
difficulties meet strict criteria for a diagnosis of ASD or rather reflect prodromal 
psychotic symptoms, expressive communication problems secondary to 
velopharyngeal insufficiency, deficits in attention shifting or anxiety symptoms 
(Ogilvie et al., 2000; Eliez, 2007; Angkustsiri et al., 2014). A recent study addressed 
this in 22q11.2DS using stringent gold-standard assessment tools - the Autism 
Diagnostic Interview-Revised [ADI-R; (Lord, Rutter and Le Couteur, 1994)] and the 
Autism Diagnostic Observation Schedule [ADOS; (Lord et al., 1989)] - as well as a 
clinician’s best-estimate diagnosis. The authors found that 17.9% of participants 
met criteria for an ASD diagnosis (Ousley et al., 2017), suggesting ASD rates are 
indeed high in 22q11.2DS. Furthermore, another recent study found no 
association between ASD symptoms in childhood and later psychotic symptoms 
in 22q11.2DS, suggesting that social communication problems in 22q11.2DS do 
not reflect prodromal symptoms of schizophrenia (Fiksinski et al., 2017). 
 
Anxiety disorders 
Anxiety disorders are highly prevalent in 22q11.2DS, with high rates of 
generalised anxiety disorder, specific phobia, social phobia, panic disorder, 
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separation anxiety and obsessive compulsive disorder being reported (Angkustsiri 
et al., 2012; Niarchou et al., 2014; Schneider et al., 2014; Stephenson et al., 2015). 
In the pooled IBBC sample, anxiety disorders were prevalent across the age 
spectrum but were particularly common in childhood and adolescence (Schneider 
et al., 2014). Many participants had multiple comorbid anxiety disorders. Anxiety 
disorders have been associated both with mood disorders and schizophrenia in 
22q11.2DS (Gothelf et al., 2007a; Schneider et al., 2014; Stephenson et al., 2015; 
Chawner et al., 2019), with studies finding anxiety symptoms to be predictive for 
the onset of psychotic symptoms at follow-up (Gothelf et al., 2007a; Chawner et 
al., 2019). The presence of anxiety symptoms may therefore be a useful 
prognostic indicator for psychosis risk. 
 
Cognitive impairment  
Children with 22q11.2DS commonly have developmental delay and special 
educational needs. In early childhood, language delay is frequently reported and 
is independent of velopharyngeal problems (Solot et al., 2000). Several studies 
report that IQ follows a normal distribution in 22q11.2DS but is shifted 
approximately 30 points to the left of the general population (Swillen et al., 1997; 
De Smedt et al., 2007; Niarchou et al., 2014). Particular deficits have been found 
in mathematical skills (De Smedt et al., 2009; Woodin et al., 2001) and language 
comprehension (Glaser et al., 2002). Cognitive development in 22q11.2DS is 
variable between individuals with deviant trajectories being reported compared 
with those of the typically-developing population (Duijff et al., 2012; Vorstman et 
al., 2015; Swillen and McDonald-McGinn 2015; Chawner et al., 2017). In the IBBC 
sample, people with 22q11.2DS and a psychotic disorder had lower IQ than those 
without psychosis and a steeper decline in verbal IQ in childhood (Vorstman et al., 
2015). It has been proposed that children with cognitive deterioration may be at 
heightened risk of developing psychosis, suggesting that regular monitoring of 
cognitive ability should be performed and cognitive remediation strategies 
developed (Swillen and McDonald-McGinn 2015; Vorstman et al., 2015). 
However, clear evidence of cognitive deterioration in 22q11.2DS was not 
replicated in a large sample of children with 22q11.2DS who were compared to 
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sibling controls (Chawner et al., 2017), indicating that these suggestions may be 
premature. Clear associations between cognitive ability and other mental 
disorders, for example ASD, ADHD or anxiety, have not been robustly 
demonstrated (Duijff et al., 2012; Niarchou et al., 2014; Chawner et al., 2017). The 
nature of the relationship between cognitive ability and psychopathology remains 
to be elucidated due to the lack of large, adequately controlled longitudinal 
studies with adequate follow-up periods. 
 
1.2.3 How does 22q11.2 deletion syndrome confer risk of psychopathology 
and cognitive impairment? 
The mechanisms by which 22q11.2 deletion increases risk of psychopathology and 
cognitive impairment are still not well understood. The 22q11.2 region contains 
about 60 genes but as yet no gene or combination of genes has been found to be 
either necessary or sufficient for the neurodevelopmental, psychiatric or 
cognitive phenotype. People with the deletion have only one copy of the genes 
within the deleted region (hemizygosity). It may be that reduced dosage of one or 
more genes in the region (haploinsufficiency) leads to the clinical manifestations, 
although other possibilities such as the unmasking of a recessive allele and 
position effects are also possible.  
 
While there are many interesting candidate genes in the region - including 
PRODH, COMT, DGCR8 and TBX1 - none of these has been convincingly implicated 
as the sole factor underlying the increased risk of neurodevelopmental, 
psychiatric or cognitive phenotypes. It therefore remains possible that the 
increased risk of mental disorders and cognitive impairment is conferred by the 
impact of the deletion on more than one and possibly several genes.  
 
Another possibility is that sets of functionally related genes (sometimes known as 
pathways) are particularly impacted by 22q11.2DS and other pathogenic CNVs. A 
recent pathway analysis across different CNVs has pointed to the role of synaptic 
genes influencing the balance of cortical excitation and inhibition in psychiatric 
risk, implicating both glutamatergic and GABAergic neurotransmission 
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(Pocklington et al., 2015). This is an attractive model, since alterations in 
excitatory-inhibitory balance have been reported in idiopathic schizophrenia, 
ADHD and ASD, and therefore may help to explain the overlapping symptoms 
experienced by people with 22q11.2DS, though which gene or genes in the 
22q11.2 region are implicated in these pathways remains unclear. 
 
1.2.4 Why does 22q11.2 deletion syndrome have a pleiotropic outcome? 
There has been much interest in what factor or factors influence the variable 
neurodevelopmental, psychiatric and cognitive outcomes seen in 22q11.2DS. As 
outlined above, the majority of patients with 22q11.2DS (85%) have a 3Mb 
deletion, whilst approximately 10% have a nested 1.5Mb deletion. It could be that 
the size of the deletion influences phenotypic outcome. While few studies have 
identified significant differences in the psychiatric phenotype between those with 
a 1.5 or a 3Mb deletion, a recent collaborative brain imaging study did find 
structural brain differences between carriers of the 1.5 and 3Mb deletions (Sun et 
al., 2018). Furthermore, another recent study using data from the IBBC found that 
carriers of the A-D deletion had poorer cognitive performance than A-B carriers 
(Zhao et al., 2018).  
 
Another possibility is that “second hits” from CNVs outside the 22q11.2 region 
may affect phenotypic expression. The overall burden of rare CNVs (>200Kb) 
outside the 22q11.2 region has been associated with intellectual disability in 
22q11.2DS (Jensen et al., 2018). Additional CNVs have also been associated with 
schizophrenia risk in 22q11.2DS. Bassett and colleagues used a large dataset from 
the IBBC and found that although overall CNV burden was not associated with 
schizophrenia in 22q11.2DS, people with 22q11.2Ds and schizophrenia had more 
rare duplications overlapping genes from nervous system gene sets (Bassett et al., 
2017).  
 
Genomic studies have clearly indicated the polygenic nature of psychiatric and 
neurodevelopmental disorders. In schizophrenia, for example, about a quarter of 
the genetic variance is captured by the combined effects of many hundreds of 
12 
 
common SNPs (Lee et al., 2012), and it is now possible to assay this using the 
polygenic risk score approach. People with schizophrenia and known pathogenic 
CNVs have been found to have an excess burden of common risk alleles compared 
with controls (Tansey et al., 2016; Bergen et al., 2018), but interestingly, 
schizhoprenia cases with risk CNVs had lower polygenic risk scores than cases 
without risk CNVs suggesting an interaction between polygenic risk scores and 
pathogenic CNVs. In people carrying risk CNVs, the polygenic risk score is 
diminished relative to the effect size of the CNV. In people with 22q11.2 deletions, 
little additional polygenic risk was required in schizophrenia cases (Bergen et al., 
2018). Further analysis of polygenic risk in 22q11.2DS is being conducted in the 
IBBC sample and should yield interesting results.   
 
The effects of environmental factors have not yet been the focus of much 
research in 22q11.2DS, but studying the interaction between genes and 
environment in this at-risk group will be crucial to our understanding of pleiotropy 
and also of environmental risk factors for neurodevelopmental and psychiatric 
disorders more generally. As larger samples are collected and combined in large 
international collaborations, some of these questions can start to be addressed. 
 
As one of the strongest known risk factors for mental disorders, 22q11.2DS is a 
useful model in which to investigate mechanisms underlying risk of 
psychopathology. As yet the mechanisms underlying increased risk across the 
diagnostic spectrum are not well understood but are the focus of much research. 
Furthermore, as there is extensive pleiotropy, 22q11.2DS offers the opportunity 
to investigate modifiers of risk and to explore the overlaps between traditional 
categorical diagnoses. Much more data are needed to explore predictors of risk, 
including clinical symptoms and intermediate phenotypes, for example 
neuroimaging abnormalities. 
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1.3  Neuroimaging 
1.3.1 Why use neuroimaging to study 22q11.2 deletion syndrome? 
The brain is a relatively inaccessible organ, making it challenging to study the 
impact of genetic syndromes on its structure and function and to relate this to 
clinical and cognitive phenotypes. In recent years, there have been tremendous 
advances in neuroimaging technology, providing a unique window to brain 
mechanisms underlying risk of neurodevelopmental and psychiatric disorders. 
Cross-sectional comparisons between people with 22q11.2DS and controls enable 
differences in brain structure and function to be detected, while longitudinal 
neuroimaging studies can track these differences over time. These studies may 
help to identify neural markers that could be used to predict which CNV carriers 
are most at risk across the spectrum of neurodevelopmental and psychiatric 
pathologies. This information would be valuable not only to those with 
22q11.2DS, but would also provide important insights into disease mechanisms in 
idiopathic neurodevelopmental and psychiatric disorders, potentially leading to 
advances in diagnosis, prognosis and treatment.  
 
1.3.2 What neuroimaging tools are available to investigate 22q11.2 deletion 
syndrome? 
Magnetic resonance imaging 
Magnetic resonance imaging (MRI) is a non-invasive neuroimaging technique that 
can be used to probe both brain structure and function. It principally uses a strong 
static magnetic field, radiofrequency pulses and magnetic gradients to alter the 
spins of protons within water molecules in the body. Energy that is released by 
protons when they return to their original state can be detected by an MRI 
receiver coil. Using different sequences to exploit different properties within the 
signal, detailed information about brain morphology, white matter 
microstructure, neurochemical composition and blood flow can be ascertained.  
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Structural MRI creates images from the signal generated by the varying relaxation 
times of protons in different tissues. This signal conveys both spatial and contrast 
information. Structural MRI can be used to look for discrete abnormalities of brain 
structure (qualitative studies), to study the volume or density of particular brain 
regions (region-of-interest (ROI) studies), to measure volume and density of the 
whole brain (e.g. voxel-based morphometry, VBM (Ashburner and Friston, 2000)) 
or surface structure such as cortical folding and thickness (e.g. Freesurfer (Dale, 
Fischl and Sereno, 1999)).  
 
Diffusion MRI uses diffusion-sensitising magnetic field gradients to measure the 
displacement of water molecules in brain tissue. Displacement that occurs equally 
in all directions (e.g. in the cerebrospinal fluid (CSF)) is described as isotropic while 
displacement that occurs preferentially along a particular axis is known as 
anisotropic. In white matter, the diffusion of water molecules is constrained and 
occurs preferentially along the axis of white matter bundles. Studying the relative 
anisotropy of different brain regions or between individuals gives useful 
information about white matter microstructure (Jones 2008).  
 
Functional MRI (fMRI) relies on the blood oxygen level dependence (BOLD) signal 
to infer information about brain activity in particular brain regions (Logothetis, 
2003). When a region in the brain is active, the ratio of oxygenated to 
deoxygenated blood increases. Oxygenated and deoxygenated blood have 
different magnetic properties. Oxygenated blood interferes with the MRI signal 
less than deoxygenated blood which results in improved signal in areas with 
increased blood flow.  
 
Magnetic resonance spectroscopy (MRS) allows measurement of endogenous 
brain metabolites non-invasively. MRS detects radiofrequency signals that arise 
from hydrogen nuclear spins within metabolites. These signals have specific 
frequencies depending on the chemical environment of the nuclei. Experiments 
can be tailored to isolate particular signals from the resulting spectrum in brain 
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regions of interest, for example to investigate neurotransmitter concentrations 
(Agarwal and Renshaw, 2012).  
 
Nuclear imaging  
Nuclear imaging techniques such as single photon emission computed 
tomography (SPECT) and positron emission tomography (PET) use radioactive 
tracers attached to molecules of interest, which are injected intravenously. When 
these tracers decay, gamma rays are released and can be detected by SPECT and 
PET systems. Nuclear imaging techniques can be used to study brain metabolism 
(e.g. using [18F] fluorodeoxyglucose) and neurotransmitter systems (e.g. using 
[11]C-flumazenil which binds to benzodiazepine receptors) relevant to mental 
disorders and cognitive function (Newberg et al., 2011; Frankle et al., 2015; 
Bakker et al., 2018).   
 
Electroencephalography and magnetoencephalography 
Electroencephalography (EEG) is a non-invasive technique that uses highly 
sensitive electrodes to detect real-time electrical activity in the brain. When 
neurons fire synchronously, they generate electrical currents that can be 
measured using electrodes placed on the scalp. The source of this current is 
populations of closely-aligned and synchronously firing cortical pyramidal 
neurons (Kirschstein and Köhling, 2009; Cohen, 2017). EEG studies can be 
performed at rest, during sleep or during experimental tasks. EEG has excellent 
temporal resolution, however as EEG signals are affected by the conductance of 
the scalp and skin, source localization and therefore spatial resolution is limited 
compared to other techniques such as magnetoencephalopgraphy (MEG) and 
MRI.  
 
MEG also detects neuronal activity in the brain. However, rather than detecting 
electrical activity directly, superconducting quantum interference devices 
(SQUIDs) detect the small magnetic fields generated by the synchronous 
postsynaptic currents from populations of pyramidal neurons, being most 
sensitive to currents that are tangential to the cortical surface (Hari and Salmelin, 
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2012). As with EEG, MEG can be used to record brain activity during rest, sleep 
and experimental tasks. MEG has a significant advantage over EEG in being able 
to localize the sources of neuronal activity more precisely using techniques such 
as beamforming because, unlike the electrical signals measured with EEG, the 
magnetic field signals measured with MEG pass through the skull and scalp 
without any distortion. MEG is also sensitive to external magnetic fields and 
therefore MEG equipment has to be housed in a magnetically shielded room. MEG 
is relatively insensitive to signals from deep sources and sources parallel to the 
cortical surface. 
 
The rhythmic neuronal activity patterns commonly measured in EEG or MEG 
experiments are known as neural oscillations. These oscillations can occur 
spontaneously in resting-state paradigms or in response to a stimulus or task. 
Stimulus-related responses can either be evoked or induced. Evoked responses 
are both time- and phase-locked to the stimulus and are thought to arise from 
bottom-up sensory processing. Induced oscillations on the other hand, are time- 
but not phase-locked to the stimulus and are thought to reflect higher order 
processes (David, Kilner and Friston, 2006). Oscillatory responses (spontaneous or 
in response to stimuli) occur at different frequencies and are typically grouped 
according to the following characteristic frequency bands; delta (1-4Hz), theta (4-
8Hz), alpha (8-12Hz), beta (12-30Hz) and gamma (>30Hz). Low frequency 
oscillations are thought to reflect long-range synchronisation between different 
brain regions whereas higher frequencies reflect synchronisation in local 
networks (Schnitzler and Gross, 2005). 
 
1.3.3 What have neuroimaging studies revealed about brain structure and 
function in 22q11.2 deletion syndrome? 
Structural magnetic resonance imaging studies  
MRI studies in 22q11.2DS have identified qualitative differences between people 
with 22q11.2DS and controls. These include midline anomalies such as cavum 
septum pellucidum and cavum vergae (Chow et al., 1999; van Amelsvoort et al., 
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2001; Shashi et al., 2004), polymicrogyria (Ghariani et al., 2002; Ehara, Maegaki 
and Takeshita, 2003; Sztriha et al., 2004), pachygyria (Ehara, Maegaki and 
Takeshita, 2003; Koolen et al., 2004), ventricular enlargement (Chow et al., 1999) 
and white matter hyperintensities (van Amelsvoort et al., 2001; Chow et al., 
2002). These studies demonstrate widespread structural abnormalities in 
22q11.2DS and suggest that early cortical development and neuronal migration 
may be disrupted in the syndrome.  
 
Quantitative neuroimaging studies of 22q11.2DS have employed both region-of-
interest (ROI) and whole-brain (e.g. voxel-based morphometry (VBM)) 
approaches to better characterise brain structure in deletion carriers. Cross-
sectional studies report overall reductions in total grey and white matter volume 
in 22q11.2DS, with differences between 22q11.2DS and controls being most 
marked in the white matter (Eliez et al., 2001; Kates et al., 2001). A number of 
studies have found regional volume differences between people with 22q11.2DS 
and controls. A meta-analysis of these studies reported significant volumetric 
reductions of the hippocampus and cerebellum in 22q11.2DS, while conversely, 
the volume of the corpus callosum was increased in 22q11.2DS (Tan et al., 2009). 
Recent evidence suggests that the effects of 22q11.2 rearrangements on brain 
volume are dependent on gene dosage. A study comparing people with 22q11.2 
deletions, duplications and healthy controls found that 22q11.2 gene dosage 
varied positively with intracranial, grey and white matter volumes. Subcortical 
differences were also seen - 22q11.2 duplication carriers had a significantly larger 
right hippocampus but smaller right caudate and corpus callosum than 22q11.2 
deletion carriers (Lin et al., 2017).  
 
Cortical thickness and surface area have been measured in several small studies 
of 22q11.2DS with somewhat discrepant findings (Bearden et al., 2007; Bearden 
et al., 2009; Schaer et al., 2009; Jalbrzikowski et al., 2013). A recent large-scale 
collaborative effort by the ENIGMA 22q11.2 working group 
(enigma.ini.usc.edu/ongoing/enigma-22q-working-group) aimed to address some 
of these inconsistencies by pooling data from ten sites to give a sample of 474 
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people with 22q11.2DS and 315 controls. This study found that people with 
22q11.2DS had thicker cortical grey matter overall but focal thinning in temporal 
and cingulate regions. Surface area was reduced in 22q11.2DS with the biggest 
reductions seen in those with the 3Mb compared with the 1.5Mb deletion (Sun et 
al., 2018).  
 
Abnormal patterns of gyrification have also been reported in 22q11.2DS. 
Reductions in cortical complexity have been found in the frontal and parietal lobes 
(Schaer et al., 2006; Srivastava, Buonocore and Simon, 2012) and increased 
complexity in the occipital lobe (Bearden et al., 2009). Interestingly Schaer et al. 
(2009) found an association between a history of congenital heart disease and 
gyrification of the parieto-temporal-occipital junction suggesting a role for 
haemodynamic factors in the structural brain abnormalities seen in 22q11.2DS.  
 
Overall, cross-sectional structural imaging findings suggest a deviant 
developmental trajectory in 22q11.2DS affecting many different brain regions. 
However, identifying reliable and reproducible imaging biomarkers for 
neurodevelopmental and psychiatric disorders in 22q11.2DS requires longitudinal 
studies in large samples scanned before the onset of symptoms and followed-up 
for a sufficient period of time in order to differentiate between those who go on 
to develop psychopathology and those who do not. Such designs also have the 
advantage of controlling for many confounding variables that affect cross-
sectional designs such as the effects of psychotropic medication. Longitudinal 
studies of 22q11.2DS are currently underway and several reports have already 
been published, albeit in modestly sized samples with relatively short follow-up 
periods. Longitudinal studies to date have focused on associations between brain 
development and psychosis rather than other neurodevelopmental outcomes 
such as ASD and ADHD, which would require the recruitment of infants and young 
children. 
 
The first longitudinal study of 22q11.2DS used structural neuroimaging data from 
a small cohort of children with 22q11.2DS (n=29) who were followed-up five years 
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later (Gothelf et al., 2007b). Reduction in grey matter volume in the left dorsal 
prefrontal cortex predicted the severity of psychotic symptoms at follow-up. The 
magnitude of this change was related to COMT genotype and to change in verbal 
IQ (VIQ). Using multivariate pattern analysis, the authors were subsequently able 
to predict risk of psychotic symptoms with >94% accuracy (Gothelf et al., 2011). 
A larger study of young people with 22q11.2DS, siblings and community controls 
found that reduction in temporal lobe grey matter volume and VIQ predicted the 
presence of positive psychotic symptoms at three-year follow-up (Kates et al., 
2011). In the third published longitudinal study in 22q11.2DS, Flahault and 
colleagues (Flahault et al., 2012) compared hippocampal development between 
people with 22q11.2DS and controls, again over a three-year period. They did not 
find any significant differences in hippocampal development between the groups, 
however the size of the hippocampal head at baseline was associated with the 
presence of hallucinations at follow-up. Longitudinal changes in cortical 
complexity in 22q11.2DS have also been studied. Kunwar and colleagues (Kunwar 
et al., 2012) found that longitudinal change in gyrification of the left occipital 
region was negatively correlated with positive prodromal symptoms. 
 
Although these studies suggest longitudinal associations between regional brain 
volumes, gyrification patterns and psychotic symptoms, replication in larger 
samples and over longer time periods will be necessary in order to determine 
whether the same regional variations in childhood can reliably predict the 
development of psychotic disorders in adulthood. If this can be demonstrated, in 
addition to informing our understanding of the pathophysiology of schizophrenia, 
serial structural scanning has the potential to provide valuable prognostic 
information for clinicians and families. Data on the relationships between 
22q11.2DS and other neurodevelopmental outcomes are currently lacking but 
would be interesting to investigate in future studies with infants and young 
children using suitably adapted brain imaging procedures.  
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Diffusion MRI studies 
Studies of white matter microstructure using diffusion tensor imaging techniques 
have found widespread differences between people with 22q11.2DS and controls 
including abnormalities of the white matter pathways connecting the frontal and 
temporal lobes, limbic structures and fronto-occipital connections (Barnea-Goraly 
et al., 2003; Simon et al., 2005, 2008; Sundram et al., 2010; da Silva Alves et al., 
2011; Kikinis et al., 2012; Radoeva et al., 2012; Ottet et al., 2013; Villalon-Reina et 
al., 2013; Jalbrzikowski et al., 2014; Perlstein et al., 2014; Roalf et al., 2017; Tylee 
et al., 2017; Nuninga et al., 2017). Furthermore, graph theoretical approaches 
have been employed, using data from both structural and diffusion MRI, providing 
preliminary evidence for alterations in the structural organisation of brain 
networks in 22q11.2DS (Ottet et al., 2013).   
 
White matter abnormalities have been associated with psychopathology and 
cognitive impairment in several DTI studies of 22q11.2DS (Da Silva Alves et al., 
2011; Jalbrzikowski et al., 2014; Kates et al., 2015; Nuninga et al., 2017; Olszewski 
et al., 2017; Roalf et al., 2017; Tylee et al., 2017). These studies have found 
associations between the severity of psychotic symptoms and atypical white 
matter microstructure in a number of regions including the inferior longitudinal 
fasciculus (da Silva Alves et al., 2011; Jalbrzikowski et al., 2014; Olszewski et al., 
2017; Tylee et al., 2017), inferior frontooccipital fasciculus (Olszewski et al., 2017), 
uncinate fasciculus (Perlstein et al., 2014; Roalf et al., 2017), internal capsule 
(Perlstein et al., 2014) and cingulum (Kates et al., 2015; Roalf et al., 2017). These 
studies also found that alterations in matter microstructure were associated with 
visuospatial awareness (Simon et al., 2008) and cognitive decline in 22q11.2DS 
(Nuninga et al., 2017). 
 
Functional MRI studies  
FMRI studies have investigated both task-based and resting-state BOLD responses 
in people with 22q11.2DS. Task-based fMRI studies have found abnormal 
activation patterns across a number of task conditions in 22q11.2DS including 
working memory (Kates et al., 2007; Azuma et al., 2009; Harrell et al., 2017), face 
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processing (Andersson et al., 2008), reward processing (van Duin et al., 2016), 
emotion regulation (Coman et al., 2010) and self-referential processing 
(Schneider et al., 2012). Studies of resting state functional connectivity in 
22q11.2DS have found differences between people with 22q11.2DS and controls 
across several networks including the default-mode, sensorimotor, visuospatial, 
self-referential and visual networks (Debbané et al., 2012; Scariati et al., 2014; 
Schreiner et al., 2014; Padula et al., 2015; Mattiaccio et al., 2016). Atypical 
connectivity in the default-mode network in 22q11.2DS has been associated with 
thought disturbance (Mattiaccio et al., 2016), executive function (Debbané et al., 
2012) and social competence (Schreiner et al., 2014) in 22q11.2DS. The 
relationship with prodromal psychotic symptoms is less clear with one study 
reporting an association (Debbané et al., 2012) and another study by the same 
research group failing to replicate this (Padula et al., 2015). However, overall 
these studies provide further evidence for alterations in brain networks in 
22q11.2DS. 
 
Magnetic resonance spectroscopy  
To date there have been relatively few neurochemical imaging studies in 
22q11.2DS. Da Silva Alves and colleagues (da Silva Alves et al., 2011) used MRS to 
measure cortical neurometabolite concentrations between 22 adults with 
22q11.2DS and 23 healthy controls. While there were no between-group 
differences in metabolite concentrations between those with 22q11.2DS and 
controls, the 12 people with 22q11.2DS and a schizophrenia diagnosis had 
significantly higher concentrations of glutamate/glutamine (Glx) in the 
hippocampal region compared to the 10 participants with 22q11.2DS and no 
schizophrenia diagnosis. This is an interesting finding as abnormalities of the 
glutamatergic system have been implicated in schizophrenia. However, the 
sample size in this study was small and all those with a schizophrenia diagnosis 
were taking antipsychotic medication, potentially confounding the results. In 
another MRS study, Shashi and colleagues (Shashi et al., 2012) studied a sample 
of 26 children with 22q11.2DS and found that compared to 23 matched controls, 
their absolute levels of N-acetylaspartate (NAA, a marker of cortical maturation) 
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were significantly elevated in the dorsolateral prefrontal cortex. Higher NAA levels 
were associated with poorer global functioning and higher rates of ADHD. These 
studies provide very preliminary evidence for abnormalities of neural metabolite 
concentrations in 22q11.2DS but replication in larger samples and across different 
age ranges is warranted to confirm these findings and to investigate their 
relationship with neurodevelopmental outcomes. 
 
Nuclear imaging  
People with 22q11.2DS have reduced dosage of the COMT gene, which encodes 
an enzyme responsible for the degradation of dopamine. Dopaminergic pathways 
have been implicated in schizophrenia, so it has been hypothesised that 
disruption to dopaminergic systems may underlie risk of psychosis in 22q11.2DS ( 
(Boot et al., 2010, 2011; Gothelf et al., 2014). Vingerhoets et al.  used SPECT with 
123I-labelled iodobenzamide ([123I]IBZM) to measure striatal dopamine D2/3 
receptor binding potential between people at clinically-defined ultra-high risk for 
psychosis, people with 22q11.2DS and controls. All participants were 
antipsychotic and psychostimulant naïve. There were no significant between-
group differences in dopamine D2/3 receptor binding potential suggesting that if 
dopamine dysregulation does play a role in mediating psychosis risk in 22q11.2DS, 
the pathology may be presynaptic (Vingerhoets et al., 2018). 
 
Electrophysiology  
EEG has been used in several studies to investigate neuronal activity in 
22q11.2DS. Comparison between resting state networks in patients with 
schizophrenia, people with 22q11.2DS and healthy controls found abnormalities 
of salience and resting-state networks in both the schizophrenia and 22q11.2DS 
groups suggesting that EEG microstates might constitute a marker for 
schizophrenia (Tomescu et al., 2014). Abnormal responses to auditory and visual 
stimuli have also been reported in 22q11.2DS (Baker et al., 2005; Zarchi et al., 
2013; Larsen et al., 2018a; Larsen et al., 2018b; Rihs et al., 2013; Biria et al., 2018). 
Several studies have focused on auditory mismatch negativity (MMN) responses 
in 22q11.2DS. This is a brain response to change detection and abnormalities in 
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MMN responses have previously been reported in schizophrenia (Catts et al., 
1995; Michie, 2001; Umbricht and Krljes, 2005; Näätänen and Kähkönen, 2009). 
Baker and colleagues found that, compared with controls, people with 22q11.2DS 
had reduced auditory MMN responses in frontal regions. Two other groups failed 
to replicate these between-group differences (Zarchi et al., 2013; Larsen et al., 
2018b), however, Zarchi et al. did find that MMN amplitude was associated with 
positive and negative psychotic symptom scores. Abnormal auditory steady-state 
responses have also been found in 22q11.2DS (Larsen et al., 2018b) with a 
reduction in gamma oscillations being reported in people with the deletion. 
Finally, visual processing deficits have been found in an EEG study using an illusory 
contour task (Biria et al., 2018). In this study, activity in the occipital cortex was 
significantly different between people with 22q11.2DS and controls in both the 
early and late stages of visual processing. These electrophysiological studies 
support evidence from structural and functional MRI of cortical network 
dysfunction in 22q11.2DS. 
 
1.4 Excitatory-inhibitory balance 
1.4.1 What is excitatory-inhibitory balance? 
Cortical excitability reflects the balance between excitation and inhibition in brain 
networks. These networks consist of different types of neurons that each have a 
role in maintaining this homeostatic balance. These can be broadly divided into 
excitatory neurons which use glutamate as their primary neurotransmitter and 
inhibitory neurons which mainly use gamma-aminobutyric acid (GABA). 
Glutamatergic neurons are the most abundant neuronal type in the neocortex 
and are predominantly pyramidal neurons that either synapse locally or project 
to distant targets in the cortex, brainstem or deep subcortical regions (Somogyi 
et al., 1998). GABAergic interneurons constitute about 20% of cortical neurons 
and these project locally to regulate neuronal activity. Both types of neurons are 
further subclassified based on their properties and connections (Markram et al., 
2004; Sugino et al., 2006).  
 
24 
 
The prefrontal and sensory cortices consist of narrow radial arrays of neurons 
known as minicolumns which are the basic units of signal processing and have 
been linked to both sensory processing and working memory (Rao and Ballard, 
1999; Opris and Casanova, 2014). The activity of pyramidal cells is tightly 
regulated within and between adjacent minicolumns by the action of inhibitory 
interneurons. The integration of excitatory and inhibitory activity can control and 
stabilise network responses. Disruption of synaptic integration in minicolumns 
could therefore lead to abnormal cortical excitation (Hansel and Sompolinsky, 
1996; van Vreeswijk and Sompolinsky, 1996; Tatti et al., 2017). 
 
As well as being linked synaptically, glutamate and GABA are linked metabolically, 
with glutamate being the metabolic precursor to GABA, which in turn is recycled 
to synthesise glutamate (Rowley et al., 2012). Alterations in neurotransmitter 
synthesis and metabolism could therefore also affect excitatory-inhibitory (E-I) 
balance in favour of either enhanced or reduced excitatory output. 
 
Local cortical synchronisation requires balanced communication between 
excitatory and inhibitory neuronal populations and there are many possible ways 
that this balance could be perturbed. For example, abnormalities in excitatory or 
inhibitory cell structure, migration, receptor density or function, and 
neurotransmitter synthesis or metabolism could alter the balance between 
excitation and inhibition. Suboptimal balance between local excitation and 
inhibition may also disrupt the formation of long-range connections via 
feedforward mechanisms, which would in turn reduce reciprocal feedback and 
top-down control of the signal to noise ratio in local cortical circuits (Kessler et al., 
2016). This could lead to diverse cognitive psychiatric and neurological 
manifestations depending on the brain regions affected as well as environmental 
and contextual factors. 
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1.4.2 How can excitatory-inhibitory balance be investigated?  
Animal studies have used optogenetics (a method that uses light to modulate 
neuronal activity selectively and precisely) to disrupt E-I balance and explore the 
subsequent effects on behavior and neuronal circuit properties. In the first of 
these experiments, Sohal et al. showed that inhibiting parvalbumin-containing 
(PV+) inhibitory interneurons suppressed high frequency neural oscillations in the 
gamma range, while driving these neurons generated gamma frequency activity. 
Gamma frequency modulation of excitatory activity enhanced signal transmission 
by increasing signal to noise ratio within cortical circuits (Sohal et al., 2009). In a 
second experiment, Yizhar et al. used optogenetics to elevate E-I balance in the 
medial prefrontal cortex of freely moving mice and recorded multiunit activity and 
local field potentials before and after elevation. They found that this manipulation 
increased high frequency and reduced low frequency oscillatory activity as well as 
affecting the animals’ behavior (Yizhar et al., 2011). These rodent studies 
measured oscillatory activity using invasive techniques. While such approaches 
would not be possible in human studies, electrical activity can be measured non-
invasively using EEG and MEG, as described above.  
 
Animal studies of neurotransmitter concentrations have also employed invasive 
techniques, such as microdialysis (Castro et al., 2014). Accessing the 
glutamatergic and GABAergic neurotransmitter systems non-invasively in humans 
presents some challenges. While plasma concentrations can be assayed, these do 
not give insight into cortical concentrations, particularly since these transmitters 
do not readily cross the blood-brain barrier. PET/SPECT studies require the 
injection of radioligands that bind to receptors of interest in the brain. While some 
ligands for GABA and glutamate receptors are available (Delforge et al., 1993; Fu 
et al., 2018), these tracers typically have short half-lives, meaning that an on-site 
cyclotron is necessary and experiments may be lengthy and involve multiple 
injections, limiting their use in non-clinical studies of children. The most non-
invasive method available for assaying GABA and glutamate concentrations in 
children is MRS. However, due to their relatively low concentrations in the brain, 
large voxels and spectral-editing techniques need to be used to dissociate GABA 
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and glutamate signals from overlapping and more abundant metabolites (Puts 
and Edden, 2012).  
 
1.4.3 What is the evidence for excitatory-inhibitory imbalance in 
neurodevelopmental disorders? 
It has been proposed that the core features of many neurodevelopmental and 
psychiatric disorders including schizophrenia, ASD and ADHD can result from 
disruptions in E-I balance. Evidence for this comes from a number of sources. In 
schizophrenia for example, genetic studies have converged on the role of the 
synapse in psychosis risk (Hall et al., 2015) and pathway analysis has implicated 
both glutamatergic and GABAergic signaling (Pocklington et al., 2015). 
Postmortem studies have identified a reduction in pyramidal cell dendritic spine 
density in schizophrenia (Glantz and Lewis, 2000; Sweet et al., 2009) as well as 
reduced expression of GAD67 in PV+ inhibitory interneurons (Volk et al., 2000; 
Hashimoto et al., 2003). The amplitude of gamma oscillations has also been found 
to be reduced in patients with schizophrenia using EEG and MEG (Kwon et al., 
1999; Wilson et al., 2008) and alterations in both glutamate and GABA 
concentrations have been reported in MRS studies (Yoon et al., 2010; Marsman 
et al., 2014).  
 
In ASD, genetic studies also implicate synaptic genes (Weiss, 2009; Gilman et al., 
2011). Postmortem studies in ASD have found increased dendritic spine density 
on pyramidal cells (Hutsler and Zhang, 2010), lower numbers of PV+ inhibitory 
interneurons in the prefrontal cortex (Zikopoulos and Barbas, 2013), reduced 
GAD65 and GAD67 levels (Fatemi et al., 2002; Yip, Soghomonian and Blatt, 2007) 
and alterations of GABAA and GABAB receptors (Collins et al., 2006; Oblak, Gibbs 
and Blatt, 2010). Electrophysiological studies have reported atypical gamma band 
responses in people with ASD (Stroganova et al., 2015; Sun et al., 2012) and a 
SPECT study found reduced accumulation of the GABAA receptor ligand I-123 
iomazenil (Mori et al., 2011). MRS studies in ASD have shown equivocal results for 
glutamate concentrations between people with ASD and controls (Page et al., 
2006; DeVito et al., 2007; Bernardi et al., 2011; Brown et al., 2013; Hassan et al., 
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2013; van Elst et al., 2014; Horder et al., 2018). However, MRS studies of GABA 
have reported consistent reductions in ASD (Harada et al., 2011; Gaetz et al., 
2014; Rojas et al., 2014). 
 
There has been less evidence for E-I imbalance in people with ADHD. Genetic 
studies have provided some evidence for the role of glutamatergic pathways in 
ADHD (Elia et al., 2012). MRS studies have found lower Glx  concentrations in the 
basal ganglia, anterior cingulate cortex and medial prefrontal cortex of adults with 
ADHD (Perlov et al., 2007; Dramsdahl et al., 2011; Maltezos et al., 2014) but 
higher Glx concentrations in the frontal lobes of children with ADHD (MacMaster 
et al., 2003; Courvoisie et al., 2004; Moore et al., 2006). MRS studies of GABA 
concentrations have found reductions in both children and adults with ADHD 
(Edden et al., 2012; Bollmann et al., 2015; Schür et al., 2016). Interestingly, 
patients treated with stimulant medication in childhood had lower baseline levels 
of GABA than those who were first treated in adulthood, and higher responsivity 
to stimulant challenge with increased GABA concentrations being found after 
administration of methylphenidate (Solleveld et al., 2017).  There is also 
preliminary evidence for reduced gamma band activity in adults with ADHD which 
increased after administration of stimulant medication (Wilson et al., 2012).  
 
1.4.4 Is there evidence for excitatory-inhibitory imbalance in 22q11.2 
deletion syndrome? 
As discussed above, 22q11.2DS is associated with pleiotropic outcomes. In terms 
of psychopathology, the range of disorders most commonly reported in 
22q11.2DS include those which have been associated with E-I imbalance. This, 
coupled with the finding that 22q11.2DS is associated with a number of seizure-
related disorders, including epilepsy, leads one to hypothesise that people with 
22q11.2DS may be at increased risk across this spectrum of disorders due to the 
effects of the 22q11.2 deletion on E-I balance. 
 
There are several lines of evidence that suggest that E-I balance may be perturbed 
in 22q11.2DS. Firstly, deficiency in PRODH, a gene in the 22q11.2 region, has been 
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shown to affect GABA synthesis and gamma band activity in murine models 
(Crabtree et al., 2016). Secondly, these models have also found abnormal PV+ 
inhibitory interneuron migration in 22q11.2DS, a finding that is mirrored in 
postmortem studies of humans with 22q11.2DS (Kiehl et al., 2009; Meechan et 
al., 2009; Mori et al., 2011; Meechan et al., 2012; Piskorowski et al., 2016).  
 
Despite this evidence, few studies have directly investigated markers of E-I 
balance in people with 22q11.2DS. Advances in human electrophysiological 
techniques such as EEG and MEG offer the opportunity to investigate patterns of 
neuronal oscillations that are thought to be driven by E-I balance, in particular by 
the action of the PV+ GABAergic interneurons that have abnormal density, 
morphology and migration patterns in 22q11.2DS (Meechan et al., 2009, 2012; 
Piskorowski et al., 2016). As described above, a recent EEG study of cortical 
responses to auditory stimulation suggests that these oscillatory patterns are 
indeed atypical in 22q11.2DS (Larsen et al., 2018a) but this has not been 
replicated under other experimental conditions and in other brain regions. 
Furthermore, the effects of 22q11.2DS on longer-range brain networks has not 
yet been explored. Recent advances in neurochemical imaging now enable 
measurement of both glutamate and GABA in vivo. Two previous studies have 
reported on glutamate/glutamine concentrations in 22q11.2DS but to my 
knowledge, there have been no published studies of GABA concentrations in 
22q11.2DS. 
 
1.5 Summary, rationale and objectives 
22q11.2DS is a copy number variant syndrome associated with high rates of 
cognitive impairment and psychopathology across the age spectrum. It has a 
pleiotropic outcome and, as yet, the mechanisms underlying this pleiotropy are 
not well understood. A number of different neuroimaging methods have been 
employed to investigate 22q11.2DS. These have found evidence for abnormal 
brain structure and function in 22q11.2DS which has been associated with some 
of the phenotypic outcomes of the disorder. However, as yet, these 
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methodologies have not given clear mechanistic insight into the neural pathways 
underlying risk or resilience in 22q11.2DS. One potential mechanism which has 
not received much attention in brain imaging studies of 22q11.2DS to date is E-I 
balance. The work presented in this thesis aims to address this gap in our current 
knowledge by investigating markers of E-I balance in children with 22q11.2DS and 
investigating how these relate to psychopathology and cognitive impairment.  
 
The overall objectives of this thesis are: 
 
1. To compare the following markers of excitatory-inhibitory balance between 
children with 22q11.2DS (probands) and children without neurodevelopmental 
CNVs (controls): 
 
x Resting-state neural oscillatory patterns using MEG 
x Visual gamma oscillations using MEG 
x Occipital GABA concentrations using MRS 
 
2. To investigate associations between these markers, psychopathology and 
cognitive function. 
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2 General methodology 
An overview of the methods relevant to the subsequent experimental chapters 
are outlined in this section. Detailed information about the neuroimaging analysis 
pipelines is described separately in each experimental chapter. 
 
2.1 Participants and procedures 
Participants were recruited from the ongoing Experiences of people with copy 
number variants (ECHO) study at Cardiff University 
(https://www.cardiff.ac.uk/mrc-centre-neuropsychiatric-genetics-
genomics/research/themes/developmental-disorders/echo-study-cnv-research). 
This is a longitudinal study of people with CNVs which commenced in 2010. People 
over the age of six years old with 22q11.2DS or other neurodevelopmental CNVs 
were recruited to the ECHO study from clinical genetics services located across 
the United Kingdom, from charities (including Max Appeal, Unique and the 
22Crew) and from self-referral via the ECHO study website and social media 
pages. Where applicable, an unaffected sibling over the age of six years old was 
also invited to take part. For families with more than one unaffected child, those 
closest in age to the affected child(ren) were invited to participate. CNV status 
was confirmed by medical reports from NHS medical genetics laboratories and, 
where possible, blood and saliva samples were collected for microarray testing in 
the laboratory of the Division of Psychological Medicine and Clinical 
Neurosciences (DPMCN). 
 
The brain imaging study commenced in 2013. Families taking part in the ECHO 
study with children aged between 10-17 years old were contacted by letter, 
telephone or email and asked if they would like to receive an information booklet 
about the research. Once families had received this booklet, further contact was 
made by telephone or email to ask if they had any questions about the study and 
if they wished participate. Potential participants and their accompanying parents 
or carers then underwent rigorous safety screening by telephone to identify 
potential contraindications for neuroimaging. Any concerns identified during 
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screening were discussed with radiographers and laboratory managers at Cardiff 
University’s Brain Research Imaging Centre (CUBRIC). When necessary, and with 
the consent of the participant and their parents or carers, medical information 
was sought from their responsible clinician (e.g. paediatrician, cardiologist or 
general practitioner) to determine whether it was safe for the child to take part 
in the study. 
 
Families who wished to take part in the brain imaging study were invited to visit 
Cardiff at a time convenient to them. Prior to recruitment into the study, written 
informed consent was obtained from either parents, carers or participating 
children depending on the child’s age and their capacity to provide consent. 
Children under the age of 16 years old or those over the age of 16 years old who 
lacked capacity to consent for themselves were asked to complete an assent form. 
Recruitment for the study was carried out in accordance with protocols approved 
by South East Wales National Health Service (NHS) Research Ethics Committee.  
 
Families were given the option to complete the ECHO study’s questionnaires, 
psychiatric and cognitive assessments (see below) during their visit to Cardiff or 
at another time (e.g. during a separate home visit or by telephone). Typically, 
families spent 1-2 days in Cardiff but on some occasions (e.g. when there were 
multiple affected family members), up to five days were required to complete 
scans, questionnaires and assessments. 
  
2.2 Brain imaging  
Neuroimaging data were collected at CUBRIC. This facility was upgraded and 
relocated during the data collection period and while the same MEG system was 
migrated during this move, the MRI scanner was replaced. Between March 2013 
and August 2016 data were collected on a 3T General Electric HDx MRI system (GE 
Medical Systems, Milwaukee, WI) and from August 2016 to February 2018 a 3T 
Siemens Prisma MAGNETOM MRI system (Siemens, UK) was used. MRS data were 
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collected using the GE system only, however, T1 structural MRI data for the co-
registration of MEG data were acquired on both MRI systems. 
 
2.2.1 MEG session 
MEG data were collected using a CTF-275 MEG system enclosed within a shielded 
room. Participants were given plenty of time to become familiar with the MEG 
environment and had time to practise each task before data recording 
commenced. If requested and if no contraindications were present, a parent 
could accompany their child in the shielded room during recordings for 
reassurance. Participants were monitored throughout the recordings and 
experiments were terminated early if participants wished to stop or if they were 
observed to be uncomfortable or moving excessively. Participants were offered a 
break between recordings. 
 
Participants and, where applicable, their accompanying parent or carer removed 
all metallic items prior to entering the shielded room. Children with refractive 
errors were offered MEG compatible glasses to wear during recordings. Head coils 
were positioned 1cm above the nasion and 1cm in front of each tragus. Where 
tolerated, EOG electrodes were placed around the eyes to record eye blinks and 
eye movements during the recordings. Stimuli were presented on a Mitsubishi 
Diamond Pro 2070 monitor or PROPixx LCD projector (1024 x 768 pixel and 100Hz 
frame rate (monitor) or 120Hz frame rate (projector)). Data presented in the 
thesis will be based on recordings made at rest and during the presentation of a 
static visual grating. 
 
In the resting-state experiment, participants were instructed to focus on a red 
fixation point presented in the centre of the screen on a mean luminance 
background for five minutes. During the visual task, a static vertical square-wave 
grating pattern with maximum contrast and a spatial frequency of three cycles 
per degree was presented on a mean luminance background with a red central 
fixation point. The grating pattern was located in the centre of the display with 8˚ 
x 8˚ of visual angle and was presented for 1.5-2 seconds followed by a rest period 
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of 2 seconds in which only the fixation point was presented. Children were 
instructed to press a response button as soon as the stimulus disappeared. They 
were given 0.75 seconds to make this response. If no response was detected, a 
warning message appeared on the screen. The session contained 100 trials and 
took approximately eight minutes to complete. Data quality and head motion 
were monitored during the MEG session and recordings were repeated if 
necessary and with the consent of the participant and their family. I collected the 
majority of the MEG data presented in this thesis with the assistance of colleagues 
from the ECHO field team and experienced MEG operators. 
 
2.2.2 MRI session 
Participants and their families were invited to visit the ‘mock’ scanner before the 
MRI session commenced. The ‘mock’ scanning suite aims to reproduce the MRI 
environment but as the scanner does not contain a magnet, it is a safe even for 
those with contraindications for MRI. During the ‘mock’ scanning session, children 
were invited to lie in the scanner and listen to audio recordings of real scanner 
noises. The aim of this session was to familiarise young people and their families 
with the MRI environment in order to alleviate anxiety. 
 
For the MRI session, parents were invited to accompany their children into the 
scanning suite if they wished to do so and if they did not have any 
contraindications for MRI. Children and their accompanying parent or carer 
(where applicable) were asked to remove any loose metal items and change into 
alternative clothing if necessary (e.g. surgical scrubs). Participants were able to 
watch a movie of their choice during the session. Children with refractive errors 
were offered MRI compatible glasses to wear during scanning. MRI data were 
collected by experienced MRI operators at CUBRIC. I was present throughout the 
majority of the scanning sessions, screening participants, demonstrating the mock 
scanner and chaperoning the family.  
 
T1 structural images were acquired with a 3D fast spoiled gradient echo (FSPGR) 
sequence on the General Electric system (TR=7.8ms, TE=3.0ms, voxel size = 1mm 
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isotropic) and a 3D magnetization prepared rapid acquisition gradient echo (MP-
RAGE) sequence on the Siemens scanner (TR=2.3ms , TE=3.06ms voxel size = 1mm 
isotropic). MRS data were collected using a Mescher-Garwood point resolved 
spectroscopy [MEGA-PRESS; (Mescher et al., 1998)] sequence (TR=2000ms, 
TE=68ms) with a 3cm x 3cm x 3cm voxel placed in the midline of the occipital lobe. 
Gaussian editing pulses (duration = 16ms) were placed at either 1.9ppm (ON) or 
7.5ppm (OFF) to produce GABA edited spectra. Data were visually inspected after 
acquisition and the sequence was repeated if data quality was poor and the 
participant consented to repeating the scan. 
 
2.3 Psychiatric assessment 
Psychiatric assessments were conducted by trained researchers from the ECHO 
field team under the supervision of experienced psychologists and psychiatrists 
by means of semi-structured interviews with primary carers using the Child and 
Adolescent Psychiatric Assessment [CAPA; (Angold et al., 1995)] and the Autism 
Diagnostic Interview-Revised [ADI-R; (Lord, Rutter and Le Couteur, 1994)]. In 
addition, psychotic experiences were assessed through child-report using the 
psychosis section of the Child CAPA.  Interviews were audio-taped for monitoring 
purposes. As a clinical member of the study team, I was conducted a small 
proportion of these assessments, double coded interviews and reviewed 
diagnoses, particularly when there was diagnostic uncertainty.  
 
The CAPA is a semi-structured interview which assesses the presence or absence 
of a broad range of psychiatric symptoms in the three months preceding the 
interview. The interview does not cover symptoms of ASD so these were assessed 
separately using the ADI-R. The ADI-R assessed ASD symptomatology across three 
domains: reciprocal social interaction, communication and language, and 
restricted and repetitive stereotyped interests and behavior. Unlike the CAPA 
which focusses on the last three months, the ADI-R focusses on both current 
behavior and developmental history.  
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Diagnostic  criteria were applied to the CAPA interview scores using the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition - Text Revision [DSM-
IV-TR; (American Psychiatric Association, 2000)] to establish diagnoses. Diagnostic 
algorithms were applied to the ADI-R scores for ASD diagnosis.  
 
The DSM-IV-TR has mutual exclusivity rules, for example under these criteria ASD 
and ADHD cannot be co-diagnosed. However, it is now recognised that these 
disorders are highly comorbid in people with 22q11.2DS (Niarchou et al., 2014) 
and in the general population (Leitner, 2014), so for the purposes of this study, 
mutual exclusivity rules were not applied. Psychotic experiences (e.g. 
hallucinatory experiences or abnormal beliefs) were recorded as being present if 
they were reported by either the parent or child. Total symptom scores were 
generated by counting the number of symptoms present for the most prevalent 
DSM-IV-TR diagnoses identified by the CAPA for use in the regression analyses. 
ADI-R algorithm items were used to derive ASD symptom scores. 
 
2.4 Cognitive assessment 
Cognitive assessments were performed by trained researchers from the ECHO 
field team. I received training in the administration and scoring of these measures 
and conducted a small number of assessments during the study period.  
 
Global cognitive ability was assessed using the Wechsler Abbreviated Scale of 
Intelligence [WASI; (Wechsler, 1999)]. This comprises four subtests: vocabulary, 
similarities, block design and matrix reasoning. The vocabulary subtest requires 
the participant to define pictures or words and the similarities subtest assesses 
the participant’s ability to express the similarity between objects and concepts. 
Verbal IQ (VIQ) is derived from these subtests. In the block design subtest, the 
participant has to replicate a geometric pattern using coloured cubes within a 
predetermined time limit. Matrix reasoning involves completing patterns by 
choosing between five possible options. These subtests measure performance IQ 
(PIQ). Full scale IQ (FSIQ) is calculated from the scores on all four subtests. Ratings 
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were made by two independent researchers who were blind to deletion status. 
Raw scores were converted to age-adjusted t-scores for each of the four subtests 
according to normative sample tables in the WASI manual. Final FSIQ, VIQ and PIQ 
scores were calculated by transforming the additive total of the age-adjusted t-
scores from the four subtests. The resulting score distributions had a mean of 100 
and a standard deviation of 15.  
 
The Wisconsin Card Sorting Test [WCST; (Heaton et al., 1993)] was used to assess 
executive function. In this task, participants match response cards to stimulus 
cards without being explicitly told the matching rule. After ten correct responses, 
the rule is changed. Failure to respond to this change is recorded as a 
perseverative error. The total number of perseverative errors is used as a measure 
of set-shifting ability. Raw scores were transformed to age-adjusted standardised 
scores according to WCST normative sample tables. The resulting distibutions had 
a mean of 100 and a standard deviation of 15.  
 
The Cambridge Neuropsychological Test Automated Battery (CANTAB; Cambridge 
Cognition Limited, UK, 2006) is a computerised touch screen platform with which 
tasks assessing different cognitive domains can be administered. The Spatial 
Working Memory (SWM) task measures spatial working memory aspects of 
executive function. This task requires the participant to locate a blue token hidden 
in one of several coloured boxes. Once a token has been found in a particular box, 
it will not appear in that location during the next round. The outcome measure is 
the number of times the participant revisits a box in which a token has been 
previously found. The Stockings of Cambridge (SOC) task measures the spatial 
planning aspect of executive function. In this task the participant is shown two 
displays each with three coloured balls which are stacked in suspended stockings. 
They must use the balls in the lower panel to copy the pattern in the upper panel. 
The outcome measure is the number of times they complete the problem in the 
minimum number of moves possible. The 5-choice Reaction Time (RTI) task is a 
measure of processing speed in which participants hold down a press pad until a 
yellow spot appears in one of five locations on the screen. When they see the 
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spot, they release the pad and tap it. The time taken to release the pad is recorded 
as the reaction time. The Match to Sample (MTS) task measures visual attention. 
A patterned stimulus appears in the centre of the screen. Similar patterns are then 
displayed in boxes around the edge of the screen. The participant must identify 
the matching pattern. The number of correct responses is recorded as their score. 
The Rapid Visual Processing (RVP) task is a measure of sustained attention. Digits 
between 2 to 9 are presented on the screen. Participants are instructed to 
respond when the digits 3, 5 and 7 appear in a row. The outcome measure is 
sensitivity to the target sequence. With the exception of the MTS data, all CANTAB 
scores were transformed to age-adjusted scores according to CANTAB normative 
sample tables. CANTAB standardised scores were calculated as a z-score with a 
mean of zero and a standard deviation of one. As no normative data are available 
for the MTS data, raw scores were used for this task. 
 
For all cognitive tasks used in the results chapters that follow, higher scores 
indicate better cognitive performance. 
 
2.5 Questionnaires 
Questionnaires were given to parents or carers of participating children during 
their brain imaging visit or were sent separately by post. The questionnaire pack 
included questions about family background (e.g. maternal education and 
household income), ethnicity and general health. The questionnaire packs also 
included the Social Communication Questionnaire [SCQ; (Rutter, Bailey and Lord, 
2003)], a 40-item questionnaire which is derived from the ADI-R and is designed 
to be completed by parents and carers to identify behaviours that may indicate 
an ASD diagnosis.  
 
2.6 Data analysis 
2.6.1 Data cleaning and preprocessing 
After data collection, MEG data were downsampled to 600Hz, stimulus markers 
were added and data were epoched. Epoched data were then imported into the 
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data analysis package DataEditor for preprocessing. Each dataset was recorded in 
3rd order mode to reduce noise artefact. In addition, data were filtered by 
removing the direct current (DC) offset. Each trial was manually inspected for 
artefacts. Trials containing artefacts were removed from the dataset by labelling 
these trials as ‘bad’.  
 
Structural MRI data were downloaded from CUBRIC servers and imported into the 
package MRIViewer. Structural MRI and MEG data were co-registered by marking 
the locations of the nasion and bilateral preauricular fiducials on the participant’s 
MRI scan. Where a participant was unable to have an MRI scan (e.g. due to 
contraindications) or where the MRI data quality was too poor for co-registration, 
a suitable alternative MRI scan was identified by matching the distances between 
the participant’s fiducial locations with those of another participant. MEG data 
were subsequently analysed using in-house analysis pipelines based around the 
FieldTrip package (Oostenveld et al., 2011). These will be described in detail in 
Chapters 4 and 5. 
 
MEGA-PRESS data were downloaded from CUBRIC servers. Voxel locations were 
checked using the package FSLView (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FslView) 
to confirm their location in the occipital cortex. MRS data were subsequently 
analysed using the Gannet toolkit (version 2.0, www.gabamrs.com) in MATLAB 
(version R2015a, MathWorks).  The MRS analysis pipeline is described in detail in 
Chapter 6. 
 
Demographic, psychiatric and cognitive data were coded and inputted into 
databases created and maintained by the ECHO field team. Data relevant to each 
chapter were cleaned, scored and exported into R studio (version 1.1383 for Mac, 
www.rstudio.com) for statistical analysis together with variables extracted from 
the neuroimaging analysis pipelines.  
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2.6.2 Statistical analyses 
The data distributions for each variable of interest were checked using Shapiro-
Wilk’s test of normality. Between-group differences for normally-distributed data 
(e.g. age) were analysed using parametric statistical tests e.g. t-tests. Non-
normally-distributed data (e.g. psychiatric diagnoses and WCST scores) were 
analysed using non-parametric statistical tests e.g. chi-squared tests or Fisher’s 
exact tests (for categorical variables) and Mann-Whitney U tests (for continuous 
data). Linear regression was used to explore the relationships between brain 
imaging measures, cognitive function and psychopathology as well as to examine 
the effects of covariates and potential confounders. Brain imaging variables were 
included as dependent variables in the regression models while cognitive and 
psychiatric variables were included in the models as independent variables. 
Dependent variables that were not normally distributed were transformed using 
Tukey’s Ladder of Powers and transformed into z-scores with a mean of zero and 
a standard deviation of one before inclusion in the regression models. The effects 
of covariates on the relationships between dependent and independent variables 
were assessed in a hierarchical manner. The variables that were included as 
covariates were age, gender and handedness. 
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3 Sample phenotype 
3.1 Summary 
22q11.2DS is associated with high rates of psychopathology and cognitive 
impairment but the phenotype is highly variable. Many of the phenotypic features 
of 22q11.2DS pose barriers to participation in research, particularly 
neuroimaging. A history of surgery involving implanted metal, dental prostheses, 
learning difficulties, anxiety, hyperactivity and hypersensitivity to noise are some 
of the issues that are common in children 22q11.2DS and which can be 
challenging for neuroimaging research.  
 
The aim of this chapter was to characterise the sample of children with 22q11.2DS 
(probands) who participated in the brain imaging study study (n=39) and to 
compare their demographic, psychiatric and cognitive profile to controls (n=26) 
and to probands taking part in research at Cardiff University (the ECHO study) but 
who did not participate in brain imaging (n=32).  
 
In line with existing literature in 22q11.2DS, probands had poorer cognitive ability 
than controls and higher rates of psychopathology. Anxiety disorders, ADHD and 
ASD were the most common diagnoses in the proband group. Probands who 
participated in the brain imaging study had higher IQ scores and better sustained 
attention scores than probands who did not participate. There were no 
statistically significant differences in the burden of psychopathology between 
proband groups. Mothers of participating probands had higher educational 
attainment than mothers of those who did not. These findings suggest that the 
cohort of children participating in the brain imaging studies described in Chapters 
4, 5 and 6 of this thesis are broadly representative of the wider ECHO cohort and 
do not represent an atypical subgroup of children with 22q11.2DS. 
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3.2 Introduction 
22q11.2DS is associated with a variable phenotype in terms of psychopathology, 
cognition and physical health. There are high rates of psychopathology across the 
lifespan, with the most common presentations in the age range of interest for the 
present study (10-17 years old) being ADHD, ASD and anxiety disorders (Niarchou 
et al., 2014; Schneider et al., 2014). These are conditions that present particular 
challenges in neuroimaging research as they can potentially affect a participant’s 
ability to tolerate the scanning environment and remain adequately still for good 
quality data to be obtained.  
 
The IQ distribution in 22q11.2DS has been found to follow a normal distribution 
that is shifted approximately 30 points to the left of the typically developing 
population (Niarchou et al., 2014; Chawner et al., 2017). This means that some 
children with 22q11.2DS may have difficulties in comprehending instructions, 
communicating responses and performing tasks, which could also limit their 
ability to participate in brain imaging, particularly task-related functional imaging 
studies.   
 
Children with 22q11.2DS also have high rates of physical health problems that 
may prevent participation in MRI and MEG studies. For example, congenital 
cardiac defects are highly prevalent and are often the initial indication for referral 
to clinical genetics services. Surgical intervention for such defects and other 
22q11.2-related physical health problems (such as scoliosis) can involve devices 
and implants that are either not safe (or are not known to be safe) in 3T MRI 
environments, or could cause large artefacts during MRI scanning or MEG 
recordings. 
 
3.3 Rationale, aims and hypotheses 
The primary aim of this chapter is to characterise the sample of children who were 
recruited to the brain imaging investigations that are described in the subsequent 
results chapters. In line with existing literature, it is hypothesised that children 
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with 22q11.2DS have higher rates of psychopathology and lower cognitive ability 
than children without neurodevelopmental CNVs. A secondary aim of this chapter 
is to compare the phenotype of children taking part in neuroimaging with those 
who either declined to participate or who were unable to participate due to 
contraindications, in order to determine whether the imaging subsample is 
representative of the wider 22q11.2DS ECHO cohort. Due to the practical 
challenges presented by brain imaging studies, it is hypothesised that those taking 
part in brain imaging have a milder phenotype with lower rates of psychiatric 
disorders and better cognitive function than children who did not take part in 
brain imaging. 
 
3.4 Methods 
3.4.1 Recruitment 
Participants were recruited from the Experiences of people with copy number 
variants (ECHO) cohort at Cardiff University. As described in Chapter 2, this is a 
longitudinal follow-up study of people over the age of six years old with 
neurodevelopmental CNVs and their unaffected siblings. Children between the 
ages of 10-17 years old with a confirmed 22q11.2 deletion (probands) or who 
were siblings of a child with a neurodevelopmental CNV (controls) were invited to 
take part in the imaging study. When the neuroimaging study commenced in 
2013, there were 61 families in the ECHO cohort who had a child with 22q11.2DS 
aged between 10-17 years old and who had consented to be contacted about 
future research. Of these, 35 expressed interest in participating and 26 did not 
wish to participate. The most common reasons for families not wishing to take 
part were distance to the imaging centre, difficulty taking time off school and 
work to attend imaging appointments, and concerns that their child would not 
cope in the scanner environment. Ten additional eligible families were recruited 
to the ECHO study during the course of this investigation, increasing the potential 
sample size to 45 probands. 27 families with an unaffected sibling aged between 
10-17 years old expressed interest in participating. 22 of these were siblings of 
children with 22q11.2DS and five were siblings of children with other 
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neurodevelopmental CNVs (three siblings of children with 16p11.2 deletions, one 
sibling of a child with a neurexin deletion and one sibling of a child with a 22q11.2 
duplication). 
 
Before taking part in the study, potential participants underwent rigorous 
screening over the telephone to identify potential contraindications to their 
participation in the MEG session, the MRI session or both. Where necessary, 
screening was followed-up by correspondence with medical professionals 
involved in the child’s care to determine whether it was safe for the child to 
participate in the MEG session, MRI session or both. Following screening, a further 
6 probands were excluded from the whole study, one was excluded from the MEG 
session only and 15 were excluded from the MRI session only. No controls were 
excluded during the screening process. 
 
 
Figure 3-1 Flowchart of proband recruitment. 
 
CNV status was confirmed for all participants in the study. 36 probands were 
tested by microarray in the laboratory of the Division of Psychological Medicine 
and Clinical Neurosciences (DPMCN) and of these, 34 had the 3Mb deletion (A-D) 
and two had the nested 1.5Mb deletion (A-B). Three children did not have in-
house genetic testing however, all had medical records from clinical genetics 
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services confirming their diagnosis of 22q11.2DS (either by fluorescent in-situ 
hybridisation (FISH) or microarray). Two probands had an inherited CNV, other 
probands had de novo deletions. All controls had microarray testing at the 
DPMCN. One child was found to have a neurodevelopmental CNV (16p11.2 
deletion) and was excluded from control sample. 
 
In total 39 probands and 26 sibling controls participated in the study. This sample 
comprised 14 sibling pairs, other participants were unrelated. 38 probands and 
26 controls took part in the MEG session and 24 probands and 26 controls took 
part in the MRI session. Recruitment for the study was carried out in accordance 
with protocols approved by South East Wales National Health Service (NHS) 
Research Ethics Committee.  
 
3.4.2 Demographic information 
Demographic information about participating families was collected by means of 
a parent questionnaire and telephone screening. Data were collected on 
participant age, gender, handedness, ethnicity, maternal education and 
household income. Maternal education was categorised according to the highest 
qualification obtained by the participating child’s mother. ‘Low’ maternal 
education indicates that a GCSE or equivalent qualification was the highest 
obtained, the ‘middle’ category indicates that A-levels (or equivalent) or a 
vocational qualification was the highest obtained and ‘high’ maternal education 
indicates that a university degree or higher postgraduate qualification was 
obtained.  
 
3.4.3 Psychopathology and medication use 
Detailed information about proband and sibling psychopathology was collected 
using the Child and Adolescent Psychiatric Assessment [CAPA; (Angold et al., 
1995)]. This semi-structured interview was conducted with the primary caregiver 
and provided detailed information about the major psychiatric disorders coded in 
the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition – Text 
Revision [DSM-IV-TR; (American Psychiatric Association, 2000)] except autism 
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spectrum disorders (ASD). The psychosis sub-section of the Child CAPA was also 
used to assess for the presence of psychotic symptoms. These were coded as 
being present if they were reported by either the child or their parent. ASD 
symptomatology was assessed using the Autism Diagnostic Interview-Revised 
[ADI-R; (Lord, Rutter and Le Couteur, 1994)] in probands and the Social 
Communication Questionnaire [SCQ; (Rutter, Bailey and Lord, 2003)] in both 
probands and siblings. CAPA interviews were conducted in Cardiff during imaging 
visits or separately during a home visit or by telephone. Due to time constraints 
during imaging and home visits, the majority of ADI-R interviews were conducted 
over the telephone. Information about past medical history and medication use 
was obtained from parent questionnaires, telephone screening and parent 
interviews. 
 
3.4.4 Cognitive ability 
IQ estimates were derived from performance on the Wechsler Abbreviated Scale 
of Intelligence [WASI; (Wechsler, 1999)], including verbal (VIQ), performance 
(PIQ) and full-scale IQ (FSIQ). Other domains of cognitive functioning were 
assessed using the Cambridge Neuropsychiatric Test Automated Battery 
(CANTAB; Cambridge Cognition Limited, UK, 2006) and the Wisconsin Card Sorting 
Task [WCST; (Heaton et al., 1993)]. The CANTAB metrics used for between-group 
analyses were: number of correct items in the Match to Sample (MTS) task, a 
measure of visual attention; reaction time in milliseconds in the 5-choice Reaction 
Time (RTI) task, a measure of processing speed; ability to discriminate target 
stimuli from distractors in the Rapid Visual Processing (RVP) task, which measures 
sustained attention; problems solved in minimum moves in the Stockings of 
Cambridge (SOC) task, which measures spatial planning; and number of errors in 
the Spatial Working Memory (SWM) task. For the WCST, the number of 
perseverative errors was analysed as this reflects set-shifting ability. IQ and WCST 
scores were transformed to age-adjusted standardised scores with a mean of 100 
and a standard deviation of 15. With the exception of the MTS task, scores on 
each of the CANTAB subtests were age-adjusted and standardised to z-scores with 
a mean of zero and a standard deviation of one. As no CANTAB norms were 
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available for the MTS task, raw scores were used. For all tasks, higher scores 
represent better performance. As with the psychiatric interviews, cognitive 
assessments were carried out during the imaging visits or separately at 
participants’ homes. 
 
3.4.5 Statistical analysis 
Demographic, psychiatric and cognitive data were coded and inputted into 
dedicated databases maintained by the ECHO study team. From these databases, 
data were extracted for participants who were invited to take part in the brain 
imaging study. Data were then cleaned, scored and imported into R Studio 
(version 1.1383 for Mac, www.rstudio.com) for statistical analysis.  
 
Group comparisons were conducted between probands and controls who took 
part in brain imaging and between probands who took part in brain imaging and 
those who did not take part in brain imaging. Group differences in categorical 
variables such as ethnicity, maternal education, family income, gender, and 
psychiatric diagnoses were investigated using chi-squared tests or Fisher’s exact 
tests when expected cell counts were low. Between-group differences in 
continuous variables e.g. age and cognitive scores were compared with t-tests or 
Mann-Whitney U-tests as appropriate with respect to normality. P values were 
not corrected for multiple comparisons. 
 
3.5 Results 
3.5.1 Demographics 
Probands who took part in brain imaging had a mean age of 13.3 years (SD=1.9 
years) which was not significantly different from the mean age of those who did 
not participate (13.1 years, SD=2.0 years, t=0.45, p=0.65). Controls taking part in 
brain imaging were approximately one year older than participating probands 
with a mean age of 14.4 years (SD=1.8 years, t=-2.20, p=0.03). There were no 
significant differences between the gender distributions of participating and non-
participating probands (p=0.86) or between participating probands and controls 
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(p=0.48). Table 3-1 shows the data on ethnicity, maternal education and family 
income for probands and controls, demonstrating that there were no significant 
differences between groups. 
 
Table 3-1 Family background of participating probands and controls 
 Probands Controls P 
 
Ethnicity    >0.99 
 
European 82.1% 84.6%  
 
Other 12.8% 11.5%  
 
Unknown 5.1% 3.9%  
 
    
 
Maternal education    0.21 
 
None 15.4% 3.8%  
 
Low 10.3% 15.4%  
 
Middle 30.8% 15.4%  
 
High 41.0% 57.7%  
 
Unknown 2.6% 7.7%  
 
    
 
Income    0.70 
 
<19,999 25.6% 15.4%  
 
20,000-39,999 20.5% 15.4%  
 
40,000-59999 17.9% 26.9%  
 
>60,000 33.3% 30.8%  
 
Unknown 2.6% 11.5% 
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Table 3-2 shows the same data comparing probands who participated in the brain 
imaging study with those who did not.  
 
Table 3-2 Family background of participating and non-participating probands 
 Participating 
probands 
Non-participating 
probands 
P 
 
Ethnicity    0.31 
 
European 82.1% 96.9%  
 
Other 12.8% 3.1%  
 
Unknown 5.1% 0.0%  
 
    
 
Maternal education    0.01* 
 
None 15.4% 3.1%  
 
Low 10.3% 37.5%  
 
Middle 30.8% 34.4%  
 
High 41.0% 18.8%  
 
Unknown 2.6% 6.2%  
 
    
 
Income (%)   0.65 
 
<19,999 25.6% 28.1%  
 
20,000-39,999 20.5% 25.0%  
 
40,000-59999 18.0% 21.9%  
 
>60,000 33.3% 18.7%  
 
Unknown 2.6% 6.3%  
 
 
These data show that while there were no statistically significant between-group 
differences in ethnicity or household income, there was a significant difference in 
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maternal education, with higher qualifications being obtained by mothers of 
children who participated in neuroimaging than mothers of those who did not. 
 
3.5.2 Psychopathology and medication use 
Probands and controls who took part in the brain imaging study were first 
compared. DSM-IV-TR categorical diagnoses were assigned based on scores from 
the CAPA with the exception of ASD diagnoses, which were derived from ADI-R 
scores (probands only) and SCQ scores (probands and controls). CAPA interview 
data were available for 37 probands and 21 controls, ADI-R data for 26 probands 
and SCQ data for 29 probands and 20 controls.  
 
As shown in table 3-3, the burden of psychopathology in the sample was very high, 
however at the level of individual diagnoses, between-group differences were not 
statistically significant with the exception of putative autism spectrum disorder 
(ASD) derived by the SCQ (p=0.04). 17 of the 25 probands with complete CAPA 
and ADI-R data (68.0%) had at least one DSM-IV-TR diagnosis and comorbidity was 
very common with 12 of the 25 (48.0%) having more than one disorder. ASD was 
the most common diagnosis (50.0%) of which 30.8% of the sample had narrowly-
defined autism. Anxiety disorders were highly prevalent (29.7%) as was attention 
deficit hyperactivity disorder (ADHD, 16.2%). Furthermore, psychotic experiences 
were described by 16.2% of probands, although none of these children met the 
criteria for a psychotic disorder. Rates of psychiatric disorders were much lower 
in controls with only one child meeting the criteria for a DSM-IV-TR disorder 
(social phobia). One child described psychotic symptoms but these did not reach 
the threshold for diagnosis of a psychotic disorder.  
 
Although ADI-R data were not available for controls, SCQ data were collected for 
both probands and controls. Using these data, 27.6% children with 22q11.2DS 
screened positive for possible ASD using an SCQ cut-off score of 15 while no 
siblings scored above this cut-off. There was a marked discrepancy between the 
rates of ASD derived from the ADI-R (50.0%) and SCQ (27.6%). 23 probands had 
data available for both measures. Of these, ten had an ADI-R derived ASD 
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diagnosis and six had an SCQ-derived diagnosis (SCQ score ≥15). Five of the six 
with a positive SCQ screen also received an ASD diagnosis by the ADI-R criteria. 
The child who did not had a borderline SCQ score of 15. The correlation between 
ADI-R score and SCQ score was 0.57 (t=3.14, p=5.16x10-3).  
 
Table 3-3 Rates of psychiatric and neurodevelopmental disorders in participating 
probands and controls  
 Probands  Controls  Odds 
ratio 
P 
 
CAPA  N=37 N=21   
Any CAPA diagnosis 48.6% 4.8% 10.0 <0.01* 
Any anxiety disorder 29.7% 4.8% 6.10 0.09 
Social anxiety 18.9% 4.8% 3.90 0.25 
Agoraphobia 10.8% 0.0% NA 0.29 
Specific phobia 10.8% 0.0% NA 0.29 
Separation anxiety 8.1% 0.0% NA 0.54 
GAD 8.1% 0.0% NA 0.54 
Selective mutism 2.7% 0.0% NA >0.99 
OCD 2.7% 0.0% NA >0.99 
MDD 2.7% 0.0% NA >0.99 
ADHD 16.2% 0.0% NA 0.17 
ODD 10.8% 0.0% NA 0.29 
Tic disorder 2.7% 0.0% NA >0.99 
Psychotic experiences 16.2% 4.8% 3.37 0.41 
ADI-R  N=26 N=0   
ASD 50% NA NA NA 
SCQ  N=29 N=20   
SCQ score ≥15  27.6% 0.0% NA 0.04* 
Abbreviations: CAPA, Child and Adolescent Psychiatric Assessment; GAD, generalised 
anxiety disorder; OCD, obsessive compulsive disorder; MDD, major depressive disorder; 
ADHD, attention deficit hyperactivity disorder; ODD, oppositional defiant disorder; ADI-R, 
Autism Diagnostic Interview – Revised; ASD, autism spectrum disorder; SCQ, Social 
Communication Questionnaire. P values are uncorrected. 
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One proband had a past medical history of epilepsy but had not had any recent 
seizures and was not taking anticonvulsant medication. Few children were taking 
any regular medication at the time of the scans. Four probands (11.4%) were 
taking melatonin for sleep problems. One of these children was also taking 
aripiprazole 5mg once daily for challenging behaviour. No controls were taking 
any medication for neurological, psychiatric or sleep disorders.  
 
To determine whether probands taking part in the brain imaging study had a 
different neurodevelopmental and psychiatric phenotype than those who did not 
participate in brain imaging but did undergo phenotypic assessment as part of the 
longitudinal ECHO cohort, rates of DSM-IV-TR disorders were compared between 
groups.  
 
As shown in table 3-4, the burden of psychopathology was remarkably similar 
between probands who participated and who did not participate in brain imaging. 
Although not statistically significant, the rates of CAPA-derived diagnoses were 
higher overall in the imaging subsample. The rates of ASD diagnoses derived from 
the SCQ were identical in both groups, however fewer of the non-participating 
probands had an ADI-R derived ASD diagnosis and the correlation between ADI-R 
and SCQ scores was higher than for children who participated in brain imaging 
(r=0.86, t=8.23, p=2.61x10-8). Three of the children who did not participate in 
brain imaging were taking melatonin, one child was taking fluoxetine for anxiety 
and two children were taking anticonvulsant medication for seizures 
(carbamazepine and lamotrigine). 
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Table 3-4 Rates of psychiatric and neurodevelopmental disorders in participating and non-
participating probands  
 Participating 
proband 
Non-participating 
proband 
Odds  
ratio 
P 
CAPA  N =37 N=32   
Any diagnosis 48.6% 43.8% 1.11 0.83 
Any anxiety disorder 29.7% 21.9% 1.35 0.61 
Social anxiety 18.9% 12.5% 1.50 0.75 
Agoraphobia 10.8% 6.3% 1.72 0.68 
Specific phobia 10.8% 3.1% 3.41 0.37 
Separation anxiety 8.1% 3.1% 1.29 >0.99 
GAD 8.1% 12.5% 0.65 0.70 
Selective mutism 2.7% 3.1% 0.87 >0.99 
OCD 2.7% 0.0% NA >0.99 
MDD 2.7% 3.1% 0.87 >0.99 
ADHD 16.2% 15.6% 1.04 >0.99 
ODD 10.8% 15.6% 0.70 0.73 
Tic disorder 2.7% 3.1% 0.87 >0.99 
Psychotic experiences 16.2% 9.4% 1.72 0.50 
ADI-R  N=26 N=25  0.31 
ASD 50.0% 36.0% 1.78  
SCQ  N=29 N=29  >0.99 
SCQ score ≥15  27.6% 27.6% 1.00  
Abbreviations: CAPA, Child and Adolescent Psychiatric Assessment; GAD, generalised 
anxiety disorder; OCD, obsessive compulsive disorder; MDD, major depressive disorder; 
ADHD, attention deficit hyperactivity disorder; ODD, oppositional defiant disorder; ADI-R, 
Autism Diagnostic Interview–Revised; ASD, autism spectrum disorder; SCQ, Social 
Communication Questionnaire. P values are uncorrected. 
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3.5.3 Cognitive ability 
Table 3-5 shows the cognitive performance of probands and controls who took 
part in brain imaging.  
 
Table 3-5 Cognitive performance of participating probands and controls  
      Probands         Controls  
 
 N Mean SD N Mean SD P 
WASI        
FSIQ 
 
38 74.4 12.2 25 107.3 11.0 <0.01* 
VIQ 
 
38 77.6 14.9 25 104.4 13.1 <0.01* 
PIQ 
 
38 76.6 14.4 25 108.1 10.6 <0.01* 
CANTAB        
Visual attention  
(MTS) 
35 43.1 8.5 24 46.3 1.8 0.02* 
Processing speed  
(RTI) 
34 -0.1 1.6 24 0.6 0.7 0.02* 
Sustained 
attention (RVP) 
32 -0.7 1.2 24 0.4 0.9 <0.01* 
Spatial planning  
(SOC) 
36 -1.2 1.2 24 -0.8 1.5 0.28 
Spatial working 
memory (SWM) 
36 -1.1 0.9 24 -0.2 0.9 <0.01* 
WCST        
Set-shifting ability 
 
34 81.7 32.6 23 99.1 46.6 0.03* 
 
Abbreviations: WASI, Wechsler Abbreviated Scale of Intelligence; FSIQ, full-scale IQ; VIQ, 
verbal IQ, PIQ, performance IQ; CANTAB, Cambridge Neuropsychological Test Automated 
Battery; MTS, Match-to-Sample; RTI, 5-choice Reaction Time; RVP, Rapid Visual 
Processing; SOC, Stockings of Cambridge; SWM, Spatial Working Memory; WCST, 
Wisconsin Card Sorting Test. P values are uncorrected. 
 
There were statistically significant differences between groups in IQ with a mean 
FSIQ difference of 32.9 points. There were also significant deficits in visual 
attention (MTS), processing speed (RTI), sustained attention (RVP), spatial 
working memory (SWM) and set-shifting ability (WCST). However, no significant 
differences were found between probands and controls for spatial planning 
(SOC). 
54 
 
Table 3-6 shows the cognitive performance of probands who took part in brain 
imaging and those who did not.  
 
Table 3-6 Cognitive performance of participating and non-participating probands  
 Participating 
probands 
Non-participating 
probands 
 
 N Mean SD N Mean SD P 
WASI        
FSIQ 
 
38 74.4 12.2 32 68.0 11.2 0.03* 
VIQ 
 
38 77.6 14.9 32 69.4 10.9 0.02* 
PIQ 
 
38 76.6 14.4 32 71.5 11.7 0.13 
CANTAB        
Visual attention  
(MTS) 
35 43.1 8.5 32 43.7 5.2 0.69 
Processing speed  
(RTI) 
34 -0.1 1.6 32 <0.1 1.2 0.78 
Sustained 
attention (RVP) 
32 -0.7 1.2 30 -2.0 3.0 0.04* 
Spatial planning  
(SOC) 
36 -1.2 1.2 31 -1.2 0.9 0.94 
Spatial working 
memory (SWM) 
36 -1.1 0.9 32 -1.4 1.3 0.36 
WCST        
Set-shifting ability 
 
34 81.7 32.6 32 95.2 16.5 0.23 
Abbreviations: WASI, Wechsler Abbreviated Scale of Intelligence; FSIQ, full-scale IQ; VIQ, 
verbal IQ, PIQ, performance IQ; CANTAB, Cambridge Neuropsychological Test Automated 
Battery; MTS, Match-to-Sample; RTI, 5-choice Reaction Time; RVP, Rapid Visual 
Processing; SOC, Stockings of Cambridge; SWM, Spatial Working Memory; WCST, 
Wisconsin Card Sorting Test. P values are uncorrected. 
 
Children who did not participate in brain imaging had a mean FSIQ which was 6.4 
points below children who took part in neuroimaging and a mean VIQ that was 
8.2 points lower than participating children. They also had lower sustained 
attention than participating children. There were no between-group differences 
in other CANTAB tasks or the WCST. 
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3.6 Discussion 
Recruiting a large neuroimaging sample of children with 22q11.2DS and controls 
presented a number of challenges. Firstly, 22q11.2DS is a relatively rare disorder 
(Botto et al., 2003; Oskarsdottir, 2004; Maisenbacher et al., 2017) and although 
the ECHO cohort is one of the largest in the world, there were only 61 probands 
who fell within the study age range when data collection commenced. Secondly, 
due to the relative rarity of 22q11.2DS and other neurodevelopmental CNVs, the 
ECHO study recruits families from across the UK. This posed substantial logistical 
difficulties for many families who wished to take part but lived a long distance 
from the imaging centre in Cardiff. This also precluded after-school or evening 
scanning appointments for the vast majority of participants and meant that 
families needed to give up a lot of their time to participate in the study, with some 
staying in Cardiff over one or more nights, which had a subsequent negative 
impact on participation rates. Furthermore, due to families’ school and work 
commitments, scanning was largely restricted to school holiday periods, reducing 
the number of families who could be given appointments within the data 
collection period. Thirdly, children with 22q11.2DS have high rates of congenital 
cardiac malformations and other physical health problems such as skeletal 
abnormalities (Kobrynski and Sullivan, 2007; McDonald-McGinn et al., 2015) 
which can require surgical intervention, often in the early years of their lives. 
These procedures may involve the insertion of implants or devices (such as 
prosthetic heart valves, stents or metallic rods) that are either not safe or not 
known to be safe in a 3T MRI environment. For this reason, many interested 
families were unable to take part in the MRI session either because of a known 
MRI incompatible implant or because of lack of available documentation to 
confirm MRI safety (although in most cases, these children were able to take part 
in the MEG session). In addition, several potential participants (both probands 
and controls) had dental prostheses or braces which prevented their participation 
in either the MEG session, the MRI session or both (depending on the type, size 
and location of the prosthesis or brace). The frequency of implants and devices in 
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potential participants limited the neuroimaging sample size, particularly in the 
proband group.  
 
One of the major concerns when undertaking clinical neuroimaging research is 
whether the sample is representative of the population of interest (LeWinn et al., 
2017). One could hypothesise that those who are interested in taking part in 
research and who are able to cooperate with brain imaging procedures could 
represent a high-functioning subgroup of the population of interest. In the design 
of this study, every attempt was made to ensure that any child who wished to 
participate could do so, as long as they had no contraindications for brain imaging. 
Imaging visits were arranged at times convenient to each family and imaging 
sessions conducted on either the same or different days, according to each child’s 
ability and family’s preferences. Travel and accommodation were arranged on the 
families’ behalf and the cost of meals reimbursed so that families were not 
prevented from participating due to financial constraints. A ‘mock’ MRI scanner 
was used to introduce children to the MRI environment in a relaxed and informal 
manner in order to reduce anxiety. Extra time was booked in the imaging suites 
so that there was plenty of time for children and their families to become familiar 
with the equipment, take breaks, and repeat imaging sequences and recordings if 
data quality was poor, for example due to head motion. Parents or carers were 
able to accompany their child during scans and recordings for reassurance and 
children were also able to watch a movie during their MRI scan. These steps aimed 
to minimise bias towards a higher functioning subsample by facilitating children’s 
involvement, whatever their abilities or difficulties.  
 
The data presented in this chapter are broadly in line with previously published 
reports of psychopathology and cognition in children with 22q11.2DS both from 
the ECHO sample (Niarchou et al., 2014; Chawner et al., 2017), and from the 
International Brain and Behaviour Consortium (IBBC, (Schneider et al., 2014; 
Swillen and McDonald-Mcginn 2015)). Data from the first wave of the ECHO 
sample showed that more than half (54%) of the sample had a CAPA-derived DSM-
IV-TR diagnosis which is similar to the rate reported in this chapter (48%). This 
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study finds higher rates of psychotic experiences and lower rates of ADHD in this 
sample at a mean age of 13.4 years compared to data published from wave one 
when children had a mean age of 10.2 years (Niarchou et al., 2014). This is 
consistent with the literature in 22q11.2DS (Schneider et al., 2014) which shows 
that ADHD symptoms decline and psychotic disorders emerge in late adolescence 
and early adulthood. While the rates of DSM-IV-TR diagnoses were similar to 
those reported previously, in contrast to the study by Niarchou et al., there were 
no statistically significant differences between the rates of specific phobia, ADHD 
and oppositional defiant disorder between probands and controls. This is most 
likely due to the smaller sample size recruited for the current brain imaging study 
than for the previous phenotyping study (80 probands and 39 controls), which will 
have affected the power to detect such differences. In terms of cognition, an IQ 
deficit of approximately 30 points was found in children with 22q11.2DS 
compared with controls, which is consistent with waves 1 and 2 of the ECHO study 
(Niarchou et al., 2014; Schneider et al., 2014) and other studies of cognition in 
22q11.2DS (Swillen et al., 1997; De Smedt et al., 2007). There were also significant 
deficits in performance in the MTS task (a measure of visual attention), the RTI 
task (a measure of processing speed), the RVP task (a measure of sustained 
attention) the SWM task (a measure of the spatial working memory aspect of 
executive function) and the WCST (a measure of set-shifting ability) which is again 
consistent with previously published data from the ECHO sample. However, no 
significant differences were found between probands and controls for the 
Stockings of Cambridge task, which assesses spatial planning. 
 
Reported rates of ASD in 22q11.2DS are highly variable depending on the 
ascertainment and assessment methods used (Fine et al., 2005; Vorstman et al., 
2006; Kevin M. Antshel et al., 2007; Niklasson et al., 2009; Angkustsiri et al., 2014; 
Ousley et al., 2017). The rates of probable ASD derived from the SCQ in the 
present sample are similar to those found in the first wave of the ECHO study 
(Niarchou et al., 2014) and the IBBC study (Schneider et al., 2014). However, the 
prevalence of ASD as derived by the ADI-R in the current study is much higher at 
50%. Similar prevalence figures have previously been reported in 22q11.2DS using 
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the ADI-R (Vorstman et al., 2006). The correlation between ADI-R score and SCQ 
score in the imaging sample was calculated to be 0.57 (t = 3.13, p=5.16x10-3). This 
correlation is lower than that of the sample who did not participate in brain 
imaging and that reported in non-22q11.2DS samples (Bishop and Norbury, 2002; 
Howlin and Karpf, 2004). Interestingly, the correlation between SCQ and ADI-R 
score in the imaging sample was similar to the correlation between SCQ score and 
total anxiety score (r=0.65, t=5.48, p=2.38 x 10-6), suggesting that the SCQ may be 
a relatively insensitive and non-specific screening tool for ASD in this sample. 
Gold-standard assessment of ASD typically involves gathering information from 
three sources: parent interview (e.g. using the ADI-R), child observation (e.g. using 
the Autism Diagnostic Observation Schedule (ADOS)), and a clinician’s best 
estimate diagnosis (Ousley et al., 2013). However, until recently, no studies had 
applied such a rigorous assessment approach in 22q11.2DS. A recent study in 56 
people with 22q11.2DS found ASD rates of 37.5% based on the ADI-R alone, 41.1% 
using the ADOS alone and 17.9% using a combination of ADI-R, ADOS and a 
clinician’s best estimate consensus diagnosis (Ousley et al., 2017). This suggests 
that people with 22q11.2DS do have elevated rates of ASD, even when strict 
diagnostic criteria are applied. The discrepancy between the rates based on 
consensus data and the rates from either ADI-R interviews or ADOS assessments 
alone highlights the importance of using multiple sources of information in 
diagnostic decision-making. Although observational data were not collected in the 
current study, this will be an important consideration for future research. 
 
Comparison between children who took part in brain imaging and those who did 
not showed that, in line with the hypotheses, participating children had higher 
FSIQ and VIQ scores than children who did not participate. However, they did not 
differ in other tests of cognitive function or in the burden of psychopathology 
experienced. The association between cognitive performance and participation 
status may be related to parental concern about the ability of children with lower 
levels of cognitive functioning to cope with the demands of the neuroimaging 
sessions. There may also be a relationship between cognitive ability and the 
severity of medical problems in 22q11.2DS (Swillen, Moss, and Duijff 2018). 
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Children with 22q11.2DS and congenital heart disease have been found to have 
reductions in cortical gyrification (Schaer, Glaser, et al., 2009) and it is possible 
that those excluded from imaging due to concerns about medical or surgical 
contraindications, may be a more cognitively impaired group.   
 
While there were no significant differences in ethnicity or household income 
between families who participated and those who did not, mothers of children 
who participated in brain imaging had obtained more high-level qualifications 
than those who did not. The reasons for these differences are likely to be 
multifactorial and may reflect differing levels of interest in scientific research 
among mothers from different educational backgrounds or associations between 
the cognitive abilities of mothers and their children (Olszewski et al., 2014; 
Beemer et al., 2016). However, maternal educational attainment does not only 
reflect maternal IQ, so caution should be used in making any further 
interpretation of this finding. 
 
While the psychiatric phenotype of the imaging subsample is similar to the wider 
ECHO cohort (Niarchou et al., 2014) and the IBBC cohort (Schneider et al., 2014), 
one cannot generalise these data to all individuals with 22q11.2DS in the absence 
of population-level data. In the United Kingdom, 22q11.2DS is not part of routine 
screening programmes and therefore genetic testing is only performed when 
there is clinical suspicion of a genetic disorder e.g. due to developmental delay, 
psychiatric symptoms or congenital malformations, potentially resulting in 
ascertainment bias in studies of the 22q11.2 phenotype. Furthermore, families 
with children who are severely affected may be more likely to take part in 
research, further biasing studies towards more severe phenotypes. However, it is 
worth noting that few of the children in the present study were receiving 
psychiatric care and only one was taking psychotropic medication, suggesting that 
in most cases referral for genetic testing was not due to the presence of 
psychopathology.  
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3.7 Strengths and limitations 
This study benefited from the existence of a large sample of children with 
22q11.2DS and a sample of siblings of children with neurodevelopmental CNVs 
who were already taking part in a longitudinal study of CNV phenotypes. Steps 
were taken to ensure maximum participation in the imaging study where this was 
deemed safe. Due to the ongoing ECHO study, it was possible not only to compare 
the psychiatric and cognitive phenotypes of participating probands and controls, 
but also to compare probands who took part in brain imaging with those who did 
not take part, to assess the representativeness of the sample. Despite the steps 
taken to maximise the sample size for the imaging study, the relatively rarity of 
22q11.2DS, logistical considerations and imaging contraindications resulted in a 
modest sample size for phenotypic comparison and subsequent neuroimaging 
data analysis. The study is also limited by the lack of an observational autism 
assessment such as the ADOS to further characterise social communication 
difficulties in affected children. 
 
3.8 Conclusions 
39 children with 22q11.2DS (probands) and 26 sibling controls were recruited to 
the brain imaging study. Recruitment and data collection were challenging, 
resulting in a modest sample size for analysis. Probands were on average one year 
younger than controls but there were no significant differences in ethnicity, 
maternal education, family income, gender and handedness. As predicted, 
probands had higher rates of psychopathology than controls and the most 
common disorders were ASD, ADHD and anxiety disorders. Despite high rates of 
psychopathology, only one child was taking psychotropic medication. IQ was 
approximately 30 points lower in probands than in controls and probands also 
had significant deficits in visual attention, processing speed, sustained attention, 
spatial working memory and set-shifting ability. In line with the hypotheses, 
children taking part in the imaging study had higher cognitive ability than those 
who did not participate, however, there were no differences in the rates of 
psychiatric disorders. Maternal educational attainment was lower in mothers of 
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children who did not participate but there were no differences in ethnicity or 
household income. Overall, the characteristics of the imaging sample were similar 
to the wider ECHO sample, suggesting that they do not represent an atypical 
subgroup of children with 22q11.2DS.  
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4 Resting-state connectivity in 22q11.2 deletion 
syndrome 
4.1 Summary 
Resting-state brain activity reflects excitatory-inhibitory balance in coordinated 
neural networks and can be studied using different methodologies (e.g. EEG, fMRI 
and more recently MEG). Previous studies have identified characteristic resting-
state networks with altered dynamics in neurodevelopmental disorders including 
schizophrenia, ADHD and ASD. Preliminary reports using fMRI in 22q11.2DS 
indicate alterations in the resting-state networks of people with the deletion.  
 
Resting-state MEG offers the opportunity to investigate brain networks with 
excellent temporal and good spatial resolution. This study aimed to investigate 
MEG resting-state networks across six frequency bands (delta, theta, alpha, beta, 
low gamma and high gamma) in children with 22q11.2DS and controls and to 
relate measures of network connectivity to cognitive function and 
psychopathology.  
 
38 children with 22q11.2DS (probands) and 26 controls were recruited to the 
study and MEG data were recorded during a five minute eyes open resting-state 
paradigm. An amplitude-envelope correlation approach was used to compare the 
strength of amplitude-amplitude coupling between 90 brain regions across the six 
frequency bands. Statistical thresholding procedures were used to identify valid 
connections which were then compared these between groups. Connectivity 
scores were extracted for the frequency bands showing between-group 
differences and the relationships between these scores, cognitive function and 
psychopathology were explored. 
 
Overall, probands had lower amplitude-envelope correlation scores than controls 
in delta, alpha and beta bands, particularly affecting posterior brain regions. The 
specific brain regions with the most significant between-group differences in 
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probands and controls were the visual cortex, insula, precuneus and inferior 
parietal cortex. In the alpha band, global and right precuneus connectivity scores 
were associated with anxiety and ASD symptom scores. This study provides 
preliminary evidence for altered excitatory-inhibitory balance in children with 
22q11.2DS which is related to psychopathology. 
 
4.2 Introduction 
Resting-state neuroimaging studies measure brain activity while participants sit 
or lie motionless without performing any particular task. In these conditions, the 
brain shows spontaneous patterns of oscillatory activity across different regions 
known as resting-state networks (Fox and Raichle, 2007). These oscillations reflect 
the synchronous firing of populations of neurons and are mediated by excitatory 
and inhibitory interactions. The networks of brain regions that are active in the 
resting-state are remarkably similar to those involved when the brain is 
performing tasks or responding to external stimuli (Smith et al., 2009). 
Understanding the properties of these intrinsic brain networks can provide insight 
into the structure and function of cortical circuitry, and how this circuitry is 
impacted by high-risk genetic syndromes such as 22q11.2DS.   
 
Resting-state networks can be investigated using different imaging modalities 
such as fMRI, EEG and MEG. Resting-state protocols have practical advantages 
over task-based studies enabling the investigation of between-group differences 
in circumstances where participants may find behavioural tasks difficult, e.g. 
studies of children and those with low cognitive ability. The results of resting-state 
studies are not therefore biased by participants’ ability to perform tasks, 
removing the need to match study groups on task performance, which can be 
challenging in small samples. However, in the absence of a task, it can be difficult 
to control the behaviour and mental activity of participants during resting-state 
studies and participants may become drowsy or even fall asleep, particularly 
during eyes-closed paradigms or when recordings are conducted in the supine 
position (van Diessen et al., 2015). 
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FMRI uses the Blood Oxygen Level Dependent (BOLD) signal to infer information 
about neural activity. The BOLD response has been shown to correlate with local 
field potentials, reflecting the input and local cortical processing in a given brain 
region (Logothetis et al., 2001). Resting-state fMRI studies measure the temporal 
correlation of spontaneous BOLD signal between brain regions with the 
underlying assumption that functional networks will have correlated activity 
(Biswal et al., 1995; Fox and Raichle, 2007). While there are many analysis 
methods available, the majority of studies employ either seed-based approaches, 
independent component analysis (ICA) or graph theory to examine functional 
connectivity. Seed-based approaches extract fMRI signal from voxels located in a 
specific region of interest (ROI) and create a map by calculating the correlations 
between the seed region and all other voxels of the brain (Fox and Raichle, 2007). 
ICA is a data-driven approach in which all voxels are considered simultaneously 
and data are separated into spatial maps of four dimensional MRI signal (the 
dimensions being space and time (Calhoun, Liu, and Adali 2009)). Graph 
theoretical approaches model the brain as a network consisting of nodes and 
edges in which nodes represent brain regions and edges the connections between 
them. Different metrics can then be used to characterise local and global 
connectivity patterns (Wang, Zuo and He, 2010). One of the major advantages of 
resting-state fMRI studies is their excellent spatial resolution, however, the 
temporal resolution is poor and non-neural physiological confounds such as 
movement, cardiac and respiratory activity can influence apparent associations 
(Murphy, Birn and Bandettini, 2013).   
 
MEG is a more direct measure of neural activity with excellent temporal 
resolution, meaning that correlations between activity within and across different 
brain regions can be determined with millisecond accuracy. This allows 
researchers to investigate alterations in neural synchronisation patterns 
(oscillations) across characteristic frequency bands (delta (1-4Hz), theta (4-7Hz), 
alpha (8-13Hz), beta (13-30Hz) and gamma (30-90Hz)). Low frequency oscillations 
are thought to reflect long-range synchronisation between different brain regions 
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while higher frequencies reflect synchronisation in local networks (Schnitzler and 
Gross, 2005). 
 
Techniques such as beamforming, which estimate the contributions of different 
brain positions to the measured field, enable the sources of any observed signals 
to be localised with good spatial resolution, particularly for structures located 
near the brain surface (Hillebrand and Barnes, 2005). As with resting-state fMRI, 
there are several analysis methods available for investigating resting-state 
connectivity using MEG. These methods use the spectral coherence, phase delay 
or amplitude coupling of oscillation patterns to estimate resting-state 
connectivity (Stam, Nolte and Daffertshofer, 2007; Brookes, Woolrich and Barnes, 
2012; Hipp et al., 2012; Palva and Palva, 2012; Marzetti et al., 2013; Colclough et 
al., 2016). While there are advantages and disadvantages to each approach, 
amplitude-envelope correlation has been shown to be one of the most consistent 
methods for connectivity estimation, being robust, reproducible and repeatable 
(Colclough et al., 2016). This method measures functional connectivity by 
estimating the amplitude coupling between different ROIs using linear 
correlations of the envelopes of the band-pass filtered signals (Brookes, Woolrich 
and Barnes, 2012). 
 
Atypical functional connectivity within and between brain networks has been 
reported in resting-state fMRI studies of schizophrenia (Bluhm et al., 2007; 
Whitfield-Gabrieli et al., 2009; Argyelan et al., 2014; Wang et al., 2017), ASD (Assaf 
et al., 2010; Anderson et al., 2011; Di Martino et al., 2011; Abrams et al., 2013; 
Cerliani et al., 2015) and ADHD (Castellanos et al., 2008; Cao et al., 2009; Fair et 
al., 2010; Tomasi and Volkow, 2012). There have been relatively fewer resting-
state MEG studies in these disorders. In schizophrenia, however, atypical 
connectivity patterns have been shown across a number of frequency bands and 
brain regions (Kissler et al., 2000; Rutter et al., 2009; Hinkley et al., 2011; Kim et 
al., 2014; Chen et al., 2016; Houck et al., 2017). While there is a lack of consistency 
between studies, overall these data show alterations in local and long-range 
oscillatory dynamics, suggesting that both local and global neural organisation is 
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altered in schizophrenia (Alamian et al., 2017). MEG studies of ASD have found 
similarly variable results with hypo- and hyperconnectivity being reported in both 
short and long-range connections (Cornew et al., 2012; Edgar et al., 2015; 
Kitzbichler et al., 2015; Datko et al., 2016; Brodski-Guerniero et al., 2018; Lajiness-
O’Neill et al., 2018). ADHD has been less extensively investigated but atypical 
connectivity has been shown across a broad range of frequency bands (Wilson et 
al., 2012; Franzen et al., 2013; Sudre et al., 2017). These atypical patterns have 
been found to improve with the administration of stimulant medication (Wilson 
et al., 2012; Franzen et al., 2013).  
 
Despite the considerable variability in the findings across disorders, one network 
that is repeatedly implicated in resting-state fMRI and MEG studies across 
neurodevelopmental disorders is the default-mode network (DMN (Bluhm et al., 
2007; Whitfield-Gabrieli et al., 2009; Assaf et al., 2010; Franzen et al., 2013; Kim 
et al., 2014; Sudre et al., 2017)). This network comprises the precuneus, posterior 
cingulate, medial prefrontal and parietal cortices. It is known to be active during 
the resting-state and is deactivated during goal-directed activity (Binder et al., 
1999; Raichle et al., 2001). Covariation patterns in DMN functional connectivity 
are moderately heritable (Glahn et al., 2010) and abnormalities of this network 
have been found in relatives of people with schizophrenia (Whitfield-Gabrieli et 
al., 2009; Jang et al., 2011; Liu et al., 2012; van Buuren, Vink and Kahn, 2012) and 
those at clinical high-risk of schizophrenia (Wang et al., 2016).  
 
Several resting-state fMRI studies in 22q11.2DS have shown altered connectivity 
in a number of resting-state networks including the DMN (Debbané et al., 2012; 
Schreiner et al., 2014; Padula et al., 2015; Mattiaccio et al., 2016; Zöller et al., 
2017), sensorimotor, visuo-spatial and high-level visual networks (Debbané et al., 
2012). Alterations in the DMN have been also been associated with impaired 
social competence (Schreiner et al., 2014) and psychotic symptoms (Debbané et 
al., 2012; Padula et al., 2015; Mattiaccio et al., 2016) in 22q11.2DS. There has 
been one resting-state EEG study in 22q11.2DS. This study found abnormal EEG 
microstates in adolescents with 22q11.2DS (Tomescu et al., 2014). To my 
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knowledge there have been no previous resting-state MEG studies of 22q11.2DS 
meaning that patterns of resting-state neural oscillatory activity have not yet 
been examined in this high-risk group.  
 
4.3 Rationale, aims and hypotheses 
The variability in the results of resting-state neuroimaging studies across 
neurodevelopmental disorders may be due to a number of experimental factors 
including the sample size, imaging modality (fMRI or MEG), resting-state 
paradigm (e.g. eyes-open or eyes-closed (Nair et al., 2018)) and analysis 
approaches used.  Furthermore, sample characteristics including participant age 
(particularly when children and adults are included in the same sample), 
ascertainment method (e.g. based on clinical diagnosis), medication use 
(particularly common in clinical and/or adult samples) and control group selection 
(e.g. community controls from a different socioeconomic background than cases) 
are potential confounding factors which make it difficult to interpret findings to 
identify cortical circuit abnormalities relevant to these disorders. 
 
This study seeks to investigate neural circuit abnormalities in children with 
22q11.2DS, a syndrome associated with high-risk across the spectrum of 
neurodevelopmental disorders, by comparing CNV carriers to children without 
neurodevelopmental CNVs using MEG. In this chapter, eyes-open resting-state 
connectivity was investigated across the whole cortex for six frequency bands 
(delta, theta, alpha, beta, low-gamma and high-gamma) using an amplitude-
envelope correlation approach. These methods were selected as they are robust, 
reproducible and repeatable. This study tried to address potential confounding 
factors by recruiting a group of children, who were ascertained by CNV status 
rather than by clinical diagnosis, together with a group of unaffected siblings of 
CNV carriers who were from a similar genetic and socioeconomic background. 
Detailed phenotypic information was collected so that associations between 
psychiatric and cognitive variables could be explored.  
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The primary aim of this chapter is to compare resting-state connectivity patterns 
between children with 22q11.2DS and children without neurodevelopmental 
CNVs. A secondary aim is to explore relationships between measures of 
connectivity, cognitive ability and psychopathology. As children with 22q11.2DS 
are expected to have altered E-I balance, it is hypothesised that compared to 
those without neurodevelopmental CNVs, children with 22q11.2DS have reduced 
resting-state connectivity (as measured by the strength of amplitude-envelope 
correlations) across multiple frequency bands. It is further hypothesised that the 
severity of resting-state network dysfunction will be associated with the severity 
of cognitive impairment and psychopathology. 
 
4.4 Methods 
4.4.1 Participants 
Participants were recruited from the Experiences of people with copy number 
variants (ECHO) cohort at Cardiff University (See Chapters 2 and 3 for a detailed 
description of recruitment methods and sample characteristics). Children aged 
between 10-17 years old with a diagnosis of 22q11.2DS (probands) or who had a 
biological sibling with a neurodevelopmental CNV (controls) were invited to 
participate. CNV status was confirmed for all participants. Probands were 
excluded from the study if a 22q11.2 deletion was not confirmed either by in-
house testing or by clinical genetics report. All controls had microarray testing at 
the Division of Psychological Medicine and Clinical Neurosciences (DPMCN) and 
were excluded if they were found to have a pathological CNV. Exclusion criteria 
for the MEG session were photosensitive epilepsy, the presence of orthodontic 
braces and metallic implants or prostheses in the upper half of the body. For the 
MRI session, participants were excluded if they had contraindications to MRI at 
3T (e.g. the presence of a pacemaker or cochlear implant, intracerebral shunt, 
some types of orthodontic braces or a history of surgery which may have involved 
metallic implants not certified as MRI safe).  
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45 children with 22q11.2DS and 27 siblings of children with neurodevelopmental 
CNVs expressed interest in participating in the study. All potential participants 
were screened over the telephone for contraindications for MEG and MRI. In 
cases where participants had potential contraindications, advice was sought from 
CUBRIC’s radiographers and laboratory managers and when necessary the 
participants’ doctors were contacted to ensure that it was safe for them to 
participate. Seven probands were unable to participate in the MEG session and 
21 probands were unable to participate in the MRI session due to 
contraindications. One control was found to have a 16p11.2 deletion and was 
therefore excluded from the study. In total, 38 probands and 26 controls had a 
resting-state MEG recording with 24 probands and 26 controls also having a 
structural MRI scan for co-registration of their MEG data. For probands who were 
able to take part in the MEG session but not the MRI session, an alternative 
strategy was used for co-registration of their MEG data (see below). The controls 
included 22 siblings of children with 22q11.2DS and four siblings of children with 
other neurodevelopmental CNVs. Of the siblings of children with 22q11.2DS, 14 
were related to participating probands and 12 were unrelated. 
 
Ethical approval for the study was obtained from South East Wales National 
Health Service (NHS) Research Ethics Committee. Participants over the age of 16 
years old with capacity to consent gave written informed consent to participate 
in the study. Children under the age of 16 years old or those over the age of 16 
years old who lacked the capacity to consent for themselves gave written and/or 
verbal assent to take part and their parents or carers provided consent for their 
participation.  
 
Participants fulfilling the criteria for participation in the study were invited to visit 
Cardiff for brain imaging at a time convenient to them. Demographic, psychiatric 
and cognitive data were collected either during the imaging visit (n=16) or during 
a home visit (n=48) (mean time gap=0.71 months, SD=6.48 months). The 
assessments used in the ECHO study have been described in detail in Chapters 2 
and 3. Briefly therefore, psychiatric interviews with the child’s primary caregiver 
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were conducted using the Child and Adolescent Psychiatric Assessment [CAPA; 
(Angold et al., 1995)] to derive DSM-IV-TR (American Psychiatric Association, 
2000) diagnoses and symptom counts, and the Autism Diagnostic Interview-
Revised [ADI-R; (Lord, Rutter and Le Couteur, 1994)] to derive ASD diagnoses and 
symptom counts. Cognitive assessments were conducted with participating 
children using the Wechsler Abbreviated Scale of Intelligence [WASI;(Wechsler, 
1999)], the Wisconsin Card Sorting Test [WCST; (Heaton et al., 1993)] and a 
selection of tests from the Cambridge Neuropsychological Test Automated 
Battery (CANTAB, Cambridge Cognition Limited, UK, 2006; see Chapters 2 and 3 
for a description of the subtests used). Parents or carers were also asked to 
complete a questionnaire about their child and the wider family. This pack 
included questions about family background (ethnicity, family income and 
maternal education) and standardised questionnaires including the Social 
Communication Questionnaire [SCQ; (Rutter, Bailey, and Lord 2003)] for ASD 
symptomatology. 
 
4.4.2 MEG data acquisition 
Children and their accompanying parents or carers were given plenty of time to 
familiarise themselves with the MEG environment before the session 
commenced. Parents were invited to accompany their child into the MEG-
shielded room if they felt that this would make their child more relaxed and 
comfortable. Once they were happy to proceed, participants, and where 
applicable, their accompanying parent or carer removed any metallic clothing and 
make-up. Electromagnetic coils were placed at three fiducial locations (bilateral 
preauricular regions and nasion) and their position relative to the MEG sensors 
was localised at the beginning and end of each recording. Five minute whole-head 
MEG recordings were acquired at a 1200Hz sample rate using a 275-channel CTF 
radial gradiometer system. An additional 29 reference channels were recorded 
for noise cancellation purposes. Primary sensors were analysed as synthetic third-
order gradiometers (Vrba and Robinson, 2001). Participants were seated upright 
in the MEG system during the recordings and were instructed to keep their eyes 
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open and to attend to a red fixation point presented on a mean luminance 
background using a Mitsubishi Diamond Pro 2070 monitor (100Hz frame rate) or 
PROPixx LCD projector (120Hz frame rate). Relative head position at the beginning 
and end of the recording was used to as a proxy measure of participant head 
motion. 
 
 
 
Figure 4-1 Resting-state stimulus display 
 
4.4.3 MRI data acquisition 
Individual 1mm isotropic, T1-weighted anatomical MRIs were acquired when 
possible from participating children for co-registration of MEG data. From March 
2013 to August 2016, fast spoiled gradient echo (FSPGR) images (TR=7.8ms, 
TE=3.0ms, voxel size = 1mm isotropic) were acquired on a 3T General Electric MRI 
system (GE medical systems, Milwaukee, WI). Due to the upgrade and relocation 
of CUBRIC facilities during the summer of 2016, from August 2016 to February 
2018 magnetisation prepared rapid gradient echo (MP-RAGE) images (TR=2.3ms, 
TE=3.06ms voxel size = 1mm isotropic) were acquired on a 3T Siemens Magnetom 
Prisma MRI scanner (Siemens, UK) .  
 
4.4.4 MEG analysis pipeline 
After the recordings, MEG data were downsampled to 600Hz, band-pass filtered 
at 1-150Hz and segmented into 2s epochs, generating 150 trials per participant. 
Data were then visually inspected for artefacts such as motion, muscular 
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contraction and eye movements. Trials containing such artefacts were removed 
from the dataset and excluded from further analysis. Datasets were filtered into 
the following bandwidths: delta (1-4 Hz), theta (4-8Hz), alpha (8-13Hz), beta (13-
30Hz), low gamma (30-50Hz) and high gamma (50-90Hz). Participants with head 
motion greater than 30mm or with greater than half of their trials containing 
artefacts were excluded from further analysis (n=4). After quality control, data 
from 35 probands and 25 controls remained and were included in the subsequent 
analyses. 
 
Co-registration was performed by manually labelling the fiducial points on each 
participant’s MRI using the software package MRIViewer. In cases where it was 
not possible to acquire MRI data from a child taking part in the MEG study (e.g. 
due to MRI contraindications), or when MRI data were not of sufficient quality 
(e.g. due to movement during data acquisition), an appropriate alternative co-
registered MRI scan was selected. The most appropriate alternative was identified 
by comparing the relative distances between the fiducial points for each 
participant and matching these with another participant’s dataset. The resulting 
head models were visually inspected to ensure goodness of fit. 
 
Amplitude-amplitude coupling between brain regions was analysed by spatial 
down-sampling to regions of the Automated Anatomical Labelling (AAL) atlas 
(Tzourio-Mazoyer et al., 2002). 90 cortical and subcortical regions were identified 
and time-series from these ROIs were extracted and analysed. Source 
reconstruction was performed for each participant and each frequency band 
using a linearly-constrained minimum variance (LCMV) beamformer on a 6mm 
grid using FieldTrip (version 20161011, www.fieldtriptoolbox.org). Single shell 
source models were registered to the Montreal Neuroimaging Institute’s (MNI) 
standard coordinate space. Virtual sensors were estimated for each of the voxels 
on a 6 x 6 x 6mm grid. Within each of the 90 ROIs, the virtual sensor with the 
maximum temporal standard deviation was chosen as the representative time-
series for each atlas region. These 90 signals were then orthogonalised using 
linear regression to suppress any zero-time-lag correlation suggestive of signal 
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leakage in order to reduce any spurious correlations (Colclough et al., 2015). The 
amplitude (Hilbert) envelope of source-space neural oscillatory activity for every 
AAL region per frequency band was then computed from these orthogonalised 
signals. A median spike removal filter was applied to smooth large deflections in 
the data before further analysis. 
 
Cross-correlations of the amplitude envelope for each pair of AAL regions and for 
each frequency band were computed across the entire MEG time-series giving a 
single correlation coefficient value per pair and frequency band. Amplitude 
correlations were converted to variance-normalised z-scores by applying a Fisher 
transform. Each participant’s connectivity matrix was then z-scored to have zero 
mean and unit variance across all connections, in order to correct for variability in 
data quality between participants (Siems et al., 2016). Connectivity matrices were 
then constructed for each participant using the z-statistics as edge weights for all 
the AAL atlas regions, with each connection edge representing the relative 
strength of amplitude correlations, compared to the mean, for each participant. 
The averaged, groupwise data and between-group differences were plotted on 
connectivity matrices and visually compared. The top 5% of connections in 
probands and siblings were then plotted on circle plots together with plots of 
group differences.  
 
To avoid analysing noise connections, signals were classified as signal or noise 
using a statistical thresholding procedure based on Gaussian mixture modelling 
(GMM, (Plataniotis and Hatzinakos, 2017)) for each frequency band. Using the 
expectation-maximisation algorithm with two components randomly selected as 
the initial component means, a Gaussian mixture distribution was fitted to the z-
statistics by maximum likelihood. Only connections with greater than 50% 
probability of being signal were accepted as being valid. To ensure that important 
between-group differences were not missed, this procedure was carried out 
separately for probands and controls and connections were labelled as valid if 
they reached the threshold in either group. The most valid connections were then 
plotted onto connectivity maps. The signal z-statistic for each region was then 
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summed horizontally to give the strength of their connectivity with the rest of the 
brain. Global connectivity was calculated for each group by summing the strength 
of all signal connections. 
 
The analysis pipeline is summarised in figure 4.2. 
 
 
  
Figure 4-2 MEG analysis pipeline 
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4.4.5 Statistical analysis 
Network statistics were performed in MATLAB (version R2015a, MathWorks). 
Descriptive statistics and exploratory analyses of the relationships between 
cognitive ability, psychopathology and connectivity metrics were conducted in R 
studio (version 1.1383 for Mac, www.rstudio.com).  
 
Descriptive data 
Between-group differences in age, gender, handedness, head motion and number 
of trials were analysed using the appropriate parametric or non-parametric test 
e.g. t-test, Mann-Whitney U test or chi-squared test. For continuous data, 
distributions were first checked using the Shapiro-Wilk’s test of normality in order 
to determine the most appropriate statistical test. 
 
Between-group differences in amplitude-envelope correlations (connectivity) 
Between-group differences at each of the valid connection edges identified in the 
GMM analysis were tested using unpaired t-tests of the corrected z-scores to 
identify significant edges at p<0.05 (uncorrected). Permutation testing of the 
maximum t-statistic was then performed to correct for multiple comparisons 
within each frequency band; case and control labels were swapped randomly to 
create two artificial matrices which were then compared. This was repeated 2000 
times to generate a null distribution and compared with the results previously 
generated from the real data to determine the probability that the results 
occurred by chance. This was performed for each of the frequency bands of 
interest. No correction was applied for testing across the different frequency 
bands. 
 
Sensitivity analyses 
Sensitivity analyses were conducted to examine the effects of potential 
confounding factors such as age and medication use on the between-group 
differences. This involved excluding individual participants and re-running 
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analyses to determine whether the exclusion of these participants affected any 
observed results. 
 
Relationships between resting-state connectivity, cognitive ability and 
psychopathology 
Each participant’s global connectivity score (corrected z-scores summed across all 
90 AAL nodes) was extracted for each of the frequency bands that showed signal 
connections in the GMM analysis. The AAL node with the most significant 
difference in connectivity strength (corrected z-score) between probands and 
controls was then identified for each of these frequency bands and z-scores were 
extracted for each participant. The relationships between these scores, cognitive 
ability and psychopathology were explored using linear regression.  
 
As cognitive ability is strongly associated with group status (proband or control), 
associations between cognitive scores and connectivity scores were explored in 
each group separately. Full-scale IQ (FSIQ), CANTAB subtest and WCST scores 
were used as measures of cognitive ability and were included in the regression 
models as independent variables. Due to the low rates of psychopathology in the 
control group, the relationships between connectivity scores and 
psychopathology were computed in the proband group only using symptom 
counts for the most common disorders as independent variables. As outlined in 
Chapter 3, the most common psychiatric conditions in the sample were anxiety 
disorders, ADHD and ASD. Age, gender and handedness were added hierarchically 
to the regression models to control for these potential confounders. These 
exploratory analyses were not corrected for multiple testing. 
 
4.5 Results 
4.5.1 Descriptive data 
As shown in table 4-1, probands were on average 11 months younger than 
controls, although this difference was not statistically significant at p<0.05 (mean 
age probands=13.5 years, age range 10.5-17.9 years; mean age controls=14.4 
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years, age range 10.5-17.5 years, p=0.06). There were no statistically significant 
differences in the gender or handedness between groups.  
 
 
Table 4-1 Age, gender and handedness of participating children 
 Probands Controls t/χ2 P 
Age (SD) 13.5 (1.9) 14.4 (1.8) -1.90 0.06 
Gender, % female 17(48.6) 10(40.0) 0.02 0.88 
Handedness, % right 27(77.1) 19(76.0) <0.01 0.95 
 
One proband had a past medical history of epilepsy but had not had any recent 
seizures and was not taking anticonvulsant medication. Few children were taking 
any regular medication at the time of the scans. Four probands (11.4%) were 
taking melatonin for sleep problems. One of these children was also taking 
aripiprazole 5mg once daily for challenging behaviour. No controls were taking 
medication for neurological, psychiatric or sleep disorders. 
 
4.5.2 Resting-state functional connectivity 
Data quality 
In terms of data quality, there were no significant between-group differences in 
head motion (median=4.9mm (IQR=5.5mm) in probands, median=2.9mm 
(IQR=4.6mm) in controls, p=0.49) or the number of trials included after quality 
control (median=130 (IQR=35) in probands, median = 133 (IQR=29) in controls, 
p=0.17) for the 35 probands and 25 controls who were included in the 
connectivity analyses. 
 
Simple visual analysis of differences in the connectivity matrices between 
probands and controls 
Figure 4-3 shows the connectivity matrices for each of the frequency bands. The 
resulting matrices are symmetrical with each square representing the corrected 
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z-statistic of the amplitude-envelope correlation between one AAL brain region 
and another. The first two columns show the matrices for each group separately 
(probands and controls), while the column on the right shows the differences in 
matrix z-scores between the groups. In the within-group matrices, areas of high 
correlation are represented in red. In the matrices of between-group differences, 
brain regions in which probands have higher z-scores than controls are coloured 
red, while regions in which probands have lower z-scores than controls are 
coloured blue. 
 
These connectivity matrices indicate that across the frequency bands, but most 
markedly in the alpha and beta bands, there are strong correlations between 
activity in posterior brain regions (seen as red in the centre of the first two 
columns, representing occipital and posterior parietal regions). Furthermore, 
there are differences in the strength of these connections between probands and 
controls, with probands having lower z-scores than controls in the alpha and beta 
bands in these brain regions. In the gamma bands, there appear to be strong 
correlations between activity in frontotemporal regions (seen in the top left of 
the connectivity matrix) with higher z-scores in probands than in controls.  
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Figure 4-3 Connectivity matrices for each of the frequency bands of interest 
Probands Controls 
Group 
differences  
Delta  
1-4Hz 
 
Theta 
4-8Hz 
Alpha 
8-13Hz 
  
Beta 
13-30Hz 
 
Low 
gamma 
30-50Hz 
  
High 
gamma 
50-90Hz 
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Identification of signal connections and comparison between probands and 
controls 
Figure 4-4 shows an example of the circle plots onto which the top 5% of 
connections for each group was plotted. Each point on the map represents a 
different AAL node. The same circle plots were used in the GMM analysis. 
 
 
Figure 4-4 Circle plot of AAL nodes used in the connectivity analyses 
 
Figure 4-5 shows the connectivity maps across frequency bands with each point 
representing one of the AAL nodes illustrated in figure 4-4. The first two columns 
show the top 5% of connections for each group separately, whereas the column 
on the right shows the differences in connection strength between groups, with 
red representing higher and blue representing lower amplitude-envelope 
correlations in probands compared with controls. This figure is a simple 
visualisation of between-group differences without statistical testing.  
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Figure 4-5 Circle plots of the top 5% of connections for each of the frequency bands of 
interest 
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In the delta band, connections can be seen within and between several brain 
regions, including frontal, temporal, limbic, parietal, occipital and subcortical 
nodes. There was increased connection strength between the right precuneus 
and occipital nodes and reduced strength between the left precuneus and inferior 
parietal node in probands compared with controls. The theta band shows 
temporal, parietal and occipital signal connections with stronger connections in 
the right temporal lobe in probands than controls. In the alpha band, the most 
prominent connections for both groups are in the occipital, parietal and temporal 
regions. Comparing these connections between groups, probands can be seen to 
have a reduction in the strength of connections in the occipital and right parietal 
regions. In the beta band, occipital, parietal and temporal connections are also 
present and there are additional signal connections between frontal and parietal 
nodes. However, between-group differences are restricted to the posterior part 
of the brain with similar reductions in the strength of occipital connections as 
those seen in the alpha band as well as increased strength of left parieto-occipital 
connections. In the high gamma band, frontotemporal, temporo-temporal, 
temporo-occipital and occipito-occipital signal connections are present with an 
increase in frontotemporal connectivity in probands compared with controls. No 
valid signal connections were identified in the low gamma band. 
 
GMM Analysis of signal connections between probands and siblings 
After GMM analysis, no signal connections were found in the theta, low gamma 
or high gamma bands. Figures 4-6 to 4-8 therefore show the results of the GMM 
analysis for delta, alpha and beta bands only.  
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In each figure (4-6 to 4-8), panel A shows the valid signal connections in probands 
and controls identified by GMM, panel B shows the uncorrected difference in the 
signal connection strength between probands and controls, panel C shows the 
corrected group differences in signal connection strength, panel D shows the 
distribution of mean z-scores between probands and controls with blue 
representing noise and red representing signal connections, panel E shows the 
sum of all signal connections at each AAL node for probands (red) and siblings 
(blue), and panel F shows the sum of the z-scores for all signal connections across 
all 90 AAL nodes in probands (red) and siblings (blue). Circle plots A, B and C in 
each figure refer to the same brain regions as shown in the circle plot in figure 4-
4.  
 
As can be seen in circle plot A in figure 4-6,  delta band signal connections were 
found throughout the brain but were particularly prominent within and between 
frontal nodes. However, when comparing the differences between probands and 
controls (circle plot C), only one connection was statistically significantly different 
at p<0.05 (corrected) - the left precuneus to the left inferior parietal cortex. In the 
alpha band, signal connections were present in the occipital lobe and precuneus 
(circle plot A) with lower strength of these connections in probands compared to 
controls (circle plot B). However, randomisation testing of the resulting t-statistic 
identified no statistically significant connections at p<0.05 (circle plot C). The most 
significant between-group difference was in the connection between the left 
calcarine region and the right lingual gyrus (p=0.07). In the beta band, signal 
connections were also focussed on posterior brain regions (circle plot A). 
Probands had reduced amplitude-envelope correlations between occipital nodes 
with the connections between the right lingual gyrus and right calcarine region 
remaining statistically significant after randomisation testing (circle plot C, 
p=0.01).  
 
The plots shown in the lower left panels (D) of figures 4-6 to 4-8 show an even 
distribution of noise connections between probands and controls (blue) across 
frequency bands suggesting that there are no between-group differences in data 
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noise. The distribution of signal connections (red) however, does differ between 
groups with lower signal connection z-scores in probands than controls. The lower 
middle plots (E) in figures 4-6 to 4-8 show the connectivity strength of each AAL 
node (calculated as the sum of the z-scores for every signal connection at each 
node (numbered 1-90)). These also show a reduction in probands (red) compared 
to controls (blue) across nodes and frequency bands. The nodes with the greatest 
difference in z-scores between probands and controls were the right precuneus 
in the alpha band, the right calcarine region in the beta band and the left insula in 
the delta band. Finally, the violin plots in the lower right panels show the global 
connectivity scores for each group (F). This score is calculated as the sum of the 
signal z-scores across all 90 nodes for probands (red) and controls (blue). This 
shows lower global connectivity in cases and controls, which is statistically 
significant at p<0.05 for delta (p<0.01), alpha (p=0.04) and beta (p=0.04) bands.  
 
Relationships between connectivity measures, cognitive ability and 
psychopathology  
In the alpha band, exploratory linear regression analyses found no statistically 
significant associations between global connectivity scores and age, IQ, WCST 
performance or CANTAB subtest scores in either proband or control groups. 
However, in the proband group, total z-scores in the right precuneus were 
significantly associated with performance in the Stockings of Cambridge (SOC) 
task of spatial planning and the Rapid Visual Processing (RVP) task of sustained 
attention. These associations survived correction for age (SOC: estimate=0.25, 
SE=0.11, r2=0.11, p=0.03; RVP: estimate=0.28, SE=0.12, r2=0.14, p=0.03) but not 
age and gender (SOC: estimate=0.21, SE=0.13, r2=0.08, p=0.12; RVP: 
estimate=0.23, SE=0.13, r2=0.26, p=0.08). Furthermore, a statistically significant 
relationship was found in the proband group between global and right precuneus 
connectivity scores and CAPA derived total anxiety scores and SCQ scores (see 
tables 4-2 and 4-3, and figures 4-9, 4-10, 4-11 and 4-12). These associations 
remained statistically significant even when age, gender and handedness were 
included in the regression models (global connectivity and total anxiety score, 
estimate= -3.70, SE=1.44, r2= 0.10, p=0.02; right precuneus connectivity and total 
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anxiety score, estimate= -0.04, SE=1.39, r2=0.08, p<0.05; global connectivity and 
SCQ score, estimate= -4.48, SE=1.44, r2=0.27, p<0.01; right precuneus 
connectivity and SCQ score, estimate= -0.05, SE=0.02, r2=0.18, p=0.02). However, 
ASD scores derived from the ADI-R and ADHD scores derived from the CAPA were 
not associated with either global or right precuneus connectivity. There were no 
statistically significant associations between connectivity scores and age, 
cognitive or psychiatric variables in either the beta or delta bands.  
 
Table 4-2 Relationships between alpha band global connectivity, psychopathology and 
cognitive ability in probands  
 Estimate Standard  
Error 
 R2 P 
Age 
 
3.18 5.87 <0.01 0.59 
ADHD Score 
 
-2.24 2.69 0.03 0.42 
ADI-R Score  
 
-0.92 0.87 0.06 0.30 
SCQ Score 
 
-4.23 1.57 0.29 0.01* 
Anxiety Score 
 
-3.59 1.36 0.21 0.01* 
FSIQ  
 
0.82 0.85 0.03 0.34 
WCST (set-shifting 
ability) 
<0.01 0.20 <0.01 0.96 
Visual attention  
(MTS) 
1.42 1.17 0.03 0.23 
Spatial working memory 
(SWM) 
13.85 7.74 0.06 0.08 
Spatial planning  
(SOC) 
10.86 6.22 0.06 0.09 
Processing speed  
(RTI)  
-5.56 7.39 0.02 0.46 
Sustained attention  
(RVP) 
10.68 9.44 0.05 0.27 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge;  RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
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Table 4-3 Relationship between alpha band connectivity in the right precuneus, 
psychopathology and cognitive ability in probands 
 Estimate Standard  
Error 
  R2 P 
Age <0.01 0.07 <0.01 0.99 
ADHD Score 
 
<0.01 0.03 <0.01 0.79 
ADI Score 
 
-0.02 <0.01 0.16 0.08 
SCQ Score 
 
-0.06 0.02 0.29 <0.01* 
Anxiety Score 
 
-0.04 0.02 0.16 0.03* 
FSIQ 
 
<0.01 0.01 0.02 0.46 
WCST (set-shifting  
ability) 
<0.01 <0.01 0.02 0.52 
Visual attention 
(MTS)  
<0.01 0.01 0.01 0.53 
Spatial working memory 
(SWM) 
0.20 0.15 0.06 0.18 
Spatial planning 
(SOC) 
0.24 0.11 0.16 0.03* 
Processing speed  
(RTI)  
-0.02 0.09 <0.10 0.81 
Sustained attention  
(RVP) 
0.26 0.11 0.20 0.02* 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-Scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge;  RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
 
 
Figures 4-9 to 4-12 show that global alpha connectivity and right precuneus 
connectivity in the alpha band are lower in probands with higher anxiety scores 
and social communication problems. 
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Figure 4-9 Relationship between alpha global connectivity and total anxiety score in 
probands 
 
 
Figure 4-10 Relationship between right precuneus connectivity and total anxiety score in 
probands 
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Figure 4-11 Relationship between alpha global connectivity and Social Communication 
Questionnaire (SCQ) score in probands 
 
 
Figure 4-12 Relationship between right precuneus connectivity and Social Communication 
Questionnaire (SCQ) score in probands 
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Sensitivity analyses 
Although not statistically significant, there was a mean age difference of 11 
months between probands and controls who took part in the study. In the 
regression analyses reported above, age was not significantly associated with 
connectivity measures. However, to ensure that age differences between groups 
were not responsible for the observed differences in connectivity, analyses were 
re-run on the oldest 25 cases and the 25 controls. Mean age in this analysis was 
14.2 years for probands (SD=1.7 years) and 14.4 years (SD=1.8 years) for controls. 
Analyses were also re-run excluding the child who was taking antipsychotic 
medication. These analyses confirmed the findings above with reductions in 
connectivity seen in the same frequency bands and brain regions.  
 
4.6 Discussion 
In this resting-state MEG study of children with 22q11.2DS, significant differences 
in global connectivity were found between probands and controls in the alpha, 
beta and delta bands. Furthermore, in the GMM analysis, probands had a 
statistically significant reduction in the strength of signal connections between 
the right lingual gyrus and right calcarine region in the beta band. There were also 
reductions in connection strength between the right lingual gyrus and the left 
calcarine region in the alpha band, but this did not survive correction for multiple 
testing at p<0.05. In the delta band, there was a reduction in the strength of the 
connection between left inferior parietal cortex and precuneus. While the simple 
analysis of differences suggested an increase in frontotemporal connections in 
the high gamma band in participants with 22q11.2DS, GMM analysis indicated 
none of these connections were valid signal. The apparent between-group 
differences may have been driven by outlier participants or by differences in noise 
between groups, e.g. from facial muscle and eye motion artefacts 
(Muthukumaraswamy, 2013). No signal connections were found in the low 
gamma or theta bands.  
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The nodes that were most significantly affected by CNV status were the right 
precuneus (alpha band), the right calcarine region (beta band) and the left insula 
(delta band). The precuneus and posterior parietal cortex form part of the default 
mode network (DMN). Atypical connectivity in this network has been found in 
resting-state fMRI studies of schizophrenia (Whitfield-Gabrieli et al., 2009), ASD 
(Assaf et al., 2010), ADHD (Franzen et al., 2013; Sudre et al., 2017), and 22q11.2DS 
(Debbané et al., 2012; Schreiner et al., 2014; Padula et al., 2015; Mattiaccio et al., 
2016; Zöller et al., 2017). Abnormal oscillatory dynamics in the DMN have been 
shown in clinical samples using MEG (Franzen et al., 2013; Kim et al., 2014; 
Lajiness-O’Neill et al., 2018) but this study provides the first evidence for such 
alterations in 22q11.2DS.  
 
This study also finds evidence for atypical connectivity in the occipital cortex, 
suggesting abnormalities of the visual pathways at rest in this high-risk group. 
People with 22q11.2DS have known deficits in visual perception and processing 
(Bearden et al., 2001; Simon et al., 2005; Magnée et al., 2011; McCabe et al., 
2016) and alterations in visual processing networks have previously been 
demonstrated in both resting-state and event-related fMRI studies in 22q11.2DS 
(Andersson et al., 2008; Debbané et al., 2012). Furthermore, a recent EEG study 
in 22q11.2DS found a reduction in occipital cortical activity in 22q11.2DS 
compared to controls during an illusory contour task (Biria et al., 2018). Visual 
processing abnormalities are well-established in schizophrenia (Silverstein et al., 
2015) and ASD (Vandenbroucke et al., 2008; Baruth et al., 2010; Vlamings et al., 
2010) but the relationship between these deficits in 22q11.2DS and the risk of 
neurodevelopmental and psychiatric disorders is not yet well-understood. 
 
The altered alpha band oscillatory patterns seen in children with 22q11.2DS were 
found to be associated with psychopathology and cognitive function in the 
exploratory analyses. While caution should be exercised in interpreting these 
results, not least because they have not been corrected for multiple comparisons, 
the observed associations are nevertheless interesting. Global connectivity and 
precuneus connectivity were strongly associated with SCQ scores (a measure of 
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ASD symptomatology) but not with ADI-R scores. Although no association was 
found with ADI-R scores, fewer participants had complete ADI-R data so the 
power to detect associations was lower for this measure of ASD symptoms. 
Atypical alpha band connectivity has been reported in idiopathic ASD where it has 
been associated with symptom severity as measured by the Social 
Responsiveness Scale [SRS; (Constantino et al., 2003)], albeit in a different 
direction to the present findings, with increased alpha power being seen in an 
eyes-closed resting-state paradigm (Cornew et al., 2012). Global connectivity and 
precuneus connectivity were also strongly associated with total anxiety scores. To 
my knowledge, anxiety disorders have not previously been investigated with 
resting-state MEG. Anxiety disorders are extremely prevalent in 22q11.2DS across 
the lifespan (Schneider et al., 2014) and have been found to predict conversion to 
psychosis (Gothelf et al., 2007a; Kates et al., 2015; Tang et al., 2017).  
 
In the present study, children with higher anxiety and SCQ scores had lower global 
alpha and precuneus connectivity. Due to the low rate of psychotic symptoms in 
this sample (see Chapter 3), the relationships between alpha band connectivity, 
anxiety symptoms, ASD symptoms and psychosis could not be explored further. 
However longitudinal follow-up studies through the risk-period for the onset of 
psychosis may shed further light on these relationships and the potential utility of 
alpha band connectivity as a biomarker for psychosis risk. This could have 
important implications for risk prediction within this already high-risk group. 
 
4.7 Strengths and limitations 
The investigations presented in this chapter have a number of strengths. A sample 
of children aged between 10 and 17 years old was recruited thereby reducing the 
confounding effects of age that can impact studies which include both children 
and adults. Siblings of children with neurodevelopmental CNVs were recruited as 
controls to try to match for socioeconomic and environmental factors. Rigorous 
phenotyping was performed so that relationships between connectivity 
measures, clinical and cognitive phenotypes could be explored. Although this 
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phenotyping revealed high rates of psychopathology, few children had received a 
psychiatric diagnosis or were receiving treatment. Indeed only one child was 
taking psychotropic medication and excluding this child from the analyses did not 
affect the observed results. 
 
There are a number of different methods available to investigate functional 
connectivity using MEG. This chapter sought to identify consistent functional 
connections and to minimise the effects of noise using amplitude-envelope 
correlations of beamformer-derived oscillatory source signals. This approach was 
chosen as it is one of the most robust and repeatable methods available 
(Colclough et al., 2016). Orthogonalisation was used to suppress any zero-time-
lag correlation suggestive of signal leakage. A Gaussian mixture modelling 
approach was used to identify the correlations most likely to represent valid signal 
connections. A benefit of this approach is that any observed between-group 
differences are unlikely to be due to spurious correlations however, this is a 
conservative approach that can miss weaker correlations that may be relevant to 
pathology. 
 
There are a number of limitations of the present study. The sample size, while 
fairly large in the field of 22q11.2DS research, is nevertheless modest for a MEG 
study and so without replication, the findings should be interpreted cautiously 
due to the risks of both type 1 and type 2 error (Button et al., 2013). The relatively 
short duration of the resting-state paradigm was chosen to balance data quantity 
and quality, however this will have resulted in lower signal to noise ratios than a 
longer paradigm such as those conducted in adults and typically developing 
participants (Liuzzi et al., 2017). Unfortunately a longer recording would not have 
been feasible for the majority of children taking part in this study. The frequency 
of surgical and other contraindications for MRI scanning meant that it was not 
possible to co-register MEG data to each participant’s own MRI scan. While every 
attempt was made to closely match the fiducial locations to those of another 
participant, this is not a perfect substitute for using participants’ own data and 
this may have affected source localisation. Furthermore, continuous head 
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localisation was not used during data acquisition as this was not standard practice 
in the CUBRIC MEG laboratory when the study commenced. This meant that 
detailed analysis of head movement and correction for this was not possible. 
Head localisation before and after recordings was used as a proxy for head 
motion, however, this does not give any indication about the amount of 
movement during the recording. While it is reassuring that this proxy measure did 
not differ between groups, without continuous monitoring, one cannot be certain 
that there were no differences between groups in the amount of movement 
during the task. Finally, there were some psychiatric and cognitive data missing at 
the time of analysis. This was particularly problematic for the ADI-R data, which 
were only available for 26 probands (74% of the sample). This will have affected 
the power to detect relationships between ADI-R scores and connectivity scores. 
 
4.8 Conclusions 
In conclusion, in this resting-state MEG study of children with 22q11.2DS and 
controls, there was evidence for a reduction in resting-state connectivity in alpha, 
beta and delta bands, particularly affecting posterior brain regions. In the alpha 
band, this reduction was associated with SCQ and total anxiety scores. This finding 
supports the hypothesis of altered resting-state connectivity in 22q11.2DS which 
is associated with the severity of psychopathology and provides preliminary 
evidence for excitatory-inhibitory imbalance in children with 22q11.2DS. 
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5 Visual gamma responses in 22q11.2 deletion 
syndrome 
5.1 Summary 
High frequency neuronal oscillations in the gamma band are generated by 
reciprocal connections between excitatory glutamatergic pyramidal cells and 
inhibitory GABAergic interneurons. These oscillations can be enhanced by simple 
sensory stimuli such as visual gratings. The amplitude, power and frequency of 
gamma responses to such stimuli are thought to reflect excitatory-inhibitory 
balance.  
 
Gamma responses are highly heritable and are altered in schizophrenia, ASD and 
ADHD. Evidence from postmortem and animal studies suggests that the 
distribution and function of GABAergic interneurons is perturbed in 22q11.2DS 
but only one previous study has investigated gamma oscillations, finding reduced 
power of the EEG auditory steady-state response.  
 
This study aimed to compare visual gamma and evoked responses between 
children with 22q11.2DS and controls and to explore relationships between these 
responses, cognitive ability and psychopathology. 36 probands and 26 controls 
were recruited to the study. MEG recordings were performed while children 
observed 100 trials of a stationary, vertical square-wave grating, presented at 
two-second intervals. A beamformer approach was used to identify sources of 
peak gamma activity in the visual cortex (virtual sensors). Peak gamma amplitude 
and peak gamma frequency were calculated from time-frequency analysis of the 
sustained response at these virtual sensors. The sum of broadband gamma power 
during the sustained response was also computed. The amplitude of visual evoked 
potentials was investigated by performing time-frequency analysis of the evoked 
response. Relationships between age, psychopathology, cognitive ability, induced 
gamma and evoked responses were explored using linear regression. 
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Probands had a marked reduction in the sum of broadband gamma power 
between 35-70Hz during the sustained response. In the exploratory analyses, 
probands’ cognitive performance was positively associated with the sum of 
broadband gamma power, peak gamma amplitude and the amplitude of the 
evoked response. The sum of broadband gamma power, peak gamma frequency 
and the amplitude of the evoked response were negatively associated with ASD 
symptoms. These findings support the hypothesis of altered excitatory-inhibitory 
balance in 22q11.2DS and provide preliminary evidence for an association with 
cognitive ability and social communication problems. 
 
5.2 Introduction 
In Chapter 4, it was shown that low frequency oscillations (in the delta, alpha and 
beta bands) were altered in 22q11.2DS using a resting-state MEG paradigm. No 
signal connections were observed in higher frequency bands in the GMM analysis. 
While low frequency oscillations are thought to predominantly reflect relatively 
long-distance communication, oscillations at higher frequencies, e.g. the gamma 
band, are thought to reflect synchronisation in local and distributed circuits 
(Singer, 1999; von Stein and Sarnthein, 2000; Uhlhaas and Singer, 2010; Donner 
and Siegel, 2011).   
 
Previous MEG studies have shown that gamma oscillations can be enhanced by 
simple sensory stimuli. For example, in the visual cortex, gamma oscillations can 
be induced by high contrast gratings, producing both an early transient gamma 
spike and a later sustained response (Adjamian et al., 2004; Hoogenboom et al., 
2006; Muthukumaraswamy et al., 2009; Swettenham, Muthukumaraswamy and 
Singh, 2009; Perry et al., 2011). These responses can be modulated by altering 
stimulus parameters such as contrast (Ray and Maunsell, 2010), orientation 
(Koelewijn et al., 2011), spatial frequency (Adjamian et al., 2004), motion 
(Swettenham, Muthukumaraswamy and Singh, 2009) and size (Perry et al., 2013). 
In contrast to visual evoked potentials, which occur within 100ms after stimulus 
onset and are time- and phase-locked to it, induced gamma band responses occur 
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between approximately 300 and 1500ms and are not phase-locked to the 
stimulus. While evoked responses are considered to reflect bottom-up sensory 
processing involving driving inputs e.g. from the visual pathways, induced 
responses are thought to reflect higher order top-down processes such as 
feature-binding, which involve additional modulatory inputs (Tallon-Baudry et al., 
1996; David, Kilner and Friston, 2006). 
 
Gamma oscillations are thought to be generated by reciprocal connections 
between excitatory pyramidal cells and inhibitory interneurons (Traub, Jefferys 
and Whittington, 1997; Bartos, Vida and Jonas, 2007; Whittington et al., 2011; 
Buzsáki and Wang, 2012). Fast-spiking parvalbumin-containing (PV+) 
interneurons are critical to maintaining balance in these networks. These cells 
represent approximately 50% of GABAergic interneurons in the cortex and consist 
of both chandelier and basket cells which form GABAA synapses on target neurons 
and also synchronise each other through gap junctions. They are recruited by 
phasic glutamatergic input from pyramidal cells and provide inhibition to 
pyramidal cells and thus act as a pacemaker for oscillatory activity (Gonzalez-
Burgos, Cho and Lewis, 2015). Optogenetic studies in mice have provided in vivo 
evidence that these interneurons are essential for driving cortical gamma 
oscillations (Cardin et al., 2009; Sohal et al., 2009). 
 
Computational studies have shown that gamma amplitude, power and frequency 
are determined by local excitatory-inhibitory (E-I) balance (Brunel and Wang, 
2003; Spencer, 2009). Furthermore, pharmaco-MEG studies have found that the 
gamma responses are affected by drugs that target GABAergic neurotransmission 
(Saxena et al., 2013; Campbell et al., 2014; Lozano-Soldevilla et al., 2014; 
Magazzini et al., 2016). Previous studies have shown that while there is 
considerable variability in peak gamma frequency between individuals, this is 
reproducible over time (Muthukumaraswamy et al., 2010) suggesting that 
individuals have a characteristic gamma band response to visual stimuli, albeit 
one that decreases with age (Gaetz et al., 2012; Robson et al., 2015). As with 
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oscillations in lower frequency bands, gamma frequency has been found to be 
highly-heritable, with an estimated heritability of 91% (Vogel, 1970; Young, Lader 
and Fenton, 1972; van Beijsterveldt and van Baal, 2002; van Pelt, Boomsma and 
Fries, 2012).  
 
Atypical gamma band responses have been reported in patients with 
schizophrenia as well as their unaffected relatives during simple perceptual and 
cognitive tasks (Kwon et al., 1999; Spencer et al., 2003; Spencer, Niznikiewicz, et 
al., 2008; Spencer, Salisbury, et al., 2008; Haenschel et al., 2009; Tsuchimoto et 
al., 2011; Hamm et al., 2011; Mulert et al., 2011; Liu et al., 2012; Grützner et al., 
2013; Sun et al., 2013; Hirano et al., 2015). While the majority of studies report a 
reduction in gamma amplitude or synchrony, increased gamma responses in 
circumscribed brain regions have been associated with positive symptoms (Lee et 
al., 2003; Spencer et al., 2009). Furthermore, patients with schizophrenia have 
been found to have lower gamma frequency than controls in response to a visual 
gestalt stimulus (Spencer et al., 2004). Gamma band abnormalities have also been 
reported in people with ASD in response to different stimuli (Grice et al., 2001; 
Brown et al., 2005; Milne et al., 2009; Sun et al., 2012; Wright et al., 2012; 
Snijders, Milivojevic and Kemner, 2013) and in unaffected relatives of people with 
ASD (Rojas et al., 2008, 2011). Correlations have been found between gamma 
responses and clinical symptoms measured by the SRS (Maxwell et al., 2015). The 
peak frequency of gamma responses in the motor cortex has been shown to be 
reduced in ASD and to be negatively correlated with ASD severity, measured by 
the ADOS (An et al., 2018). As with resting-state MEG/EEG studies, there have 
been few studies of gamma band responses in ADHD. However, a pharmaco-MEG 
study using an auditory stimulus found reduced gamma band activity in adults 
with ADHD, which increased after administration of stimulant medication (Wilson 
et al., 2012)  
 
Post-mortem studies have shown that the distribution and function of GABAergic 
interneurons is perturbed in patients with 22q11.2DS (Kiehl et al., 2009; Mori et 
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al., 2011). Murine models of 22q11.2DS provide further evidence for 
abnormalities in GABAergic neurons in this syndrome. These studies have found 
abnormal density, morphology and migration of PV+ interneurons (Meechan et 
al., 2009, 2012; Piskorowski et al., 2016) as well as abnormal cortical network 
activity (Sigurdsson et al., 2010; Amin et al., 2017). Despite this evidence for 
abnormal inhibitory networks in 22q11.2DS, there has been little research into 
gamma oscillations in humans with the microdeletion. To date, there has been 
only one published study of gamma oscillations in 22q11.2DS. This EEG study of 
auditory steady state responses recruited a mixed sample of children and adults 
with 22q11.2DS and found reduced gamma power and inter-trial phase 
coherence in 22q11.2DS compared to healthy non-carriers (Larsen et al., 2018a).  
 
People with 22q11.2DS are known to have deficits in visual processing (Bearden 
et al., 2001; Simon et al., 2008; Biria et al., 2018). In Chapter 4,  abnormal 
connectivity was found in the occipital cortex in a resting-state MEG paradigm, 
consistent with a previous fMRI study in 22q11.2DS (Debbané et al., 2012). To my 
knowledge, there have been no previous studies of induced gamma responses to 
visual stimuli in 22q11.2DS using MEG, meaning that local excitatory-inhibitory 
balance in the occipital cortex has not been investigated in people with the 
syndrome. 
 
5.3 Rationale, aims and hypotheses 
Evidence from cellular, animal and human studies suggest that excitatory-
inhibitory balance is disrupted in neurodevelopmental disorders and that this is 
reflected by atypical gamma band activity. As outlined in Chapter 4, variability 
across studies in terms of participant age, clinical status, medication use and 
control group selection affect the ability to draw firm conclusions about the 
nature of cortical circuit abnormalities in these disorders. Studying a group of 
children at high genetic risk for neurodevelopmental disorders offers the 
opportunity to address some of these biases and confounds.  
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This study used MEG to compare neural responses to visual stimulation between 
children with 22q11.2DS (probands) and children without neurodevelopmental 
CNVs (controls). In this chapter, induced and evoked responses to a static visual 
grating are investigated. This is an approach that has been shown to produce 
reliable and repeatable responses in the visual cortices of healthy controls 
(Muthukumaraswamy et al., 2010). Detailed phenotypic information was 
collected so that associations between visual responses, cognitive and psychiatric 
variables could be explored.  
 
The primary aim of this chapter is to compare visually-induced gamma oscillations 
(peak amplitude, peak frequency and total sum of gamma power between 35-
70Hz) between children with 22q11.2DS (probands) and children without 
neurodevelopmental CNVs (controls). A secondary aim is to compare visual 
evoked responses between probands and controls. A final aim is to explore 
relationships between visual responses (induced and evoked), cognitive ability 
and psychopathology. Previous studies of people with neurodevelopmental 
disorders find atypical gamma band responses with variable directions of effect. 
As people with 22q11.2DS have visual processing abnormalities and as the 
deletion is associated with abnormalities of interneuron distribution and function, 
I hypothesise that compared to children without neurodevelopmental CNVs, 
children with 22q11.2DS have reduced evoked and induced gamma band 
responses. It is further hypothesised that these responses are positively 
associated with cognitive ability and negatively associated with the severity of 
psychopathology. 
 
5.4 Methods 
5.4.1 Participants 
Participants were recruited from the Experiences of people with copy number 
variants (ECHO) cohort at Cardiff University (See Chapters 2 and 3 for a detailed 
description of recruitment methods and sample characteristics). Children with 
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22q11.2DS and unaffected siblings of children with neurodevelopmental CNVs 
were invited to take part. Ethical approval for the study was obtained from South 
East Wales National Health Service (NHS) Research Ethics Committee. Participants 
over the age of 16 with capacity to consent gave written informed consent to 
participate in the study. Children under the age of 16 or those over 16 who lacked 
the capacity to consent for themselves gave written and/or verbal assent to 
participate and their parents/carers provided consent for their participation. 
 
All potential participants were screened over the telephone for contraindications 
for MEG and MRI. In cases where participants had potential contraindications, 
advice was sought from CUBRIC’s radiographers and laboratory managers and 
where necessary the participants’ doctors were contacted to ensure that it was 
safe for them to participate. Inclusion criteria were age 10-17 years old with a 
diagnosis of 22q11.2DS or a genetically-related sibling of a child with a 
neurodevelopmental CNV. Exclusion criteria for the MEG were photosensitive 
epilepsy and the presence of orthodontic braces or metallic prostheses in the 
upper half of the body. For the MRI, participants were excluded if they had 
contraindications to MRI at 3T (e.g. presence of a pacemaker or cochlear implant, 
intracerebral shunt, some types of orthodontic braces or a history of surgery 
which may have involved metallic implants not certified as MRI safe (or not known 
to be MRI safe)).  
 
Participants fulfilling the criteria for participation in the study were invited to visit 
Cardiff for brain imaging at a time convenient to them. Demographic, psychiatric 
and cognitive data were collected either during the imaging visit (n=16) or during 
a home visit (n=46, mean time gap=0.69 months, SD=6.56 months). Psychiatric 
interviews with the child’s primary caregiver were conducted using the Child and 
Adolescent Psychiatric Assessment [CAPA; (Angold et al., 1995)] to derive DSM-
IV-TR (American Psychiatric Association, 2000) diagnoses and symptom counts, 
and the Autism Diagnostic Interview-Revised [ADI-R; (Lord, Rutter and Le Couteur, 
1994)] to derive ASD diagnoses and symptom counts. Cognitive assessments were 
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conducted with participating children using the Wechsler Abbreviated Scale of 
Intelligence [WASI;(Wechsler, 1999)], the Wisconsin Card Sorting Test [WCST; 
(Heaton et al., 1993)] and a selection of tests from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB, Cambridge Cognition 
Limited, UK, 2006; see Chapter 2 for a description of the subtests used). 
Parents/carers were also asked to complete a questionnaire about their child and 
the wider family. This included questions about family background (ethnicity, 
family income and maternal education) and standardised questionnaires 
including the Social Communication Questionnaire [SCQ; (Rutter, Bailey and Lord, 
2003)] for ASD symptomatology. 
 
36 Children with 22q11.2DS (probands) and 26 non-carrier siblings of children 
with neurodevelopmental CNVs (controls) took part in this study. The control 
group included 22 siblings of children with 22q11.2DS and four siblings of children 
with other pathological CNVs. Of the siblings of children with 22q11.2DS, 15 were 
related to participating probands and seven were unrelated. 
 
5.4.2 MEG data acquisition 
MEG recordings were acquired at a 1200Hz sample rate using a 275-channel CTF 
radial gradiometer system. An additional 29 reference channels were recorded 
for noise cancellation purposes. Primary sensors were analysed as synthetic third-
order gradiometers (Vrba and Robinson, 2001). Children and their accompanying 
parent/carer were given plenty of time to familiarise themselves with the MEG 
environment before the session commenced. Parents were invited to accompany 
their child into the MEG-shielded room if they felt that this would make their child 
more relaxed and comfortable. Once they were happy to proceed, participants, 
and where applicable their accompanying parent, removed any metallic clothing 
and/or make-up. Children with refractive errors affecting their ability to visualise 
the stimuli were given MEG-compatible glasses to wear during the recordings. 
Electromagnetic coils were placed at three fiducial locations (bilateral 
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preauricular regions and nasion) and their position relative to the MEG sensors 
was localised at the beginning and end of each recording. Participants were 
seated upright in the MEG system during the recordings. Relative head position 
at the beginning and end of the recording was used to as a proxy measure of 
participant head motion. 
 
The stimulus consisted of a stationary, vertical, square-wave grating with 
maximum contrast, and a spatial frequency of 3 cycles per degree, located in the 
centre of the display with 8° x 8° of visual angle. Stimuli were presented on a mean 
luminance background using a Mitsubishi Diamond Pro 2070 monitor or PROPixx 
LCD projector (1024 x 768 pixel and 100Hz frame rate (monitor) or 120Hz frame 
rate (projector)). Participants were instructed to attend to a red fixation point in 
the centre of the screen and to press a response button when the grating 
disappeared. The grating was presented for 1.5-2 seconds and participants were 
given 0.75 seconds to respond. If they failed to respond within this time, a warning 
message was displayed before the next trial. After the response period, there was 
a rest period of 2 seconds during which only the red fixation square was 
presented. In total, the session contained 100 trials and lasted approximately 
eight minutes.  
 
 
Figure 5-1 Visual stimulus display 
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5.4.3 MRI data acquisition 
Individual 1mm isotropic, T1-weighted anatomical MRIs were acquired where 
possible from participating children for co-registration of MEG data. From March 
2013 to August 2016, fast spoiled gradient echo (FSPGR) images were acquired on 
a 3T General Electric MRI system (GE medical systems, Milwaukee, WI) at CUBRIC. 
Due to the upgrade and relocation of CUBRIC facilities during the summer of 2016, 
from August 2016 to February 2018 magnetization-prepared rapid acquisition 
with gradient echo (MP-RAGE) images were acquired on a 3T Siemens Magnetom 
Prisma scanner (Siemens, UK).  
 
5.4.4 MEG analysis pipeline 
After the recording, data were epoched into 100 trials (-2 seconds to 2 seconds 
around stimulus onset) and visually inspected for artefacts such as motion, 
muscular contraction and eye movements. Trials containing such artefacts were 
removed from the dataset and were not included in the subsequent analysis. 
Participants with head motion greater than 30mm or with poor quality data (<50 
good trials) were excluded from further analysis. Following quality control, data 
from 11 probands and four controls were excluded, leaving a sample of 25 
probands and 22 controls. 
 
Co-registration was performed by manually labelling the fiducial points on each 
participant’s MRI using the software package MRIViewer. In cases where it was 
not possible to acquire MRI data from children taking part in the MEG study (for 
example, due to MRI contraindications or due to difficulty tolerating the MRI 
environment), or where MRI data were not of sufficient quality (e.g. due to 
movement during data acquisition), an appropriate alternative co-registered MRI 
scan was selected. The most appropriate alternative was identified by comparing 
the relative distances between the fiducial points for each participant and 
matching these with another participant’s data. The resulting head models were 
visually inspected to ensure goodness of fit. 
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MEG sensor data were source-localized using FieldTrip (version 20180531, 
www.fieldtriptoolbox.org). Each participant’s MRI was divided into an irregular 
grid by warping the individual MRI to the Montreal Neurological Institute’s (MNI) 
template brain and then applying the inverse transformation matrix to the regular 
MNI template grid (5mm isotropic voxel resolution) to allow source estimates at 
comparable locations across participants. For each grid location inside the brain, 
the forward model (i.e. the leadfield) was calculated for a single-dipole 
orientation by singular value decomposition (SVD), using a single-shell volume 
conduction model (Nolte, 2003). Source power at each location was estimated 
using a linear constrained minimum variance (LCMV) beamformer (Van Veen et 
al., 1997), where the weights were computed using a covariance matrix calculated 
after band-pass filtering the data between 35 and 70Hz. For each participant, the 
voxel of greatest increase in gamma power was located within the occipital cortex 
by contrasting the stimulus epochs (0.3 to 1.5 seconds) with baseline (-1.5 to -0.3 
seconds). Anatomical masks were created using the Automated Anatomical 
Labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002) to exclude sources outside the 
visual cortex. At this peak location, the source-level time-series were 
reconstructed by multiplying the sensor-level data by the beamformer weights. 
Trials were represented in the time-frequency domain by calculating the 
amplitude envelope of signal obtained with the Hilbert transform. Time-
frequency plots were visually inspected to identify sustained gamma band 
responses in these peak locations. The sum of broadband gamma power (35-
70Hz), peak amplitude and peak frequency were calculated during the sustained 
response (0.3-1.5 seconds, (Swettenham, Muthukumaraswamy and Singh, 2009)) 
and extracted for further analysis. Time-frequency analysis of the evoked 
response (0.07-0.10 seconds) was also performed for each participant. Individual 
time-frequency plots were visually inspected and for participants with a clear 
evoked response, the magnitude of the evoked response amplitude was 
calculated from the time-series peaks, which were averaged over trials and 
baselined. The amplitude of the evoked response for each participant was 
extracted for further analysis. 
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Figure 5-2 MEG analysis pipeline 
 
5.4.5 Statistical analysis 
Statistical analyses were conducted using R Studio (version 1.1383 for Mac 
(www.rstudio.com). For continuous data, distributions were first checked using 
Shapiro-Wilk’s test for normality, in order to determine the most appropriate 
statistical test. Between-group differences in age were examined using a t-test 
while head motion, number of good trials, gamma response variables (sum of 
gamma power between 35-70Hz, peak gamma amplitude, peak gamma frequency 
and evoked amplitude) were compared using a Mann-Whitney U test. Gender and 
handedness proportions were compared using a chi-squared test. P values were 
not corrected for multiple comparisons. 
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Exploratory analyses of the relationships between gamma response variables, 
evoked amplitude, age, cognitive ability and psychopathology were subsequently 
conducted using linear regression. Shapiro-Wilk’s tests showed that the 
distributions of the dependent variables were not normally distributed (sum of 
gamma power between 35-70Hz (p<0.01),  peak gamma amplitude (p<0.01),  peak 
gamma frequency (p=0.04), evoked amplitude (P<0.01)). Peak frequency was 
negatively skewed (skewness= -0.69), while the sum of gamma power between 
35-70Hz, peak gamma amplitude and evoked amplitude were positively skewed 
(skewness=1.97, 1.58 and 1.30 respectively). Due to their skewness, gamma 
response variables for each group were first transformed using Tukey’s power of 
ladders, which identified the most appropriate power transformation to make the 
data fit the normal distribution as closely as possible, before being converted to 
z-scores with a mean of zero and a standard deviation of one. Associations 
between gamma responses, evoked amplitude, age and cognitive ability were 
explored in each group (probands and controls) separately. Full-scale IQ (FSIQ), 
CANTAB subtest and WCST scores were used as measures of cognitive ability (see 
Chapters 2 and 3 for a description of the cognitive variables used). Due to low 
rates of psychopathology in the control group, associations between gamma 
parameters, evoked amplitude and psychopathology were explored in the 
proband group only. Symptom counts for the most commonly reported disorders 
were used to investigate these relationships. As outlined in Chapter 3, the most 
common disorders in the sample were anxiety, ADHD and ASD. The effects of age, 
gender and handedness on observed associations were assessed by adding these 
variables hierarchically to the regression models. These exploratory analyses were 
not corrected for multiple testing. 
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5.5 Results 
5.5.1 Descriptive data 
A comparison of the descriptive data for the two groups is shown in table 5-1. 
There were no significant differences in age, gender or handedness between the 
groups. 
 
Table 5-1 Age, gender and handedness of probands and controls  
 Probands 
(N=25) 
Controls 
(N=22) 
t/χ2 P 
Age (SD) 13.5 (1.8) 14.3 (1.8) -1.55 0.13 
Gender, female (%) 14 (56.0) 11 (50.0) -0.27 0.91 
Handedness, right (%) 20 (80.0) 16 (72.7) 0.06 0.81 
 
None of the children included in the analyses had a history of epilepsy or were 
taking psychotropic medication at the time of the study.  
 
5.5.2 Visual responses 
Data quality 
There were no statistically significant between-group differences in head motion 
(median=6.7mm (IQR=14.2mm) in probands and 2.2mm (IQR=7.2mm) in controls, 
p=0.43), or number of clean trials (n=81.0 (IQR=13.0) in probands, n=82.5 
(IQR=19.5) in controls, p=0.97) between the 25 probands and 22 controls who 
passed quality control. Seven probands and three controls had no discernible 
peak gamma sustained response in the visual cortex and so were excluded from 
the between-group analyses of peak gamma amplitude and frequency, leaving a 
sample of 18 probands and 19 controls. 21 probands and 20 controls had 
broadband sustained responses and clear evoked responses and were therefore 
included in the analyses of the sum of gamma power between 35-70Hz and the 
evoked amplitude. 
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Figure 5-3 shows the source localisation results and time-frequency plots for 
induced gamma and evoked responses for two representative participants. The 
plots in the top row are from a participant with good induced gamma and evoked 
responses. This participant has peak gamma activity in the occipital cortex, a clear 
transient gamma spike followed by a narrow band sustained response in the time 
frequency plot on the left, and a clear evoked response in the time-frequency plot 
on the right. In contrast, the lower plots are from a participant with poor 
responses. A clear source of gamma activity in the visual cortex is not evident, nor 
are induced gamma or evoked responses in the time-frequency plots. 
 
Figure 5-3 Source localisation results and time-frequency analysis for the induced and 
evoked responses in two representative participants 
 
Average group responses 
Figure 5-4 shows the group average responses between probands and controls. 
The plots on the left show the combined induced and evoked responses for both 
groups. This shows a weaker sustained response in the proband group. The plots 
on the right show the evoked responses which appear to be similar between 
groups. 
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Figure 5-4 Averaged induced and evoked responses in probands and controls 
 
Induced gamma responses 
The sum of induced gamma power between 35-70Hz was compared between 21 
probands and 20 controls. As predicted, there was a statistically significant 
difference in the percentage change from baseline in probands compared with 
controls. Probands had significantly lower total gamma power than controls 
(p=0.02). The median sum of gamma power in probands was 1845.8% 
(IQR=2671.0%) and in controls was 3904.8% (IQR=4707.5%). 
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Figure 5-5 Boxplot showing the sum of gamma power between 35-70Hz in probands and 
controls 
 
18 probands and 19 controls had clear peak gamma responses in the occipital 
cortex. In line with the hypotheses, peak gamma amplitude was lower in probands 
than controls. The median percentage change in peak gamma amplitude from 
baseline was 30.3% in probands (IQR=28.1%) and 45.2% in controls (IQR=55.24%), 
however, this difference was not statistically significant at p<0.05 (p=0.13). 
 
 
Figure 5-6 Boxplot showing peak gamma amplitude in probands and controls 
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Contrary to expectations, median peak gamma frequency was higher in probands 
than controls. Probands had a median peak frequency of 65.5Hz (IQR=10.0Hz) 
while controls had a median peak frequency of 57.5Hz (IQR=7.9Hz). This 
difference was not statistically significant at p<0.05 (p=0.06). 
 
 
Figure 5-7 Boxplot showing peak gamma frequency in probands and controls 
 
Evoked responses 
21 probands and 20 controls showed clear evoked responses in the visual cortex. 
The amplitude of the evoked response in probands was 6.4 x 10-13nAM (IQR=3.3 
x 10-13nAM) and in controls was 8.3 x 10-13nAm (IQR=5.3 x 10-13).  Contrary to the 
hypotheses, there was no statistically significant difference in the amplitude of 
the evoked response between groups (p=0.34). 
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Figure 5-8 Boxplot showing evoked responses in probands and controls 
 
Relationship between visual responses and age  
The scatterplots in figure 5-8 show that across the age range recruited to the study 
(10-17 years old), the evoked response was remarkably similar between groups. 
In contrast, for all of the gamma response variables, there were differences 
between groups across the age spectrum, with lower total broadband gamma 
power, lower peak gamma amplitude and higher peak gamma frequency in 
probands than controls. There were no statistically significant associations 
between evoked or induced gamma response variables and age for either group. 
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Figure 5-9 Scatterplots showing the relationship between age and visual response 
variables for probands (red) and controls (blue) 
 
Relationships between gamma responses, psychopathology and cognitive 
ability 
Table 5-2 shows the relationships between the sum of broadband gamma power, 
psychopathology and cognitive ability. There were significant associations 
between SCQ, SWM and MTS scores and the sum of gamma power. The 
associations between the sum of gamma power and SCQ/SWM scores survived 
correction for age, gender and handedness (SCQ estimate= -0.11, SE=0.04, 
r2=0.35, p=0.01 and SWM estimate=0.92, SE=0.37, r2=0.25, p=0.03). The 
association with MTS survived correction for age (estimate=0.07, SE=0.15, 
r2=0.13, p<0.05) but not for age and gender (estimate=0.14, SE=0.07, r2=0.13, 
p>0.05).  
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Table 5-2 Relationships between transformed sum of gamma power, psychiatric and 
cognitive variables in probands 
 Estimate Standard  
Error 
R2 P 
ADHD Score -0.08 0.07 0.08 0.26 
ADI-R Score  -0.02 0.02 0.14 0.23 
SCQ Score -0.10 0.03 0.52 3.79x10-3* 
Anxiety Score -0.08 0.04 0.22 0.06 
FSIQ 0.01 0.02 0.03 0.48 
WCST (set-shifting  
ability) 
-1.83x10-3 5.87x10-3 5.70x10-3 0.76 
Visual attention (MTS) 0.144 0.07 0.22 0.04* 
Spatial working memory 
(SWM)  
0.72 0.25 0.33 9.65x10-3* 
Spatial planning (SOC) 0.26 0.19 0.10 0.18 
Processing speed (RTI)  -0.08 0.13 0.02 0.57 
Sustained attention (RVP) 0.28 0.2 0.11 0.18 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge; RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
 
Figure 5-9 shows the relationships between SCQ, SWM and MTS scores and the 
sum of gamma power. In line with predictions, higher SCQ scores (indexing more 
social communication problems) were associated with lower total gamma power. 
Also consistent with the hypotheses, poorer cognitive performance (spatial 
working memory and visual attention) was associated with lower gamma power. 
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Figure 5-10 Relationship between transformed sum of gamma power and Social 
Communication Questionnaire (SCQ), Match to Sample and Spatial Working Memory 
score in probands 
 
Table 5-3 shows the results of the exploratory analyses for the relationships 
between transformed peak gamma amplitude, cognitive and psychiatric variables 
in the proband group. Similar to the findings for total gamma power, transformed 
peak gamma amplitude was positively associated with performance on the spatial 
working memory task. This relationship survived correction for age and gender 
(estimate=1.07, SE=0.49, r2=0.16, p< 0.05) but not age, gender and handedness 
(estimate=1.10, SE=0.51, r2=0.10, p=0.06). 
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Table 5-3 Relationships between transformed peak gamma amplitude, psychiatric and 
cognitive variables in probands 
 Estimate Standard  
Error 
R2 P 
ADHD Score -0.03 0.09 9.60x10-3 0.74 
ADI-R Score  1.22x10-3 2.94 x 10-2 1.91x10-4 0.97 
SCQ Score -0.08 0.04 0.25 0.10 
Anxiety Score -0.06 0.05 0.08 0.32 
FSIQ 3.44x10-3 0.02 1.69x10-3 0.88 
WCST (set-shifting  
ability) 
1.84x10-3 5.93x10-3 6.81x10-3 0.76 
Visual attention 
 (MTS)  
0.08 0.18 0.01 0.67 
Spatial working memory 
(SWM) 
0.71 0.31 0.28 0.04* 
Spatial planning  
(SOC)  
0.08 0.24 8.13x10-3 0.74 
Processing speed  
(RTI)  
-0.07 0.14 0.02 0.60 
Sustained attention  
(RVP) 
0.14 0.23 0.03 0.55 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge; RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
 
Figure 5-10 shows the relationship between spatial working memory and 
transformed peak gamma amplitude. In line with the hypotheses and consistent 
with findings for total gamma power, worse performance in the SWM task was 
associated with lower peak gamma amplitude. 
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Figure 5-11 Relationship between transformed peak gamma amplitude and spatial 
working memory score in probands 
 
Table 5-4 shows the relationships between transformed peak gamma frequency, 
psychiatric and cognitive variables in the proband group. Transformed peak 
gamma frequency was negatively associated with ASD symptoms measured by 
the ADI-R. This relationship survived correction for age (estimate= -0.07, SE=0.02, 
r2=0.34, p=0.03) but not age and gender (estimate= -0.05, SE=0.03, r2=0.30, 
p=0.14). 
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Table 5-4 Relationships between transformed peak gamma frequency, psychiatric and 
cognitive variables in probands 
 
 Estimate Standard  
Error 
R2 P 
ADHD Score -0.04 0.08 0.02 0.65 
ADI-R Score  -0.06 0.02 0.47 0.02* 
SCQ Score -0.05 0.05 0.09 0.34 
Anxiety Score -0.04 0.05 0.038 0.51 
FSIQ -0.02 0.02 0.05 0.37 
WCST (set-shifting 
ability) 
5.40x10-3 6.32x10-3 0.05 0.41 
Visual attention  
(MTS) 
-0.09 0.19 0.02 0.64 
Spatial working 
memory (SWM) 
0.61 0.33 0.19 0.09 
Spatial planning  
(SOC) 
0.33 0.23 0.13 0.17 
Processing speed  
(RTI) 
0.09 0.14 0.03 0.54 
Sustained attention 
(RVP) 
0.18 0.24 0.04 0.46 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge; RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
 
 
Figure 5-10 shows the relationship between transformed peak gamma frequency 
and ADI-R score. As predicted, higher ADI-R scores (indexing more ASD symptoms) 
were associated with lower peak gamma frequency. 
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Figure 5-10 Relationship between transformed gamma frequency and ADI-R score in 
probands 
 
Finally, table 5-5 shows the relationships between transformed evoked response 
amplitude, psychopathology and cognitive ability in probands. Statistically 
significant relationships were seen between SCQ, FSIQ, WCST and SWM scores 
and the transformed evoked response amplitude. The relationship with SCQ 
survived correction for age (estimate= -0.08, SE=0.04, r2=0.21, p=0.04) but not age 
and gender (estimate= -0.08, SE=0.04, r2=0.14, p=0.09). The relationships with 
FSIQ, WCST and SWM scores survived correction for age, gender and handedness 
(FSIQ estimate=0.04, SE=0.02, r2=0.21, p=0.03; WCST estimate= -0.01, SE<0.01, r2 
=0.26, p=0.02; SWM estimate=0.85, SE=0.38, r2=0.24, p=0.04).  
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Table 5-5 Relationships between transformed evoked response amplitude, psychiatric and 
cognitive variables in probands 
 
 Estimate Standard  
Error 
R2 P 
ADHD Score -2.15x10-3 0.07 6.47x10-5 0.98 
ADI-R Score  -6.55x10-3 0.02 0.01 0.75 
SCQ Score -0.08 0.03 0.31 0.04* 
Anxiety Score -0.06 0.04 0.13 0.15 
FSIQ 0.04 0.02 0.22 0.04* 
WCST (set-shifting 
ability) 
-0.01 4.28x10-3 0.40 3.91x10-3* 
Visual attention (MTS) 0.08 0.07 0.07 0.29 
Spatial working 
memory (SWM) 
0.78 0.24 0.38 5.11x10-3* 
Spatial planning (SOC) 0.23 0.19 0.08 0.25 
Processing speed (RTI) -0.07 0.14 0.02 0.61 
Sustained attention 
(RVP) 
0.26 0.21 0.09 0.23 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire; FSIQ, full-scale IQ; WCST, 
Wisconsin Card Sorting Test; MTS, Match-to-Sample; SWM, Spatial Working Memory; 
SOC, Stockings of Cambridge; RTI, 5-choice Reaction Time; RVP, Rapid Visual Processing. 
P values are uncorrected. 
 
Figure 5-11 shows the relationships between transformed evoked response, SCQ 
and cognitive performance (IQ, WCST and SWM scores). With the exception of 
WCST scores, all associations are in the expected direction. Higher SCQ scores 
(indexing social communication problems) were associated with lower amplitude 
of the evoked response. Lower IQ and SWM scores were also associated with 
lower evoked responses. However, the association with IQ appears to be driven 
by an outlier with high IQ. The association was no longer significant when this 
participant was removed from the dataset (estimate=0.02, SE=0.03, r2=0.02, 
p=0.46). Contrary to predictions, better performance on the WCST was associated 
with lower evoked responses. 
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Figure 5-12 Relationship between transformed evoked amplitude and Social 
Communication Questionnaire (SCQ), IQ, Wisconsin Card Sorting Test (WCST) and Spatial  
Working Memory scores in probands 
 
In the sibling group, the only significant association with cognitive variables was a 
negative relationship between transformed peak gamma frequency and FSIQ 
(estimate= -0.05, SE=0.02, R2=0.33, p=0.01). This association survived correction 
for age, gender and handedness (estimate= -0.05, SE=0.02, R2=0.30, p=0.01). 
 
Figure 5-12 shows the relationship between sibling IQ scores and transformed 
peak gamma frequency. Lower IQ was associated with higher peak gamma 
frequency. The association appears to be driven, at least in part, by an outlier with 
very high IQ. The association between IQ and peak gamma frequency was no 
longer significant when this individual was removed from the dataset (estimate= 
-0.03, SE=0.3, R2=0.04, p=0.20). 
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Figure 5-13 Relationship between transformed gamma frequency and IQ score in siblings 
 
 
 
5.6 Discussion 
In this investigation of neural responses to visual stimuli in 22q11.2DS, altered 
induced gamma band responses were found in probands compared to controls 
but there were no differences in evoked responses. As shown in figure 5-8, these 
group differences were consistent across the age spectrum studied.  
 
Children with 22q11.2DS had lower total sustained gamma power compared with 
controls. Although there was no statistically significant difference in peak gamma 
amplitude between groups at p<0.05, there was a trend towards lower gamma 
amplitude in the proband group. One possible reason for the discrepancy 
between results for the sum of gamma power and peak gamma amplitude is the 
lower statistical power to detect group differences in the peak amplitude 
comparison, due to the smaller sample size available for this analysis. Peak 
gamma responses show high inter-individual variability and large sample sizes 
and/or large effect sizes are needed to detect between-group differences 
(Muthukumaraswamy et al., 2010). Although a relatively large sample of children 
was recruited, poor data quality and the lack of clear gamma peaks for some 
individuals led to a large proportion of the proband sample (50%) not being 
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included in the peak gamma amplitude and frequency comparisons, which limited 
the ability to detect statistically significant differences. This may also have created 
bias in the sample as children with more severe phenotypes are more likely to 
have been excluded. Biria et al. (2018) studied visual responses in 45 participants 
with 22q11.2DS and 31 controls with EEG. The authors also had a high level of 
data loss in their 22q11.2DS group due poor data quality, leaving a sample of 25 
probands and 26 controls in their final analysis. By also investigating the total sum 
of broadband gamma power between 35-70Hz, it was possible to include three 
additional probands and one additional control in the analyses, yielding 
statistically significant between-group differences at p<0.05. Reductions in the 
amplitude and power of induced gamma band responses have been found in a 
number of neurodevelopmental disorders using EEG and MEG under different 
task conditions (Sun et al., 2012, 2013; Wilson et al., 2012). The amplitude and 
power of induced gamma responses are thought to reflect signal to noise ratio in 
reciprocal excitatory-inhibitory cortical circuits. The observation of a reduction in 
the total power of induced gamma oscillations provides some evidence of atypical 
excitatory-inhibitory circuity in 22q11.2DS. In the exploratory analyses, it was 
found that the severity of social communication problems and impairment in 
spatial working memory and visual attention were associated with reductions in 
broadband gamma power (figure 5-9). Similarly, poor spatial working memory 
performance was associated with reductions in peak gamma amplitude in 
children with 22q11.2DS but not in controls (figure 5-10). The association 
between reduced magnitude of induced gamma responses in children with high 
SCQ scores is in line with the literature on gamma responses in idiopathic ASD 
(Maxwell et al., 2015). 
 
Although not statistically significant at p<0.05, probands had higher peak gamma 
frequencies than children without neurodevelopmental CNVs. This result was also 
unexpected; patients with schizophrenia have been found to have reduced peak 
gamma frequencies in response to a visual task that required perceptual binding 
(Spencer et al., 2004) and while, to my knowledge, no previous studies have 
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reported peak visual gamma frequency in ASD, a study investigating gamma 
responses in the motor cortex found lower gamma frequencies in children with 
ASD (An et al., 2018). In the exploratory analyses within the proband group, 
children with higher ADI-R scores (and therefore more features of ASD) tended to 
have lower peak gamma frequencies than those with lower ADI-R scores. The 
same relationship was not evident for SCQ scores. In the sibling group, peak 
frequency was negatively associated with IQ but this finding did not survive after 
outlier removal. There were no associations with other cognitive variables. The 
relationship between excitatory-inhibitory balance and peak gamma frequency is 
not yet fully elucidated. While one study found that peak gamma frequency 
positively correlated with GABA concentrations (Muthukumaraswamy et al., 
2009), other investigators have failed to replicate this finding (Cousijn et al., 
2014). Furthermore, drugs that enhance GABAergic neurotransmission have been 
shown to reduce peak gamma frequency (Lozano-Soldevilla et al., 2014; 
Schneider et al., 2014; Magazzini et al., 2016). Gamma frequency is determined 
by the relative balance between N-methyl-D-aspartate (NMDA) glutamate 
receptor-mediated excitation and GABAA receptor-related tonic inhibitory 
processes on the cell membrane of inhibitory neurons. Increased frequency of 
gamma oscillations may arise due to either increased excitatory influences on 
inhibitory PV+ interneurons through NMDA receptors or through a reduction of 
tonic inhibition to the interneurons via GABAA receptors (Mann and Mody, 2010). 
 
One mechanism by which gamma responses could be affected by 22q11.2DS is 
via the effects of L-Proline on GABA synthesis. A recent study found that mice 
deficient in PRODH, a gene located in the 22q11.2 region involved in the 
degradation of L-Proline, have deficits in GABAergic neurotransmission and 
gamma oscillations (Crabtree et al., 2016). In this study, elevated L-Proline levels 
inhibited GABA synthesis by GAD67 and impaired the response of GABA synapses 
during sustained stimulation. This resulted in a reduction in strength of local field 
potentials in the gamma band. People with 22q11.2DS may therefore have 
reduced ability to increase inhibitory output when circuit activity is high, resulting 
in lower amplitude and increased frequency of gamma oscillations during 
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repeated stimulation. Interestingly, patients with 22q112.DS have been found to 
have elevations in plasma L-Proline (Goodman et al., 2000) and the severity of 
hyperprolinaemia has been found to correlate with psychotic symptom severity 
(Raux et al., 2007). Further evidence that GAD67 affects E-I balance comes from a 
study in which one allele of the GAD67 gene (GAD1) was selectively removed from 
the PV+ interneurons of juvenile mice (Lazarus, Krishnan and Huang, 2015). This 
resulted in increased pyramidal cell excitability and increased E-I balance in PV+ 
interneurons, leading to increased spike frequencies in pyramidal cells in 
response to current injections.   
There were no significant between-group differences in the evoked response. This 
was unexpected since children with 22q11.2DS have known difficulties with visual 
processing (Bearden et al., 2001; Simon, Bearden, et al., 2005; Magnée et al., 
2011; McCabe et al., 2016), and a previous EEG study in 22q11.2DS using an 
illusory contour stimulus reported reduced evoked responses in a mixed sample 
of adults and children with 22q11.2DS (Biria et al., 2018). Interestingly, in their 
experiment, Biria et al. did not find clear evoked response peaks in the 22q11.2DS 
group in response to the non-contour stimulus and hypothesised that this may 
have been either due to impairments in local visual processing or to more 
variability in the responses to non-contour versus contour stimuli in the 
22q11.2DS group. The present study also found inter-individual variability in 
evoked responses between participants (both probands and controls) and a 
positive association with cognitive function in the proband group. The amplitude 
of the evoked response was positively associated with spatial working memory 
performance but negatively associated with set-shifting ability in the WCST (figure 
5-11). These preliminary associations warrant further investigation in a larger 
sample. The amplitude of visual evoked responses has been found to be reduced 
in patients with schizophrenia (Yeap et al., 2008; González-Hernández et al., 2014) 
and ASD (Boeschoten et al., 2007; Milne et al., 2009) but this is not consistent 
between studies with some studies reporting elevated responses in ASD (Takarae 
et al., 2016). In the exploratory analyses conducted in this chapter, a negative 
association was found between the amplitude of the evoked response and SCQ 
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score, with children scoring highly on this measure of social communication 
problems having lower evoked responses. There was however, no significant 
relationship with ADI-R score. Due to the low level of reported psychotic 
symptoms in the present sample, it was not possible to explore the relationships 
between positive or negative symptoms of schizophrenia and evoked responses. 
Longitudinal follow-up of the sample through the period of risk for psychosis 
would provide interesting insights in this regard. 
 
5.7 Strengths and limitations 
This study has several strengths. It is the first study to use MEG to investigate 
induced gamma band responses in children with 22q11.2DS. It benefits from the 
recruitment of a rigorously phenotyped sample of children of a relatively narrow 
age range. Participants were recruited on the basis of genotype rather than 
phenotype, minimising some of the biases inherent in clinically ascertained 
samples. Although there are a number of potential barriers to participation in 
brain imaging research, the subsample of children participating in this experiment 
was broadly representative of the whole ECHO 22q11.2DS cohort in terms of 
demographics and levels of impairment. Despite the high levels of 
psychopathology, none of the children taking part were on psychotropic 
medication. Furthermore, the proband and sibling groups were well-matched for 
age, gender and handedness, facilitating between-group comparisons. 
 
It was clear during data collection that children with 22q11.2DS found this 
experiment more challenging than the resting-state experiment presented in 
Chapter 4. Head motion, eye movement and muscle artefact contaminated more 
trials and led to exclusion of more participants on the basis of data quality. In 
addition, ten participants (seven probands and three controls) did not generate 
discrete peak gamma responses, further reducing the sample size available for 
analysis of peak gamma variables to 18 probands and 19 controls. To maximise 
the data available for analysis total broadband gamma power during the 
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sustained response was calculated from all participants who had a clear evoked 
response to the stimulus. This meant that between-group comparisons of the 
sustained response could be performed, even in the absence of a clear gamma 
peak, which resulted in the inclusion of a further three probands and one sibling 
in the analyses. Despite these additional efforts, the sample size was still small at 
21 probands and 20 controls with limited power to detect between-group 
differences and associations with cognition and psychopathology. The results of 
the study (particularly the exploratory analyses), should therefore be considered 
preliminary until replicated in larger samples.   
 
As with the resting-state study presented in Chapter 4, the frequency of surgical 
and other contraindications for MR scanning meant that it was not possible to co-
register MEG data to each participant’s own MRI scan. While every attempt was 
made to closely match the fiducial locations to those of another participant, this 
is not a perfect substitute for using participants’ own data and this may have 
affected source localisation. Furthermore, continuous head localisation was not 
used during data acquisition as this was not standard practice in the CUBRIC MEG 
lab when the study commenced. This however meant that detailed analysis of 
head movement and correction for this was not possible. Head localisation before 
and after recordings was used as a proxy for head movement however, this does 
not give any indication about the amount of movement during the recording. 
While it is reassuring that this proxy measure did not differ between groups, 
without continuous monitoring, one cannot be certain that there were no 
differences between groups in the amount of movement during the task. Gamma 
amplitude measures may be particularly vulnerable to noise from head 
movement or distance from the MEG sensors (Magazzini et al., 2016). Finally, 
there were some psychiatric and cognitive data missing at the time of analysis. 
This was particularly problematic for the ADI-R data, which were only available for 
16 probands (76% of the sample). This will have affected the power to detect 
relationships between ADI-R scores and gamma responses. 
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5.8 Conclusions 
In conclusion, in this study of neural responses to visual stimulation in 22q11.2DS 
there was evidence for altered induced gamma band responses in affected 
children but intact evoked responses. Total broadband gamma power was 
reduced in probands and there was a trend towards a reduction in peak 
amplitude. In contrast peak frequency was increased in affected children. 
Associations were found between these variables and both cognitive and social 
communication problems. The data from this experiment further support the 
overall hypothesis of altered E-I balance in 22q11.2DS. 
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6 Occipital GABA concentration in 22q11.2 deletion 
syndrome 
6.1 Summary 
Neurodevelopmental disorders such as schizophrenia, ASD and ADHD have been 
associated with alterations in gamma-aminobutyric acid (GABA) 
neurotransmission. Abnormalities of GABAergic interneurons have also been 
reported in 22q11.2DS. Magnetic resonance spectroscopy (MRS) is a technique 
that can be used to quantify neural metabolites including GABA non-invasively. 
To date, there have been no published MRS studies of GABA concentrations in 
22q11.2DS. 
 
GABA-edited MRS data were collected from 13 children with 22q11.2DS and 14 
controls at 3T using a Mescher-Garwood Point Resolved Spectroscopy (MEGA-
PRESS) sequence with a 3cm x 3cm x 3cm voxel in the occipital cortex. GABA 
concentrations relative to water and creatine were compared between groups 
and related to psychopathology, cognitive function and gamma responses to 
visual stimuli. 
 
There were no between-group differences in GABA concentrations and no 
statistically significant relationships between GABA concentrations and any of the 
cognitive, clinical or gamma response variables tested. If there are alterations in 
GABAergic signaling in 22q11.2DS, these are not reflected by MRS derived GABA 
concentrations at 3T. 
 
6.2 Introduction 
In Chapter 5, it was shown that the frequency of visually-induced gamma 
oscillations was higher in children with 22q11.2DS than in controls. Furthermore, 
children with 22q11.2DS had lower total broadband gamma power than controls. 
Gamma responses in the proband group were associated with cognitive 
performance and social communication problems. As discussed in Chapter 5, 
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gamma band responses reflect cortical excitatory-inhibitory (E-I) balance and are 
affected by alterations in GABAergic neurotransmission (Mann and Mody, 2010; 
Campbell et al., 2014; Lozano-Soldevilla et al., 2014; Lazarus, Krishnan and Huang, 
2015; Crabtree et al., 2016; Magazzini et al., 2016). The frequency of gamma 
oscillations has previously been shown to be associated with cortical GABA 
concentrations in healthy populations (Muthukumaraswamy et al., 2009).  
 
GABA is the major inhibitory neurotransmitter in the brain. Together with the 
major excitatory neurotransmitter, glutamate, it modulates the E-I balance 
necessary for normal brain function (Markram et al., 2004). It is synthesised from 
glutamate by the enzyme glutamate decarboxylase (GAD) which exists in two 
isoforms, GAD67 and GAD65, encoded by the genes GAD1 and GAD2 respectively 
(Pinal and Tobin, 1998). There are two main types of GABA receptors: GABAA and 
GABAB. GABAA is an ionotropic receptor that mediates fast hyperpolarizing 
responses via a ligand-gated ion channel. When activated, this channel permits 
the influx of chloride ions resulting in hyperpolarization of the post-synaptic cell 
(Luján, Shigemoto and López-Bendito, 2005). GABAA receptors are located in the 
synaptic cleft where they are involved in fast, phasic inhibition as well as 
extrasynaptically, where they have a role in tonic inhibition (Lee and Maguire, 
2014). GABAB receptors are metabotropic transmembrane receptors that are 
linked to potassium channels via G-proteins. They are responsible for the late 
component of inhibitory transmission and mediate hyperpolarization of 
postsynaptic membranes and inhibition of neurotransmitter release from 
presynaptic terminals (Couve, Moss and Pangalos, 2000).  
 
While GABAeric interneurons are typically considered to be inhibitory, in early 
development they have an excitatory effect (Sun and Murali, 1999) and are 
thought to drive the maturation of synaptic networks (Pfeffer et al., 2009). The 
change in the effect of GABA from depolarizing to hyperpolarizing is known as the 
“GABA shift”. GABA has also been shown to have a trophic effect, controlling the 
proliferation and migration of neural progenitor cells (Behar et al., 1998; Wang 
and Kriegstein, 2009) as well as neuronal morphology (Cancedda et al., 2007).  
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Increased density of GABAergic interstitial white matter neurons with a 
corresponding reduction in overlying grey matter has been reported in 
schizophrenia (Yang et al., 2011; Joshi et al., 2013), suggesting abnormal 
interneuron migration from the white matter to the cortex. Reductions in GAD65 
and GAD67 expression have also been reported in schizophrenia (Akbarian and 
Huang, 2006; Thompson et al., 2009; Curley et al., 2011), as have decreased GABA 
release and reuptake (Costa et al., 2001; Yu et al., 2013). In ASD, post-mortem 
neuropathological studies have found reduced expression of GAD65 and GAD67  
(Fatemi et al., 2002) as well as of GABA receptors (Oblak, Gibbs and Blatt, 2010), 
and PET/SPECT studies have shown reduced expression of GABAA receptors in the 
brains of people with ASD (Mori et al., 2012; Mendez et al., 2013). In 22q11.2DS, 
post-mortem neuropathological studies have found evidence for abnormal 
neuronal migration (Kiehl et al., 2009). Furthermore, studies of murine models of 
22q11.2DS have found abnormalities in the proliferation of basal neural 
progenitors and the migration of parvalbumin-containing (PV+) interneurons 
(Meechan et al., 2009, 2012). Work in a mouse model of 22q11.2DS also 
demonstrated a delay in excitatory to inhibitory GABA shift, altered spontaneous 
network activity, lack of synchronisation and synaptic plasticity defects (Amin et 
al., 2017). Taken together, these studies suggest abnormal GABAergic function in 
neurodevelopmental disorders such as schizophrenia and ASD and high-risk 
genetic syndromes like 22q11.2DS. 
 
Magnetic resonance spectroscopy (MRS) is an MRI technique by which major 
brain metabolites can be quantified in vivo. In the MRI environment, protons 
precess at a frequency that depends mainly on the external magnetic field. 
However, this frequency is affected by local magnetic fields produced by 
electrons. Protons surrounded by high electron densities resonate at lower 
frequencies than those that are relatively unshielded from the external magnetic 
field. The chemical structure of a molecule will determine this shift in frequency, 
known as the “chemical shift”. These chemical shifts can be plotted to enable us 
to identify and quantify different molecules such as N-acetylaspartate (NAA), 
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creatine (Cr), choline (Cho), myo-inositol (Myo), glutamate (Glu), glutamine (Gln) 
and GABA. 
 
Measuring GABA using MRS has been more difficult than some other metabolites 
because it is present in relatively low concentrations (approximately 1mM 
compared to approximately 10mM for NAA and 7mM for creatine (Henriksen, 
1995; Puts and Edden, 2012). In addition, GABA signals are overlapped by stronger 
signals from NAA, creatine, glutamate and glutamine. In order to overcome these 
difficulties, spectral-editing techniques have been developed to separate GABA 
from other metabolites and quantify it relative to a reference metabolite 
(typically creatine) or water. 
 
To date, there have been few MRS studies in 22q11.2DS. A previous study in 
adults with 22q11.2DS found no difference in glutamate concentrations between 
probands and controls, however they did find elevated glutamate concentrations 
in the hippocampi of people with 22q11.2DS and schizophrenia compared to 
those without schizophrenia (da Silva Alves et al., 2011). Although it should be 
noted that all of the people with a diagnosis of schizophrenia were taking 
antipsychotic medication and the differences reported may therefore reflect the 
effects of medication rather than underlying abnormalities in glutamatergic 
signalling. Furthermore, the authors used water as an internal reference but did 
not correct for tissue composition. The results could therefore also be explained 
by differences in the proportions of grey matter, white matter and cerebrospinal 
fluid (CSF) between groups. Shashi et al. (2012) used MRS in children with 
22q11.2DS to investigate metabolite concentrations in the dorsolateral prefrontal 
cortex. They found elevated NAA concentrations (a marker of cortical maturation) 
in 22q11.2DS compared to controls but no difference in glutamate/glutamine 
(Glx) concentrations (Shashi et al., 2012). These studies suggest that there are no 
differences in excitatory neurotransmitter concentrations in people with 
22q11.2DS compared with controls, however, despite evidence from multiple 
sources for abnormal GABAergic function in 22q11.2DS, to my knowledge, no 
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published studies have investigated GABA concentrations in children with 
22q11.2DS. 
 
6.3 Rationale, aims and hypotheses 
Evidence from cellular, animal and human studies suggest that E-I balance is 
disrupted in neurodevelopmental disorders and that this may be due to deficits 
in GABAergic neurotransmission. In Chapters 4 and 5, evidence was found for 
altered E-I balance in children with 22q11.2DS using MEG. 22q11.2DS is a copy 
number variant syndrome associated with high-risk across the spectrum of mental 
disorders and affects genes known to influence GABA metabolism. While there 
have been previous MRS studies of 22q11.2DS, none have used spectral-editing 
techniques optimised for the measurement of relative GABA concentrations. This 
study, therefore, seeks to determine whether there are differences in the 
concentrations of GABA in the occipital cortices of children with 22q11.2DS 
compared with controls. This voxel has been chosen because GABA estimation in 
this region is robust, reproducible and stable over time (Near et al., 2014; 
Greenhouse et al., 2016; Bai et al., 2017). In addition, it is the same region from 
which visual gamma oscillations were measured in Chapter 5 and therefore the 
relationships between gamma power, amplitude, frequency and GABA 
concentrations can be explored. As in Chapters 4 and 5, attempts have been made 
to reduce the impact of potential confounding factors by recruiting children who 
have been ascertained by CNV status rather than by clinical diagnosis together 
with a control group consisting of siblings of children with neurodevelopmental 
CNVs. Detailed phenotypic information was collected so that associations 
between psychiatric, cognitive and demographic variables could also be explored.  
 
The primary aim of this chapter is to compare the concentration of GABA in the 
occipital cortex (relative to water and creatine) between children with 22q11.2DS 
and children without neurodevelopmental CNVs. A secondary aim is to explore 
relationships between GABA concentrations, gamma band responses, cognitive 
ability and psychopathology. It is hypothesised that, compared to children 
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without neurodevelopmental CNVs, children with 22q11.2DS have reduced 
relative GABA concentrations which are associated with visual gamma responses, 
cognitive impairment and psychopathology. 
 
6.4 Methods 
6.4.1 Participants 
Participants were recruited from the Experiences of people with copy number 
variants (ECHO) cohort at Cardiff University (See Chapters 2 and 3 for a detailed 
description of recruitment methods and sample characteristics). Children with 
22q11.2DS and unaffected siblings of children with neurodevelopmental CNVs 
were invited to take part. Ethical approval for the study was obtained from South 
East Wales National Health Service (NHS) Research Ethics Committee. Participants 
over the age of 16 years with capacity to consent gave written informed consent 
to participate in the study. Children under the age of 16 years or those over the 
age of 16 years who lacked the capacity to consent for themselves gave written 
and/or verbal assent to participate and a parent or carer consented to their 
participation in the study.  
 
All potential participants were screened over the telephone for contraindications 
to MRI at 3T. In cases where participants had potential contraindications, advice 
was sought from CUBRIC’s radiographers and laboratory managers and where 
necessary the participants’ doctors were contacted to ensure that it was safe for 
them to participate. Inclusion criteria were age 10-17 years old with a diagnosis 
of 22q11.2DS or a genetically-related sibling of a child with a neurodevelopmental 
CNV. Potential participants were excluded if they had contraindications to MRI at 
3T (e.g. presence of a pacemaker or cochlear implant, intracerebral shunt, some 
types of orthodontic braces, or a history of surgery which may have involved 
metallic implants not certified as MRI safe (or not known to be safe) at 3T).  
 
Participants fulfilling the criteria for participation in the study and who passed 
safety screening were invited to visit Cardiff for brain imaging at a time convenient 
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to them. Data were collected between March 2013 and the closure of CUBRIC’s 
Park Place facility in August 2016. Demographic, psychiatric and cognitive data 
were collected either during the imaging visit (n=6) or during a home visit (n=20, 
mean time gap=1.23 months, SD=6.19 months). Psychiatric interviews with the 
child’s primary caregiver were conducted using the Child and Adolescent 
Psychiatric Assessment [CAPA; (Angold et al., 1995)] to derive DSM-IV-TR 
diagnoses and symptom counts, and the Autism Diagnostic Interview-Revised 
[ADI-R; (Lord, Rutter and Le Couteur, 1994)] to derive ASD diagnoses and 
symptom counts. Cognitive assessments were conducted with participating 
children using the Wechsler Abbreviated Scale of Intelligence [WASI; (Wechsler, 
1999)], the Wisconsin Card Sorting Test [WCST; (Heaton et al., 1993)] and a 
selection of tests from the Cambridge Neuropsychological Test Automated 
Battery (CANTAB, Cambridge Cognition Limited UK, 2006; see Chapters 2 and 3 
for a description of the subtests used). Parents or carers were also asked to 
complete a questionnaire about their child and the wider family. This pack 
included questions about family background (ethnicity, family income and 
maternal education) and standardised questionnaires including the Social 
Communication Questionnaire [SCQ; (Rutter, Bailey and Lord, 2003) for ASD 
symptomatology. 
 
13 Children with 22q11.2 deletion syndrome (probands) and 14 siblings of 
children with 22q11.2DS (controls) took part in this study. There were five sibling 
pairs, other children were unrelated.  
 
6.4.2 MRI data acquisition 
Individual 1mm isotropic, T1-weighted fast spoiled gradient echo (FSPGR) images 
were acquired on a 3T General Electric MRI system (GE medical systems, 
Milwaukee, WI) for localisation of the occipital voxel.  
 
GABA was quantified from a 3cm x 3cm x 3cm voxel in the occipital cortex (see 
figure 6-2) using a Mescher-Garwood Point Resolved Spectroscopy [MEGA-PRESS; 
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(Mescher et al., 1998)] acquisition (TE/TR=68/2000ms). This sequence enables 
GABA signals to be separated from the stronger overlying signals of other 
metabolites by collecting two interleaved datasets, one with a Gaussian editing 
pulse at 1.9ppm (ON) and the other at 7.5ppm (OFF). Each editing pulse was 
applied for 16ms. The majority of peaks in the spectrum are unaffected by these 
pulses so subtraction of the “ON” spectrum from the “OFF” spectrum creates an 
edited spectrum of those peaks affected by the pulses i.e. GABA signals at 3.0ppm. 
The GABA signals obtained using this method also contain signal from 
macromolecules in the voxel so the term ‘GABA+’ will be used to refer to the 
concentrations measured. 
 
 
                                              Figure 6-1 MRS voxel placement 
     
6.4.3 MRS analysis pipeline 
GABA+ concentration was quantified using the Gannet toolkit (version 2.0, 
www.gabamrs.com) in MATLAB (version R2015a, MathWorks). Individual spectra 
were phase corrected and edited spectra were produced by subtracting “ON” 
spectra from “OFF” spectra. The edited GABA+ peak at 3.0ppm was then modelled 
as a single Gaussian and quantification performed by calculating the integral of 
the area under the peak (Edden et al., 2014).  
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                                  Figure 6-2 Example of GABA-edited MR spectrum 
 
GABA+ concentration was estimated relative to creatine and water. The fit error 
of each estimate was calculated by dividing the standard deviation of the fitting 
residual by the amplitude of the fitted peak. Each individual spectrum was visually 
inspected and poorly fitting spectra were excluded from further analysis. As water 
concentration is affected by tissue composition, GABA+/H20 measurements were 
corrected for the proportions of grey matter, white matter and cerebrospinal fluid 
in the voxel (Gasparovic et al., 2006). 
 
6.4.4 Statistical analysis 
Between-group analyses 
Statistical analyses were conducted using R Studio (version 1.1.383 for Mac, 
www.rstudio.com). For continuous data, distributions were first checked using 
the Shapiro-Wilk’s test for normality in order to determine the most appropriate 
statistical test. Between group-differences in age, cognitive variables, GABA+ 
concentrations and fit errors were examined using t-tests. Gender and 
handedness proportions were compared using chi-squared tests. P values were 
not corrected for multiple testing. 
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Relationships between GABA+ concentrations, cognitive ability and 
psychopathology 
Exploratory analyses of the relationships between GABA+ concentrations, age, 
cognitive ability and psychopathology were subsequently conducted using linear 
regression. To reduce the number of comparisons, GABA+/H2O and GABA+/Cr 
concentrations were combined by converting the concentrations into z-scores for 
each participant and averaging these to give a single estimate of GABA 
concentration. As cognitive ability is strongly associated with group status 
(proband or control), analyses were conducted in each group separately. Full-
scale IQ (FSIQ), CANTAB subtest and WCST scores were used as measures of 
cognitive ability. Due to low rates of psychopathology in the control group, the 
relationships between GABA+ concentration and psychopathology were explored 
in the proband group only. Symptom counts for the most common disorders were 
used to investigate the relationships with psychopathology. As outlined in 
Chapter 3, the most common disorders in the sample were anxiety disorders, 
ADHD and ASD. No correction was performed for multiple testing. 
 
Relationships between GABA+ concentrations, visual gamma responses and 
visual evoked responses 
The relationships between GABA+ concentrations, visual gamma responses and 
visual evoked responses were explored using linear regression with GABA+ z-
scores as the dependent variable and sum of gamma power between 35-70Hz, 
peak gamma amplitude, peak gamma frequency and evoked amplitude as 
independent variables. These exploratory analyses were not corrected for 
multiple comparisons. 
 
 
6.5 Results 
6.5.1 Descriptive data 
Following quality control, occipital GABA+ data were available for 13 probands 
and 13 controls. None of the children who were in included in the final analysis 
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were taking psychotropic medication. As shown in table 6-1, there was no 
statistically significant between-group difference in age. Probands had a mean 
age of 13.85 years (age range=12.13-17.34 years); controls had a mean age of 
14.43 years (age range=12.10-17.49 years), p=0.46. The groups were matched for 
gender and handedness. There were no significant differences in the fit errors for 
either the water or creatine contrasts. 
 
Table 6-1 Age, gender, handedness and MRS data quality in probands and controls 
 Probands  Controls  t/x2 P 
Age (SD) 13.8 (1.7) 14.4 (1.8) -0.75 0.46 
Gender, female (%) 7 (53.8) 7 (53.8) <0.01 >0.99 
Handedness, right (%) 12 (92.3) 12 (92.3) <0.01 >0.99 
Fit error H2O (SD) 4.2 (1.4) 4.2 (1.2) 0.05 0.96 
Fit error Cr (SD) 7.9 (1.4) 7.4 (2.0) 0.72 0.48 
 
 
6.5.2 Cognitive and psychiatric data 
As reported in Chapter 3 for the whole imaging sample, full scale IQ (FSIQ) was 
approximately 30 points lower in probands than controls. There were no 
statistically significant differences between groups in performance on CANTAB 
tasks or the Wisconsin Card Sorting Test (WCST) at p<0.05. In line with data in the 
whole imaging sample, children included in the GABA+ analyses had high rates of 
psychopathology. Eight probands (61.5%) had a DSM-IV-TR diagnosis, five were 
diagnosed with probable ASD (38.5%), three with ADHD (23.1%) and two with 
anxiety disorders (15.4%). Only one sibling had any DSM-IV-TR diagnoses (social 
phobia). None of the children included in the final analyses had a history of 
epilepsy and none were taking psychotropic medication at the time of the study. 
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Table 6-2 Cognitive performance in children participating in the MRS study 
 Probands Controls Group 
differences 
 Mean SD Mean SD t P 
       
FSIQ 77 14.38 106 7.40 -6.47 4.46 x 10-6* 
       
CANTAB       
Visual attention 
(MTS) 
45.09 3.39 46.58 1.78 -1.30 0.21 
Processing 
speed (RTI) 
-0.92 2.20 0.45 0.55 -2.01 0.07 
Sustained 
attention (RVP) 
-0.45 1.15 0.28 1.21 -1.47 0.15 
Spatial planning 
(SOC) 
-1.02 0.87 -0.52 1.05 -1.24 0.23 
Spatial working 
memory (SWM) 
-0.90 0.95 -0.37 0.65 -1.56 0.14 
       
WCST       
Set-shifting 
ability 
72.20 43.76 86.17 49.50 -0.70 0.49 
Abbreviations: FSIQ, full-scale IQ; CANTAB, Cambridge Neuropsychological Test 
Automated Battery; MTS, Match-to-Sample; RTI, 5-choice Reaction Time; RVP, Rapid 
Visual Processing; SOC, Stockings of Cambridge; SWM, Spatial Working Memory; WCST, 
Wisconsin Card Sorting Test. P values are uncorrected. 
 
6.5.3 GABA+ concentrations 
Between-group analyses of GABA+ concentrations 
The boxplots in figures 6-3 and 6-4 show GABA+/H2O and GABA+/Cr 
concentrations in children with 22q11.2DS and controls. 
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Figure 6-3 Boxplot showing GABA+/H2O concentrations in probands and controls 
 
 
Figure 6-4 Boxplot showing GABA+/Cr concentrations in probands and controls 
Mean GABA+/H2O concentration was 1.71 (SD=0.26) for probands and 1.68 
(SD=0.01) for controls (t=0.26, p=0.80). Mean GABA+/Cr concentration was 0.12 
(SD=0.01) for probands and 0.12 (SD=0.02) for controls (t=0.48, p=0.64). Figure 6-
5 shows that across the age range recruited to the study, there were no between-
group differences in mean GABA+ concentrations (shown in the figure as a 
combined z-score of creatine and water ratios). 
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Figure 6-5 Mean GABA+ z-score by age for probands (red) and controls (blue) 
 
Relationships between GABA+ concentrations, cognitive ability and 
psychopathology 
Table 6-3 shows the results of the exploratory analyses for the associations 
between GABA+ z-scores and cognitive variables in children with 22q11.2DS. 
There were no statistically significant associations between GABA+ concentration 
and any of the cognitive variables tested.  
Group 
Proband 
Control 
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Table 6-3 Relationships between GABA+ concentration and cognitive function in probands 
 Estimate Standard  
Error 
R2 P 
FSIQ 2.43x10-4 0.02 1.56x10-5 0.99 
WCST 
(Set-shifting ability) 
-4.37x10-3 6.81x10-3 0.05 0.54 
Visual attention  
(MTS)  
0.03 0.09 0.01 0.74 
Spatial working 
memory (SWM) 
0.33 0.30 0.12 0.30 
Spatial planning  
(SOC) 
-0.08 0.35 0.01 0.83 
Processing speed  
(RTI)  
0.10 0.14 0.05 0.50 
Sustained attention 
(RVP) 
0.27 0.25 0.10 0.32 
Abbreviations: FSIQ, full-scale IQ; WCST, Wisconsin Card Sorting Test; MTS, Match-to-
Sample; SWM, Spatial Working Memory; SOC, Stockings of Cambridge; RTI, 5-choice 
Reaction Time; RVP, Rapid Visual Processing. P values are uncorrected. 
 
Table 6-4 shows the results of the exploratory analyses between GABA+ z-scores 
and cognitive variables in controls. As for probands, no significant relationships 
were observed between GABA+ concentration and cognitive ability. 
 
 
Table 6-4 Relationships between GABA+ concentration and cognitive function in siblings 
 Estimate Standard 
 Error 
R2 P 
FSIQ 0.06 0.04 0.18 0.15 
WCST 
(set-shifting ability) 
1.83x10-3 6.70x10-3 7.47x10-3 0.79 
Visual attention  
(MTS)  
0.02 0.19 1.38x10-3 0.91 
Spatial working  
memory (SWM)  
-0.13 0.51 6.17x10-3 0.81 
Spatial planning  
(SOC)  
-0.13 0.31 0.02 0.68 
Processing speed  
(RTI)  
0.69 0.56 0.13 0.24 
Sustained attention 
 (RVP) 
0.07 0.27 6.95x10-3 0.80 
Abbreviations: FSIQ, full-scale IQ; WCST, Wisconsin Card Sorting Test; MTS, Match-to-
Sample; SWM, Spatial Working Memory; SoC, Stockings Of Cambridge; RTI, 5-choice 
Reaction Time; RVP, Rapid Visual Processing. P values are uncorrected. 
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Table 6-5 shows the relationships between GABA+ concentration and 
psychopathology in the proband group. No significant associations were found 
between the most common symptoms reported by probands and GABA+ 
concentration. 
 
Table 6-5 Relationships between GABA+ concentration and psychopathology in probands 
 Estimate Standard  
Error 
R2 P 
ADHD Score 0.03 0.07 0.01 0.72 
ADI-R Score  -0.02 0.02 0.04 0.51 
SCQ Score -0.08 0.06 0.19 0.19 
Anxiety Score -8.52x10-3 0.05 3.05x10-3 0.86 
Abbreviations: ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic 
Interview-Revised; SCQ, Social Communication Questionnaire. P values are uncorrected. 
 
Relationships between GABA+ concentrations and visual responses 
Table 6-6 shows the relationships between GABA+ concentrations and visual 
induced and evoked responses for proband and control groups. No significant 
associations between these variables were found for either group.  
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Table 6-6 Relationship between GABA+ concentration and visual responses in the MEG 
 Estimate Standard  
Error 
R2 P 
Probands     
Sum of gamma 
power 
8.90x10-5 1.04x10-4 0.13 0.43 
Gamma amplitude 0.01 8.11x10-3 0.28 0.23 
Gamma frequency -0.04 0.06 0.11 0.48 
Evoked  
response 
3.83x1010 5.50x1011 9.87x10-4 0.95 
     
Controls     
Sum of gamma 
power 
9.66x10-5 1.55x10-4 0.05 0.55 
Gamma amplitude 2.84x10-3 0.01 6.54x10-3 0.81 
Gamma frequency -0.05 0.07 0.06 0.47 
Evoked 
response 
1.11x1012 6.13x1011 0.29 0.11 
P values are uncorrected. 
 
6.6 Discussion 
In this investigation of occipital GABA+ concentrations, no differences were found 
in GABA+ concentrations between children with 22q11.2DS and children without 
neurodevelopmental CNVs. Furthermore, no associations were found between 
GABA+ concentrations, cognitive performance, psychopathology or visual MEG 
responses. This was unexpected since murine models of 22q11.2DS point towards 
abnormalities of GABAergic signaling, and in Chapter 5, alterations were found in 
visual gamma responses in 22q11.2DS which were expected to be reflected by a 
reduction in GABA concentration. 
 
The GABA signal measured by MRS reflects the total GABA present in the selected 
voxel. This includes GABA located both intracellularly and extracellularly. 
Recently, transcranial magnetic stimulation has been used to better understand 
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how GABA measured by MRS is related to GABAergic inhibitory function in healthy 
controls. Data from these studies suggest that GABA concentrations measured by 
MRS may reflect extra-synaptic inhibitory tone in a brain region rather than 
GABAergic synaptic transmission (Stagg, Bachtiar and Johansen-Berg, 2011; Dyke 
et al., 2017). If replicated in larger samples, the results of the current study could 
indicate that there is no difference in the extra-synaptic inhibitory tone of the 
occipital cortex between children with 22q11.2DS and controls, however, there 
may still be differences in phasic inhibition that cannot be measured using MRS.  
 
No relationship was found between GABA+ concentrations and psychopathology. 
MRS studies in people with neurodevelopmental disorders have produced 
variable results. In schizophrenia, some studies found GABA reductions in patient 
groups (Yoon et al., 2010; Marsman et al., 2014; Rowland et al., 2016; Thakkar et 
al., 2017) while others found no differences between patients and controls 
(Tayoshi et al., 2010; Brandt et al., 2016). Studies have differed in the brain region 
investigated, the age of participants recruited, illness stage and medication use 
which may, at least in part, explain the discrepant findings. However, a recent 
meta-analysis of MRS studies in schizophrenia found high heterogeneity between 
studies and small effect sizes (Egerton et al., 2017), and overall no significant 
differences between patients and controls. MRS studies in children with ASD have 
found reductions in GABA concentrations in several brain regions (Harada et al., 
2011; Kubas et al., 2012; Gaetz et al., 2014; Rojas et al., 2014; Puts et al., 2017). 
However, findings in adults have conflicted with those in children, reporting that 
GABA concentrations and GABAA receptor densities do not differ from controls 
(Horder et al., 2018). In a recent MRS study of adults with ASD, brain responses 
to the drug riluzole were found to differ between adults with ASD and controls. In 
ASD, riluzole increases relative GABA concentration in the prefrontal cortex but 
decreases it in controls (Ajram et al., 2017). This suggests abnormal responses to 
the perturbation of neurotransmitter systems in ASD. There has been much less 
research into the role of GABA in other psychiatric and neurodevelopmental 
disorders such as ADHD, however, one MRS study of children with ADHD found a 
reduction in GABA concentration compared with controls (Edden et al., 2012), 
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while another study of adults and children found no difference between children 
with ADHD and controls but increased GABA in adults with ADHD (Bollmann et al., 
2015). A further study found that stimulant use during childhood but not 
adulthood alters GABA concentration and responsivity (Solleveld et al., 2017). The 
relationship between GABA concentration and cognition is similarly unclear. 
Frontal GABA concentrations have been positively associated with superior 
cognitive performance in older adults (Porges et al., 2017). However, 
GABA/glutamate ratios have been negatively associated with working memory 
performance in young adults (Marsman et al., 2017). In this chapter no evidence 
was found for associations between GABA concentrations and cognitive variables 
in either the proband or control group. 
 
As discussed in Chapter 5, the relationships between gamma responses and 
GABA+ concentrations measured by MRS are not well-elucidated. While 
Muthukumaraswamy et al. (2009) found a correlation between gamma frequency 
and GABA concentration (finding a positive association), another study failed to 
replicate this finding (Cousijn et al., 2014). Cousijn et al. (2014) found no 
correlation between gamma activity and either GABA or glutamate 
concentrations in a large sample of healthy volunteers and suggested that other 
methods may be needed to explore the relationships between gamma oscillations 
and GABA/glutamate concentrations in the human brain. These methods could 
include pharmaco-MEG and PET studies. 
 
6.7 Strengths and limitations 
To my knowledge, this is the first study to investigate GABA+ concentrations in 
children with 22q11.2DS. A rigorously phenotyped sample of children of a 
relatively narrow age range was recruited on the basis of genotype rather than 
phenotype, minimising some of the biases that occur in clinically ascertained 
samples. The subsample of children participating in this study was broadly 
representative of the whole ECHO 22q11.2DS cohort in terms of demographics 
and levels of impairment. None of the participating children were taking 
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psychotropic medication. Furthermore, the proband and sibling groups were well-
matched for age, gender and handedness, facilitating between-group 
comparisons. However, a major limitation of this study is the sample size. Due to 
the closure of CUBRIC’s Park Place facility during the data collection period, the 
time available for recruitment was reduced. Furthermore, a large proportion of 
the children who wished to take part in the study were unable to do so because 
of contraindications to MRI at 3T. Some children who were able to tolerate a short 
structural scan (for MEG registration purposes) were unable to remain in the 
scanner for the MEGA-PRESS sequence either due to anxiety or difficulty 
remaining still for this longer acquisition. This resulted in the collection of only a 
modest dataset for analysis which limited the power of the study to investigate 
between-group differences and associations with cognition, psychopathology and 
gamma response variables. The results of the present study should therefore be 
interpreted cautiously. 
 
The data in this study were collected at 3T as this was the strength of the scanner 
available at the time the study commenced. However, CUBRIC now benefits from 
a 7T scanner which has the ability to collect MRS data with higher signal to noise 
ratio than previously possible. This also enables improved separation of glutamate 
signals from neighbouring peaks (e.g. glutamine). Furthermore, new sequences 
are now available that can reduce contamination from macromolecules. High 
molecular weight macromolecules may account for 40-60% of the observed MRS 
signal (Behar et al., 1994; Mikkelsen et al., 2016) and so reduction in this 
contamination will improve the precision of GABA measurements in the future. 
 
6.8 Conclusions 
In conclusion, in this study of occipital GABA+ concentration in 22q11.2DS no 
evidence was found for altered GABA+ levels in 22q11.2DS. Furthermore, no 
associations were found between GABA+ concentrations, cognition, 
psychopathology or visual MEG responses. The data from this experiment 
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suggests that if there are alterations in GABAergic activity in 22q11.2DS, these are 
not reflected by GABA signals measured using MEGA-PRESS at 3T. 
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7 General discussion 
In this thesis, magnetoencephalography and magnetic resonance spectroscopy 
were used to investigate potential neural mechanisms underlying the high risk of 
psychopathology and cognitive impairment in 22q11.2DS. Specifically, these 
investigations sought to determine whether 22q11.2DS is associated with 
alterations in excitatory-inhibitory balance and whether any observed alterations 
are associated with psychiatric, neurodevelopmental or cognitive problems. 
Three experiments were used to address these questions: firstly, as discussed in 
Chapter 4, resting-state MEG was used to investigate whole-brain neural 
oscillatory patterns; secondly, as discussed in Chapter 5, a simple visual stimulus 
was used to study induced gamma band responses in the visual cortex; and finally, 
as discussed in Chapter 6, MRS was used to determine whether GABA 
concentrations were altered in the occipital cortex. 
 
7.1 Summary of findings 
Findings from the investigations presented in this thesis contribute to our 
understanding of the impact of 22q11.2DS on developing neural circuits, 
particularly its effect on excitatory-inhibitory balance. Chapter 3 showed that the 
sample of children participating in the brain imaging experiments had psychiatric 
and cognitive phenotypes which were similar to those of children taking part in 
research at Cardiff University but who did not take part in the neuroimaging study. 
The phenotypes were also similar to those reported in previous studies of 
22q11.2DS (Schneider et al., 2014), suggesting that the imaging sample is not 
biased towards a highly functioning phenotype.  
 
In the first MEG experiment, it was found that the low frequency oscillatory 
patterns that underlie communication between different brain regions at rest, 
were atypical in children with 22q11.2DS. Globally, children with 22q11.2DS had 
lower connectivity (as inferred from amplitude-envelope correlations) in the 
delta, alpha and beta bands than children without neurodevelopmental CNVs. In 
the alpha band, there was a significant relationship between global connectivity, 
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anxiety scores and social communication problems, which survived correction for 
age, gender and handedness. The reductions in amplitude-envelope correlations 
were most evident in posterior brain regions, with a reduction in the strength of 
signal connections between the calcarine region and lingual gyrus in both the 
alpha band (uncorrected for multiple testing) and beta band (corrected for 
multiple testing). These are key brain regions involved in processing visual 
information. The calcarine cortex is the primary visual cortex which receives visual 
information from the lateral geniculate nucleus via the optic radiation. The lingual 
gyrus also forms part of the visual cortex and is believed to play a role in the 
recognition of familiar landmarks (Takahashi and Kawamura, 2002; Mendez and 
Cherrier, 2003) and facial expressions (Kitada et al., 2010), as well as being 
involved in visual memory (Bogousslavsky et al., 1987; Machielsen et al., 2000) 
and dreaming (Bischof and Bassetti, 2004). In the delta band there was a 
statistically significant reduction in the strength of signal connections between 
the precuneus and inferior parietal cortex in probands compared with controls. 
The precuneus and inferior parietal cortex form a core part of the ‘default-mode 
network’ and are thought to be involved in aspects of consciousness (Cavanna, 
2007). The precuneus has a role in episodic memory (Lundstrom et al., 2003; 
Lundstrom, Ingvar and Petersson, 2005) and visuospatial processing (Cavanna and 
Trimble, 2006), while the inferior parietal cortex has been associated with the 
perception of emotions in facial stimuli (Adolphs et al., 1996; Radua et al., 2010), 
the integration and interpretation of sensory information, visual attention, and 
the response to novel stimuli (Singh-Curry and Husain, 2009). 
 
The AAL nodes that were most significantly affected by CNV status were the left 
insula in the delta band, the right precuneus in the alpha band and the right 
calcarine region in the beta band, which all had a reduction in total z-scores in 
probands compared with controls. Connectivity in the right precuneus was 
negatively associated with anxiety scores and social communication problems. 
The insula is part of the limbic cortex with a role in self-awareness (Critchley et 
al., 2004), attention (Eckert et al., 2009) and salience (Taylor, Seminowicz and 
Davis, 2009). As outlined above, the precuneus forms part of the default-mode 
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network and the calcarine region is the primary visual cortex. These brain regions 
have all been implicated in neurodevelopmental disorders including 
schizophrenia, ASD and ADHD (Wylie and Tregellas, 2010; Ahrendts et al., 2011; 
Nickl-Jockschat et al., 2012; Whitfield-Gabrieli and Ford, 2012; Goodkind et al., 
2015; Tohid, Faizan and Faizan, 2015; Mowinckel et al., 2017; Padmanabhan et 
al., 2017; Brodski-Guerniero et al., 2018; Vetter et al., 2018). Thus the results of 
this first experiment suggest that resting-state oscillatory patterns, which are 
dependent on excitatory-inhibitory interactions, are affected by 22q11.2 deletion 
status and are associated with psychopathology.  
 
In the second MEG experiment, using a simple visual stimulus, it was found that 
induced responses in the high-frequency gamma range were affected by 
22q11.2DS. Visual evoked responses were unaffected by deletion status. Children 
with the 22q11.2 deletion had lower total induced gamma power between 35 and 
70Hz. While there were no statistically significant differences in peak gamma 
amplitude or peak gamma frequency at p<0.05, there was a trend towards a 
reduction in peak gamma amplitude and an increase in peak gamma frequency in 
22q11.2DS. In the proband group, many participants had no discernible gamma 
peak, limiting the ability to detect between-group differences in peak gamma 
amplitude and frequency. In subsequent exploratory analyses, low total gamma 
power was associated with poor performance in tasks of spatial working memory 
and visual attention as well as social communication problems, indexed by the 
SCQ. Peak gamma frequency was also associated with social communication 
problems, those with lower peak frequency had more ASD symptoms as 
measured by the ADI-R. The results of this study suggests that low level sensory 
processing of visual stimuli is intact in 22q11.2DS but higher order processes 
involving integration of sensory input by GABAergic interneurons are altered, with 
increased excitatory-inhibitory balance and lower signal to noise ratio in these 
circuits.  
 
Finally, using magnetic resonance spectroscopy, no differences were found in 
GABA+ concentrations in the occipital cortex between children with 22q11.2DS 
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and controls and there were no relationships between GABA+ concentrations and 
psychopathology, cognitive ability, visual evoked or induced gamma band 
responses. This finding was unexpected since GABA concentration measured 
using MRS is thought to reflect inhibitory tone, which was hypothesised to be 
reduced in 22q11.DS. GABA+ concentrations measured by MRS reflect total GABA 
in the voxel studied. While this can give important insights into the total GABA 
pool, it does not help to distinguish extracellular and intracellular GABA nor 
functional GABA activity at the synapse. Furthermore, it does not give insights into 
dynamic changes in GABA concentrations which may be affected by 22q11.2DS.  
Alternative methods such as pharmaco-MEG, pharmaco-MRS, transcranial 
magnetic stimulation (TMS) or PET will be required to further investigate the 
effects of 22q11.2DS on GABAergic neurotransmission. 
 
7.2 Implications of this research 
To my knowledge, there have been no previous MEG studies or GABA-edited MRS 
studies in children with 22q11.2DS. This series of investigations therefore brings 
novel insights into imaging markers of excitatory-inhibitory balance in children 
with 22q11.2DS, particularly implicating the visual system. 
 
7.2.1 Excitatory-inhibitory balance in 22q11.2 deletion syndrome 
In Chapters 4, 5 and 6, excitatory-inhibitory balance in children with 22q11.2DS 
was investigated. Excitatory-inhibitory balance is a crucial homeostatic 
mechanism, facilitating coordinated activity within and between different brain 
regions. Altered excitatory-inhibitory balance, particularly increased excitatory to 
inhibitory ratio, has been proposed as a potential mechanism underlying 
neurodevelopmental and psychiatric disorders such as ASD (Gao and Penzes, 
2015; Nelson and Valakh, 2015; Foss-Feig et al., 2017; Lee, Lee and Kim, 2017; 
O’Reilly, Lewis and Elsabbagh, 2017), ADHD (Naaijen et al., 2017), schizophrenia 
(Lisman, 2012; Gao and Penzes, 2015; Foss-Feig et al., 2017; Grent-’t-Jong et al., 
2018) and epilepsy (Fritschy, 2008).  
 
157 
 
22q11.2DS is highly pleiotropic and there has been intense effort to better 
understand the mechanisms conferring risk across the spectrum of mental 
disorders. One plausible mechanism is that haploinsufficiency of genes in the 
22q11.2 region alters excitatory-inhibitory balance in favour of excitation. 
Evidence from post-mortem studies and animal models shows that GABAergic 
interneurons have abnormal morphology and migration patterns in 22q11.2DS 
(Kiehl et al., 2009; Meechan et al., 2009, 2012; Mori et al., 2011; Piskorowski et 
al., 2016). Furthermore, GABAergic excitatory to inhibitory shift is delayed in 
22q11.2DS (Amin et al., 2017). The 22q11.2 region contains the gene PRODH, 
which codes for the enzyme proline oxidase, which in turn degrades L-Proline. 
Mice deficient in PRODH have elevated L-Proline which has been shown to inhibit 
GAD67, which synthesises GABA from glutamate. PRODH deficient mice have 
impaired responses at GABA synapses during sustained stimulation and lower 
local field potential strength in the gamma frequency range. Elevated plasma L-
Proline has also been found in people with 22q11.2DS (Magnée et al., 2011) and 
a recent EEG study of auditory steady-state responses found reduced gamma 
power in 22q11.2DS (Larsen, Pellegrino, et al., 2018).  
 
Overall, the results presented in this thesis support the hypothesis of altered 
excitatory-inhibitory balance in 22q11.2DS. While no between-group differences 
were found in GABA concentrations, this finding does not exclude the possibility 
that there are abnormalities of GABA signalling that are not detectable using MRS 
at 3T.  The total power of gamma responses to a simple visual stimulus was lower 
in 22q11.2DS and there was a trend towards a decrease in peak amplitude. The 
peak frequency was found to be higher in children with 22q11.2DS, which is 
consistent with an increased excitatory-inhibitory ratio. Furthermore, longer-
range connections in the delta, alpha and beta bands were also impaired in 
posterior brain regions 22q11.2DS at rest. These connections, typically mediated 
by lower frequency oscillations, are critically dependent on excitatory-inhibitory 
interactions. Low and high frequency oscillations have been found to originate 
from separate cortical layers. High frequency gamma band oscillations emerge 
from the supragranular layers (2 and 3), while alpha oscillations emerge from the 
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more superficial layers 5 and 6 (van Kerkoerle et al., 2014). It has been proposed 
that activity in the different frequency bands interacts via an interlaminar 
coupling circuit based on excitatory and inhibitory interactions (Mejias et al., 
2016). Phase amplitude-coupling (PAC) is one of the most extensively studied 
forms of cross-frequency coupling. The phase of low frequency oscillations (e.g. 
alpha) has been found to be coupled to the amplitude/power of of high-frequency 
(e.g. gamma) responses in a number of different brain regions (Voytek et al., 2010, 
Lega et al., 2014, Cho et al., 2015, Seymour et al., 2017). Deficits in PAC have been 
proposed to underlie cortical dysconnectivity in ASD (Kessler et al., 2016) and 
schizophrenia (Kirihara et al., 2012), although whether these are driven by 
aberrant bottom-up or top-down processing or a combination of both remains 
unclear. Local excitatory-inhibitory imbalance (reflected by atypical gamma band 
activity) could impede long-distance communication between different brain 
regions and the development of connections between cortical regions. In 
addition, atypical oscillatory activity in lower frequency bands could result in the 
inability of specialised cortical regions to provide feedback to regulate local 
excitatory-inhibitory balance. Directional measures of connectivity such as 
Granger causality (Granger, 1969) or dynamic causal modelling (Friston et al., 
2003) may help to elucidate the relationships between local and long-range 
cortical circuitry.  
 
Figure 7.1 shows a proposed model in which 22q11.2DS could result in E-I 
imbalance and abnormalities in long-range connectivity, and how this in turn may 
result in psychopathology and impaired cognitive function. 
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Figure 7-1 Hypothesised model of the effects of 22q11.2DS on local and long-range 
cortical circuits. The timing, nature, location and severity of these alterations as well as 
the effects of other genetic and environmental risk factors will determine the clinical and 
cognitive phenotype 
 
7.2.2 The visual system in 22q11.2 deletion syndrome 
In Chapter 4, a whole-brain AAL atlas-based approach was taken to investigate 
amplitude-envelope correlation as a marker of connection strength between 
brain regions and across frequency bands. These analyses showed that reductions 
in connectivity strength were most prominent in posterior brain regions, 
particularly the occipital lobe (visual cortex). In Chapters 5 and 6, investigations 
were focused on the visual system. Visual stimuli have previously been shown to 
induce strong gamma responses in healthy controls and are highly repeatable 
within participants (Muthukumaraswamy et al., 2010). The responses are also 
highly heritable suggesting that they are influenced by genetic factors (van Pelt, 
Boomsma and Fries, 2012). Abnormal visual gamma oscillations have also been 
reported in neurodevelopmental disorders and have been associated with clinical 
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symptoms (Spencer et al., 2008; Stroganova et al., 2015). As described above and 
in Chapter 5, atypical visually-induced gamma oscillations were found in children 
with 22q11.2DS which were associated with cognitive and social communication 
difficulties.  
 
GABA-MRS studies have shown that GABA estimation from an occipital voxel is 
robust, reproducible and stable over time (Near et al., 2014; Greenhouse et al., 
2016; Bai et al., 2017). There have been no published MRS studies of GABA 
concentrations in 22q11.2DS however, studies of occipital GABA in patient 
samples e.g. schizophrenia (Yoon et al., 2010) have reported large GABA 
reductions of up to 10% using an identical sample size to that presented in 
Chapter 6. The lack of between-group differences in GABA concentrations 
reported in Chapter 6 suggests that either the effect size is too small to be 
detected in sample of this size at 3T in 22q11.2DS or that total GABA 
concentrations in the occipital lobe are not affected by 22q11.2DS. However as 
discussed previously, measuring GABA concentrations with MRS presents a 
number of challenges and may not reflect synaptic or dynamic GABA 
concentrations. In a previous MRS study of 22q11.2DS investigating Glx 
concentrations, there were no differences between people with 22q11.2DS and 
controls; group differences were only found between participants with 22q11.2DS 
and schizophrenia and those without schizophrenia. The findings from this study 
and that of Yoon et al., suggest that neurotransmitter concentrations may be only 
be altered in people with established schizophrenia, although whether this is a 
causal relationship or secondary to the effects of chronic psychosis or 
antipsychotic use remains unclear. In order to further investigate the relationship 
between psychosis onset and GABA/Glx concentrations in 22q11.2DS, 
longitudinal studies will be required which are of sufficient size and have 
adequate follow-up periods to identify antipsychotic naïve people who develop 
psychosis and compare them to those who do not.  
 
Taken together, the evidence presented in this thesis suggests abnormal cortical 
circuitry in the visual cortex in people with 22q11.2DS. This is interesting as visual 
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processing abnormalities are well-established in schizophrenia and ASD 
(Vandenbroucke et al., 2008; Baruth et al., 2010; Silverstein et al., 2015), disorders 
for which 22q11.2DS confers high-risk (Murphy, Jones and Owen, 1999; Niarchou 
et al., 2014; Schneider et al., 2014; Ousley et al., 2017). While people with 
22q11.2DS have known difficulties with visuospatial processing (Bearden et al., 
2001; Simon, Bearden, et al., 2005; Magnée et al., 2011; McCabe et al., 2016) and 
atypical visual networks have been found in fMRI and EEG studies of 22q11.2DS 
(Andersson et al., 2008; Debbané et al., 2012; Biria et al., 2018), there has been 
little research into the mechanisms underlying these deficits. The findings 
presented in this thesis imply that these abnormalities may reflect aberrant top-
down modulation of visual responses as a result of excitatory-inhibitory 
imbalance. 
 
7.2.3 Feasibility of brain imaging research in children at high-risk of 
neurodevelopmental disorders 
A final and important implication of the research presented in this thesis concerns 
the feasibility of conducting research in children with genetic syndromes 
associated with cognitive impairment and psychopathology. I recruited children 
and their families over a five year period and encountered several barriers that 
affected families’ ability to participate in brain imaging research. These ranged 
from practical issues, such as needing to time data collection to coincide with 
school holidays, to medical and safety considerations such as a history of surgery 
involving metal implants, the presence of orthodontic braces, claustrophobia, 
sensory difficulties, attentional problems and anxiety. Despite these issues, there 
was great willingness among families of children affected by CNVs to engage in 
research perhaps because of a desire to learn more about the syndrome and to 
help other families affected by it.  
 
I selected imaging modalities and experimental tasks that were not only relevant 
to the research questions but which were acceptable to children and their 
families. Data were collected during two separate sessions (MEG and MRI) and a 
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lot of time was spent explaining the data collection process to children and their 
parents/caerers before commencing recording or scanning. In addition, prior to 
the MRI session, time was dedicated to familiarisation with the MRI environment 
in a dedicated ‘mock’ scanner which was invaluable in relieving anxiety and 
optimising scanning time. A flexible approach was taken during data collection 
sessions to make the environment as relaxed and comfortable as possible, 
allowing plenty of time for breaks between recordings or scan sequences. During 
the MRI session, children were encouraged to watch a movie in the scanner as a 
distraction in order to improve their experience and minimise head motion. In the 
MEG session, I selected tasks that were simple to perform and short in duration 
to maximise the quality of data collected.  
 
As discussed in Chapters 3-6, more children were able to take part in the MEG 
than the MRI experiments as MRI contraindications were common but did not 
preclude participation in the MEG session. While it is preferable to co-register 
MEG data to each individual’s anatomical MRI, excluding children with MRI 
contraindications would have substantially reduced the sample size recruited for 
the MEG experiments. I therefore developed an alternative strategy in which MEG 
data from children who were unable to participate in the MRI session or whose 
MRI data were not of adequate quality were co-registered to another 
participant’s MRI which closely matched the size and shape of the index 
participant. Inspection of the resulting head models suggested that this strategy 
worked well and meant that a much larger and more representative sample of 
children were able to participate than would have been possible if everyone with 
MRI contraindications was excluded from the MEG study. 
 
As described in Chapters 3-6, different numbers of children completed each of the 
experiments and the quantity of good quality data varied considerably between 
these. In the MEG, children found the resting-state MEG recording easy to 
complete and the proportion of data that survived quality control was high. 
Children found the visual task more challenging as the paradigm was longer and 
required active participation in the form of a button press. This resulted in more 
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artefacts from head motion, eye movement and muscle contraction, with the 
result that less good quality data were available for analysis. In the MRI, structural 
data collection took 5 minutes to complete and this was achievable for the 
majority of participants. GABA MRS data collection was only undertaken until the 
upgrade of CUBRIC facilities in 2016. The scan sequence was longer at ten minutes 
but was able to be completed by the majority of children, providing good quality 
data. The low numbers of participating children for the MRS experiment therefore 
reflects the high rates of MRI contraindications in this sample and the early 
termination of data collection due to a change in MRI scanning facilities, rather 
than issues related to the ability of participants to complete the scans or data 
quality. 
 
Overall, families affected by CNVs were keen to participate in brain imaging 
research. Careful selection of tasks and scan sequences as well as taking a flexible 
approach to data collection can improve the quantity and quality of data 
collected. Furthermore, alternative approaches for co-registration of MEG data 
can help to maximise sample sizes in patient groups in which MRI 
contraindications are prevalent. 
 
7.3 Strengths and limitations 
 
7.3.1 Participant ascertainment and sample size 
22q11.2DS is a rare disorder affecting approximately 1 in 4000 live births (Botto 
et al., 2003; Oskarsdottir, 2004). In addition to high rates of psychopathology and 
cognitive impairment, it is associated with a variety of physical health problems 
including global developmental delay, congenital cardiac abnormalities, cleft 
palate, renal insufficiency, immune deficiencies and musculoskeletal problems 
such as scoliosis (McDonald-McGinn et al., 2015). As the majority of cases occur 
de novo and 22q11.2DS is not routinely screened for in the UK, most children are 
diagnosed by virtue of having one (or more likely several) of the features of 
22q11.2DS. Therefore, although I did not select the proband sample according to 
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any particular phenotype (psychiatric or otherwise), the fact that participants had 
received a diagnosis in childhood may have biased the sample towards a more 
severe phenotype. The data presented in Chapter 3 suggest that the sample of 
children who took part in these investigations did indeed have a high burden of 
psychopathology. However, only one was prescribed psychotropic medication 
and few were known to mental health services or had a clinical diagnosis of a 
psychiatric illness. This suggests that these children were not referred for genetic 
testing due to psychiatric problems, but for other reasons such as cardiac 
malformations, cleft palate or developmental delay. The cognitive ability and 
psychiatric morbidity of children in brain imaging were similar to children who did 
not take part in brain imaging suggesting that the sample recruited to the 
investigations presented in this thesis is representative of the whole ECHO cohort.  
 
While 22q11.2DS is not part of current antenatal screening programmes in the 
UK, the recent introduction of cell-free DNA antenatal screening tests means that 
non-invasive antenatal testing for 22q11.2DS is now possible (Ravi et al., 2018). 
Recently, there has also been a call for the introduction of early postnatal 
screening by heel-prick test (https://hansard.parliament.uk/commons/2018-06-
05/debates/18060550000001/DigeorgeSyndrome(ReviewAndNationalHealthSer
viceDuty)). Introduction of such screening tests would likely increase the reported 
prevalence of 22q11.2DS and have many important implications for research, 
increasing the pool of potential participants and facilitating less biased sampling. 
It would also facilitate the collection of longitudinal data from birth or early 
infancy which could yield very important insights into brain development in 
22q11.2DS. 
 
Recruitment for the investigations presented in this thesis was limited to children 
taking part in the ECHO study who were aged between 10 and 17 years old in 
order to balance the need for an adequate sample size with the desire for a 
narrow age range in order to reduce the confounding effects of brain 
development on the data collected. The age range selected was also based on the 
anticipated ability of children to participate in the imaging sessions. During pilot 
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work, I found that children younger than 10 years old found it much more difficult 
than older children to remain still during data collection and to attend to the 
stimuli, therefore a lower age limit of 10 years was selected. From this reduced 
pool of potential participants, screening was performed to identify 
contraindications to MEG and MRI. Due to the frequency of surgical and 
orthodontic implants in the sample, the pool of potential imaging participants was 
further narrowed to the sample of 39 who were ultimately recruited. While 
modest, this sample size is comparable to much of the published imaging 
literature in 22q11.2DS, with the exception of recent large collaborative efforts to 
which I contributed data (Sun et al., 2018). 
 
I selected the control sample from a cohort of siblings of children with 
neurodevelopmental CNVs who were also taking part in the ECHO study at Cardiff 
University. This control sample was chosen for a number of reasons: firstly, 
siblings of children with neurodevelopmental CNVs have been exposed to a 
similar home environment as CNV carriers. Although this does not eliminate the 
potential confounding effects of environmental influences on brain structure, it 
does, however, reduce between-group differences, for example in socioeconomic 
status. Secondly, genotypic data was being collected on siblings as part of the 
wider ECHO study which meant that, in most cases, it was possible to confirm the 
CNV status of controls prior to their recruitment into the imaging study. Finally, 
many families travelled long distances to take part in the brain imaging research 
and typically they would travel to Cardiff with the whole family for several days. 
This meant that siblings were potentially available to take part in the research 
without families needing to take additional time off work and school to 
participate. When possible I tried to recruit sibling pairs, however for many 
families there was no sibling who met the age criteria. Conversely, some siblings 
took part in the absence of a participating proband, for example, when the 
proband did not fit the age criteria or had contraindications to brain imaging. Due 
to the presence of unmatched sibling pairs, it was not possible to perform 
pairwise data analysis. In total, I recruited 22 siblings who were related to a child 
with 22q11.2DS. To increase the sibling sample, I also recruited 4 children who 
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were taking part in ECHO and who were siblings of children with other 
neurodevelopmental CNVs. In the future, it would be interesting to compare 
probands to siblings in a pairwise fashion.   
 
7.3.2 Imaging and analysis methods used 
EEG and MEG are complementary methods that are commonly used to 
investigate neural oscillations with advantages and disadvantages to each 
approach. EEG systems are less costly than MEG systems and, unlike MEG, they 
are unaffected by magnetic fields in the environment and therefore don’t need to 
be used in a shielded environment. Many EEG systems are portable so 
experiments can be conducted in participants’ homes. However, EEG preparation 
time is much longer and involves participants wearing a tightly-fitting cap and 
having gel applied to the scalp. This raises potential issues for children with 
sensory difficulties. EEG measures signals that arise directly from the electrical 
potential generated from neuronal currents. These signals have contributions 
from tangential and radial currents whereas in MEG, only the tangential 
component contributes to the signal. However, unlike EEG, MEG is not affected 
by conductance differences and therefore source reconstruction is easier to 
perform, enabling cortical sources of generated signals to be identified, a factor 
that was important in the investigations presented in this thesis. 
 
While there are many metrics that could be used to estimate MEG resting-state 
connectivity, amplitude-envelope coupling is one of the most robust and 
repeatable and was therefore selected for the investigations presented in Chapter 
5. It would be interesting however, to compare alternative approaches and 
explore cross-frequency coupling. A five-minute eyes-open resting-state 
paradigm was used in Chapter 4. Longer resting-state recordings have been found 
to improve the reproducibility of MEG connectivity estimates, however these 
potential benefits have to be balanced with the ability of participants to remain 
still for longer periods of time (Liuzzi et al., 2017). Eyes-closed resting-state 
paradigms are associated with strong alpha power increases but can induce 
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drowsiness and result in participants falling asleep during recordings (Tagliazucchi 
and Laufs, 2015). Keeping one’s eyes closed for five minutes in an unfamiliar 
environment would also be daunting for many children. For these reasons,  an 
eyes-open paradigm was used. One of the major concerns in the interpretation of 
resting-state MEG/EEG data is the potential for spurious correlations or noise to 
affect the observed results. Several approaches were used to reduce the 
likelihood of spurious correlations or noise being interpreted as signal, including 
orthogonalisation of the source-level signals to reduce the effects of signal 
leakage between adjacent regions and Gaussian mixture modelling to classify 
connections as signal or noise. These approaches are conservative and may have 
led to false negatives but importantly they reduced the likelihood of false 
positives.  
 
To investigate gamma band responses between probands and controls, a simple 
visual stimulus which has previously been shown to produce strong evoked and 
induced responses in the occipital cortex was used (Muthukumaraswamy et al., 
2010). Despite selecting a task which was not cognitively demanding, many 
participants found it difficult to remain still for the ~ eight minutes required to 
complete the MEG recording and a large number of trials were contaminated by 
artefact, leading to exclusion of participants from the final analyses. Furthermore 
several children failed to generate peak gamma responses, further reducing the 
sample size for the between-group analyses. Significant reductions in the sum of 
gamma power and a non-significant trend towards a reduction in peak gamma 
amplitude and an increase in peak gamma frequency were found in the proband 
group. The lack of statistically significant group differences in peak gamma 
responses may reflect low statistical power in the limited sample who remained 
in the analyses after quality control. Future work in larger samples  will help to 
clarify whether peak gamma variables are altered in 22q11.2DS.  
 
The lack of observed GABA concentration differences between children with 
22q11.2DS and controls may also be due to type II error. This dataset was 
relatively small (13 participants in each group) and, as GABA concentrations show 
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high inter-individual variability (Muthukumaraswamy et al., 2010), this study may 
have lacked statistical power to detect significant differences between groups in 
the presence of small effect sizes. As with much of the existing literature on GABA 
MRS in clinical samples, the data for this thesis were collected at 3T which has 
lower sensitivity to detect GABA signals than higher field strengths (e.g. 7T), thus 
low signal to noise ratio at 3T may also have limited the ability to detect any group 
differences, if present. A MEGA-PRESS sequence was used to identify GABA peaks. 
While this approach was considered to be gold-standard at the time the study 
commenced, subsequent work has shown that a substantial component of the 
signal detected using MEGA-PRESS sequences at 3T is due to macromolecules 
(Mikkelsen et al., 2016). It is possible that differences in macromolecule 
concentrations between groups could mask differences in GABA+ concentrations. 
Future research using macromolecule suppression may help to elucidate this.  
 
A potential problem in interpreting between-group differences in neuroimaging 
studies is the possibility that data quality varies between study groups (e.g. due 
to higher levels of motion or other artefacts in patients than controls). In the 
investigations presented in this thesis, rigorous data cleaning and quality control 
procedures were used, after which there were no significant between-group 
differences in either the number of good trials or markers of head motion in the 
MEG experiments, or in MRS data quality (e.g. fit error), suggesting that overall 
the significant findings are not due to lower data quality in the proband group.  
 
7.3.3 Phenotyping 
Participants underwent rigorous phenotyping either at the time of imaging data 
collection or at another time in the participant’s home or by telephone. Although 
every effort was made to complete data collection in a timely fashion, some 
phenotypic data were nevertheless missing at the time of analysis. This is 
particularly relevant for ADI-R data which were only available for 26 probands and 
no controls. SCQ data were available for a larger number of participants (both 
probands and controls), however comparison between SCQ and ADI-R data 
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suggested that although these measures are both reported to index social 
communication problems, they did not correlate well with one another in this 
sample.  
 
While 22q11.2DS increases the risk of childhood-onset disorders like ASD and 
ADHD, it is also one of the strongest risk factors for schizophrenia, being 
associated with a 25-30 fold increase in risk compared to the background 
population. While data about the presence of psychotic symptoms were 
collected, these symptoms occurred at too low a rate in this sample to be included 
in the regression analyses (present in only 16.2% of probands and none met 
criteria for a DSM-IV psychotic disorder). One would anticipate that in time, as 
probands enter their late teens and early twenties, these rates will increase. 
Longitudinal follow-up of these children may help to identify cortical circuit 
abnormalities associated with psychotic symptoms and potentially the 
presymptomatic neural correlates of psychosis risk. 
 
7.4 Future research directions 
7.4.1 Larger samples and collaborations  
The data presented in this thesis provide interesting insights into neural circuit 
abnormalities in 22q11.2DS and warrant replication in a larger sample and in a 
wider age range. There are increasing efforts to combine brain imaging data 
across different sites internationally to improve the statistical power to 
interrogate data with a range of questions that could not previously have been 
addressed in small independent studies For example, through the work of 
ENIGMA 22q11.2DS (www.enigma.ini.usc.edu/ongoing/enigma-22q-working-
group), it has been possible to examine detailed brain structure in 22q11.2DS and 
to investigate the effects of factors such as deletion size (Sun et al., 2018). Such 
efforts require standardisation of data collection and analysis strategies. While 
some positive strides have been made in structural MRI collaboration, the same 
cannot be said of MEG or indeed MRS collaborations. This is therefore an 
important area for future development. 
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7.4.2 Longitudinal studies 
In order to better understand the biological mechanisms underlying risk of 
neurodevelopmental and psychiatric disorders, longitudinal studies are needed. 
While there are several relatively large longitudinal studies of the 22q11.2DS 
phenotype ( Vorstman et al., 2015; Kates et al., 2015; Chawner et al., 2017, 2019; 
Tang and Gur, 2018), there are few large longitudinal imaging cohorts 
(Ramanathan et al., 2017). Collecting MRI and MEG/EEG data from children at a 
young age (before the onset of symptoms) and following them up into adulthood 
would yield remarkable insights into brain development in 22q11.2DS and its 
relationship with psychopathology and cognitive impairment. These studies 
would have the potential to identify early signatures of risk and may therefore 
have important clinical implications such as providing diagnostic and prognostic 
information for clinicians and families. In addition, recognition of brain 
abnormalities associated with increased risk may help to identify novel 
therapeutic targets which have long been needed in psychiatry. 
 
7.4.3 Other genetic syndromes 
As our knowledge of genetic risk factors for psychopathology expands, so do the 
opportunities for research into the brain mechanisms underlying risk. Syndromes 
such as 22q11.2DS, Fragile X, Down’s syndrome and Rett syndrome have perhaps 
received most research interest to date. However, a large number of copy number 
variants associated with psychiatric and cognitive risk have now been identified 
(Doherty and Owen, 2014) and little is known about their neural substrates. Cross-
CNV work has the potential to identify common mechanisms and pathways by 
which these CNVs may act and could provide important insights into neurobiology 
that are relevant to idiopathic mental health problems. 
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7.4.4 Translational research 
One of the most exciting developments in recent years has been the ability to 
model genetic syndromes in cellular and animal models. Cells can be taken from 
patients with 22q11.2DS (e.g. via hair or skin samples) and transformed into 
induced pluripotent stem cells (iPSCs). Neuronal cells can then be generated from 
iPSCs and their properties investigated. These techniques have the potential to 
advance our understanding of the effects of 22q11.2DS on excitatory and 
inhibitory neurons in vitro. Beyond cellular models, animal models of 22q11.2DS 
can advance our understanding of the effects of the deletion on brain circuits in 
vivo (Sigurdsson et al., 2010). For example, oscillatory dynamics can be examined 
in model systems and be compared to studies of neural oscillations in humans 
using MEG/EEG both at rest and during specific task conditions. In addition, 
structural brain imaging can be used in animals to validate histologically the 
structural imaging findings from human studies.  
 
7.4.5 New technologies 
Since data collection for this study commenced, there have been advances in 
brain imaging both in terms of the hardware available and the development of 
analysis techniques. CUBRIC now has a 7T MRI scanner and a 3T Connectom 
scanner in addition to conventional 3T facilities. Higher field and gradient 
strengths can improve signal to noise ratios and provide more precise 
measurements than previously thought possible (van der Kolk et al., 2013; Huang 
et al., 2015; Fan et al., 2016). Novel analysis techniques can minimise the effects 
of head motion thus improving data quality in samples where head motion is 
particularly problematic (Federau and Gallichan, 2016). Furthermore, new MEG 
systems are being developed that do not require a shielded room and that are 
wearable so potentially less affected by participant head motion (Boto et al., 
2016). This would have obvious advantages in the study of children and young 
people with developmental disorders. 
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7.5 Conclusions 
Children with 22q11.2DS have high rates of cognitive impairment and 
psychopathology. Abnormalities in excitatory-inhibitory balance have been 
reported across the spectrum of neurodevelopmental and psychiatric disorders 
but have not previously been explored in detail in children with 22q11.2DS.  In 
this thesis, there was evidence for excitatory-inhibitory imbalance in children with 
22q11.2DS as indexed by atypical resting state and visually-induced gamma 
oscillatory patterns which were associated with some of the cognitive and 
psychiatric difficulties experienced by affected children. There were no 
corresponding abnormalities in the concentration of the major inhibitory 
neurotransmitter GABA as measured by MRS at 3T. The findings from this thesis 
merit replication in a larger sample size across the age spectrum to compare 
markers of excitatory-inhibitory balance across different stages of development. 
In the future, longitudinal studies using advanced imaging techniques will help to 
elucidate the relationship between excitatory-inhibitory balance and the onset of 
psychiatric symptoms such as psychosis. Furthermore, cross-CNV work may 
identify brain mechanisms common to high-risk groups which may identify 
important therapeutic targets which are not only relevant to people with 
neurodevelopmental CNVs but also people with idiopathic mental illness.
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